Characterization of Metalloproteins and Biomaterials by X-ray Absorption Spectroscopy and X-ray Diffraction by Frankær, Christian Grundahl
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
General rights 
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners 
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
• You may not further distribute the material or use it for any profit-making activity or commercial gain 
• You may freely distribute the URL identifying the publication in the public portal  
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
   
 
Downloaded from orbit.dtu.dk on: Dec 20, 2017
Characterization of Metalloproteins and Biomaterials by X-ray Absorption
Spectroscopy and X-ray Diffraction
Frankær, Christian Grundahl; Ståhl, Kenny; Harris, Pernille
Publication date:
2012
Document Version
Publisher's PDF, also known as Version of record
Link back to DTU Orbit
Citation (APA):
Frankær, C. G., Ståhl, K., & Harris, P. (2012). Characterization of Metalloproteins and Biomaterials by X-ray
Absorption Spectroscopy and X-ray Diffraction. Kgs.Lyngby: DTU Chemistry.
Characterization of Metalloproteins 
and Biomaterials by X-ray Absorption 
Spectroscopy and X-ray Diffraction
Christian Grundahl Frankær
PhD Thesis
Department of Chemistry
Technical University of Denmark
2012

Characterization of Metalloproteins
and Biomaterials by X-ray Absorption
Spectroscopy and X-ray Diffraction
PhD Thesis
Christian Grundahl Frankær
Physical Chemistry Group
Department of Chemistry
Technical University of Denmark
March 2012

Preface and acknowledgements
The present dissertation is submitted to the Technical University of Denmark and partially
fulfils the requirements for the PhD degree. The work has been carried out at the Depart-
ment of Chemistry in the Physical Chemistry Group with Associate Professor Kenny Ståhl
as main supervisor and Associate Professor Pernille Harris as co-supervisor. The PhD
scholarship was funded by the Technical University of Denmark.
First and foremost, I would like to thank my supervisors Kenny Ståhl and Pernille
Harris for their help and guidance throughout the project and for always being available
for questions and inspiring scientific discussions. I shall also thank them for their company
and encouragement, particularly during the long days and nights without sleep at our
synchrotron trips, struggling at the beam line.
I shall thank Astrid Schøneberg and Lise Lotte Berring for practical assistance, when it
was needed the most. Special thanks to Astrid Schøneberg for assistance, persistence and
patience with searching and mounting useful crystals of strontium ranelate among tiny
fragments. I will miss the pleasant atmosphere in the X-ray Group, which is now a part
of the Physical Chemistry Group, at Department of Chemistry and particularly our Friday
morning breakfasts.
I owe a special thank to Marianne Vad Knudsen for optimizing the crystal growth of
different insulin conformations during her BSc project. I would also like to thank Associate
Professor Irene Shim for helping me with ab initio Hartree-Fock calculations on copper
clusters. I thank Professor Annette Henriksen at Carlsberg Laboratories for testing powder
diffraction from proteins on an in-house micro-source X-ray diffractometer.
I highly acknowledge employees at MAX-lab for helpful support and special thank to
Katarina Norén for introducing me to the data treatment and analysis of X-ray absorption
spectroscopy data and Thomas Ursby for estimation of radiation damage. I also acknow-
ledge Danscatt for funding ofmy synchrotron trips. I would like to thank Elena Nazarenko
i
ii
fromUniversity of Gothenburg for introducingme to quantitative interpretation of XANES
spectra, which was a completely new topic to me. The acquaintance has resulted in a fruit-
ful collaboration. I had the opportunity to attend the HERCULES course in Grenoble,
which provided me with unsurpassed knowledge and new acquaintances for which I am
very grateful.
From the Analytical Chemistry Group I would like to thank Associate Professor Jens E.
T. Andersen for placing the bone samples for my disposal and PhD Anders C. Raffalt for
performing the quantitative analyses and for a constructive collaboration. I also acknow-
ledge Stephan Christgau and Osteorologix A/S for providing the bone samples.
I would like to thank Monika N. Løvgreen for cheerful company and fruitful scientific
discussions during almost three years in the same office. Finally, I would like to thank my
friends and family for their support and I dedicate my special thanks to my loving wife
Sarah Maria and my daughter Elisabeth for their patience and love.
Kgs. Lyngby, March 17th 2012
Christian Grundahl Frankær
Abstract
This thesis presents thework on combining complementary X-rays techniques for studying
the structures of proteins and other biomaterials, and consists of three different projects:
(i) Characterization of protein powders with X-ray powder diffraction (XRPD). (ii) The
combination of X-ray crystallography and X-ray absorption spectroscopy (XAS) applied to
studying different hexameric insulin conformations. (iii) The structures of polymorphs of
strontium ranelate and the distribution of strontium in bone tissue.
A procedure for fast identification and verification of protein powders using XRPD
was developed and tested on micro-crystals of lysozyme and insulin. Different protein
crystal forms were identified by comparing experimental powder diffraction patterns with
patterns calculated from PDB coordinates. The key factor to bring the calculated patterns
in agreement with the observed patterns was correction for disordered bulk-solvent, but
also correction for background and optimization of unit cell parameters have to be taken
into account. A sample holder was designed for collecting powder diffraction data on a
standard laboratory X-ray powder diffractometer. The background was reduced by use
of pinholes integrated in the sample holder design, and crystal forms of well diffracting
protein powders were safely identified from only 7 µl of sample. The sample holder was
furthermore adaptable for XAS experiments.
The crystal structures of three conformations of hexameric bovine zinc insulin (T6, T3R3
and R6) were solved by single crystal X-ray diffraction (XRD) to 1.40 Å, 1.30 Å and 1.80 Å
resolution, respectively. The zinc coordination in each conformation was studied by XAS
including both extended X-ray absorption fine structure (EXAFS) spectroscopy and X-ray
absorption near edge structure (XANES) spectroscopy. High quality XAS spectra were
collected at the Zn K-edge on insulin micro-crystals with EXAFS signal up to 14 Å−1 in
k-space. Regarding the hexamer as a dimer of trimers where each trimer contains a Zn2+
ion, zinc adopted tetrahedral coordination in all R3-trimers, and octahedral coordination
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in T3-trimers. The coordination distances to zinc were refined from EXAFS with standard
deviations below 0.01 Å for the first coordination sphere. In contrast to the distances de-
termined from the medium resolution crystal structures, the XAS results were in good
agreement with distances found in small molecules with similar coordination geometries,
as well as in other high resolution insulin structures. As the radiation doses for the XRD
experiments were significantly higher compared to that of XAS experiments, the single
crystals were exposed to a higher degree of radiation damage affecting the zinc coordi-
nation in the T3-sites, in particular. Furthermore, XANES spectra for the zinc sites in T6
and R6 insulin were successfully calculated using finite difference methods, and the bond
distances and angles were optimized from a quantitative XANES analysis.
T6 insulin was furthermore crystallized with iron, nickel and copper, and their XRD
crystal structures were solved to 1.90 Å, 1.50 Å and 1.45 Å resolution, respectively. As
the affinity to iron is low, iron insulin crystals were grown in presence of small amounts
of zinc. The two metal sites in the XRD structure thus contained respectively one Fe2+
and one Zn2+ ion, with respectively tetrahedral and octahedral coordination geometry.
The metal sites in nickel and copper insulin were studied by XAS. Coordination distances
were refined from EXAFS showing a very regular octahedral coordination of Ni2+, which
was further verified by calculated XANES spectra. The coordination geometry of cop-
per was, however, ambiguously determined in the XRD structure of copper insulin. The
XANES spectrum revealed the presence of copper in oxidation state +I, which was caused
by photoreduction of Cu2+ during the XAS experiments. Photoreductionwas not observed
for nickel and zinc insulin. EXAFS analysis showed a tetrahedral coordination of copper,
which was further supported by ab initio Hartree-Fock calculations, as well as calculated
XANES spectra.
Strontium ranelate, a pharmaceutical used in the treatment of osteoporosis, was syn-
thesized and crystallized and the crystal structure of the nonahydrate was solved. The
crystals were highly sensitive to humidity and temperature and easily deteriorate upon de-
hydration. Four other hydrates were observed by in situ XRPD upon dehydration. These
were identified as heptahydrate, pentahydrate, trihydrate and dihydrate by estimation of
the water content by thermogravimetric analysis.
Bone tissue from dogs treated with strontiummalonate was studied using XAS. A new
approach for analysing the X-ray absorption spectra resulted in a compositional model,
from which the relative distribution of strontium in the different bone composites was es-
timated. Approximately 35–45 % of the strontium present was incorporated into calcium
hydroxyapatite by substitution of some of the calcium ions, and at least 30 % was located
at sites with a high structural disorder similar to Sr2+ in solution. The remaining stron-
tium was absorbed in collagen. The relative distribution of strontium among the different
composites seemed to be independent of treatment period and dose level.
Dansk resumé
Nærværende ph.d.-afhandling omfatter arbejdet med at kombinere komplementære rønt-
genmetoder til at undersøge strukturen af proteiner og biomaterialer og indeholder tre
forskellige projekter: (i) Karakterisering af proteinpulvre med røntgenpulverdiffraktion
(XRPD). (ii) Kombinationen af røntgenkrystallografi og røntgenabsorptionsspektroskopi
(XAS) anvendt på et studium af forskellige konformationer af insulinhexamere. (iii) Struk-
turerne af strontiumranelat polymorfer samt fordelingen af strontium i knoglevæv.
En procedure blev udviklet til hurtigt at kunne identificere og verificere proteinpul-
vre med XRPD, og blev afprøvet på mikrokrystaller af lysozym og insulin. Forskellige
proteinkrystalformer blev identificeret ved at sammenligne eksperimentelt opnåede pul-
verdiffraktogrammer med diffraktogrammer beregnet ud fra PDB-koordinater. Korrektion
for uordnet solvent blev identificeret som den vigtigste faktor til at opnå god overensstem-
melse mellem beregnede og eksperimentelle diffraktogrammer, men også baggrundskor-
rektion samt optimering af enhedcelleparametre anses for vigtige. En prøveholder blev de-
signet til opsamling af pulverdiffraktionsdata på standard pulverdiffraktometre. Pinholes
integreret i prøveholderdesignet bevirkede reduktion af baggrunden, og krystalformer af
veldiffrakterende proteinpulvre blev identificeret fra blot 7 µl prøve. Prøveholderen var
designet til også at kunne anvendes til XAS-målinger.
Krystalstrukturerne af tre konformationer af bovin insulinhexameremed zink (T6, T3R3
og R6) blev løst med røntgendiffraktion (XRD) fra énkrystaller til opløsninger på hhv.
1.40 Å, 1.30 Å og 1.80 Å. Koordinationen af zink i de enkelte konformationer blev under-
søgtmed XAS, hvilket både inkluderede EXAFS (extendedX-ray absorption fine structure)
og XANES (X-ray absorption near edge structure). XAS-spektre blev målt på ZnK-kanten
på insulinmikrokrystaller med EXAFS-signal ud til k = 14Å−1. Ved at betragte hexameren
som en dimer af trimere, hvor hver trimer indeholder en Zn2+-ion, antog zink tetraedrisk
koordinationsgeometri i alle R3-trimere, og oktaedrisk koordination i T3-trimerene. Koor-
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dinationsafstande til zink blev forfinet vha. EXAFS med standardafvigelser under 0.01 Å
for den inderste koordinationssfære. I modsætning til de zinkafstande, der forekommer
i krystalstrukturerne til middel opløsning, stemte XAS resultaterne bedre overens med
zinkafstande observeret blandt småmolekylstrukturermed lignende koordinationsgeome-
trier, såvel som blandt andre insulinstrukturer til høj opløsning. Eftersom strålingsdoserne
for XRD-forsøgene var signifikant højere i forhold til doserne for XAS-forsøgene, var én-
krystallerne udsatte for større strålingsskade, hvilket påvirkede særligt koordinationen af
zink i T3-trimerene. Endvidere blev XANES-spektre af zinkcentrene i T6 og R6 insulin
beregnet vha. FDM (finite difference methods), og bindingsafstande samt -vinkler blev
optimeret vha. en kvantitativ analyse af XANES-spektrene.
T6 insulin blev endvidere krystalliseret med jern, nikkel og kobber, og deres krystal-
strukturer blev løst til opløsninger på hhv. 1.90 Å, 1.50 Å and 1.45 Å. Eftersom affiniteten
overfor jern er lav, blev jerninsulin krystalliseret under tilstedeværelse af små mængder
af zink. Dermed optog Fe2+ og Zn2+ hhv. hver af de to metalcentre i krystalstrukturen,
og med hhv. tetraedrisk og oktaedrisk koordinationsgeometri. Metalcentrene in nikkel-
og kobberinsulin blev undersøgt med XAS. Koordinationsafstande blev forfinet vha. EX-
AFS, som viste en meget regulær oktaedrisk koordination af Ni2+, hvilket yderligere blev
bekræftet vha. beregnede XANES-spektre. Kobbers koordinationsgeometri var flertydigt
bestemt i krystalstrukturen af kobberinsulin. XANES-spektret påviste tilstedeværelsen af
kobber i oxidationstrin +I, hvilket var forårsaget af en fotoreduktion af Cu2+ i løbet af XAS-
målingerne. Fotoreduktion blev ikke observeret for nikkel- og zinkinsulin. En efterføl-
gende EXAFS-analyse påviste tetraedrisk koordination af kobber, hvilket yderligere blev
bekræftet vha. ab initio Hartree-Fock beregninger samt beregnede XANES-spektre.
Strontium ranelat, som er et lægemiddel brugt til behandling af knogleskørhed, blev
syntetiseret og krystalliseret, hvorefter krystalstrukturen af nonahydratet blev løst. Krys-
tallerne var yderst følsomme overfor luftfugtighed og temperatur, og gik let i stykker un-
der dehydrering. Fire andre hydrater blev observeret under dehydreringen vha. in situ
XRPD. Disse hydrater blev identificeret som heptahydrat, pentahydrat, trihydrat samt di-
hydrat, ved at estimere vandindholdet ud fra en termogravimetrisk analyse.
Knoglevæv fra hunde behandlet med strontiummalonat blev undersøgt med XAS. En
ny måde at gribe dataanalysen af absorptionsspektrene an på, resulterede i en model,
hvor fra den relative fordeling af strontium i de forskellige knoglebestanddele kunne es-
timeres. Cirka 35–45 % af det tilstedeværende strontium var inkorporeret i calciumhy-
droxyapatit under udskiftning af nogle af calciumionerne med strontium, og mindst 30 %
optog uordnede sites som strukturelt ligner dem for Sr2+-ioner i vandig opløsning. Den
resterende mængde strontium var absorberet i kollagen. Den relative fordeling af stron-
tium i de forskellige knoglebestanddele forekom at være uafhængig af behandlingstid
samt dosis.
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Chapter 1
Introduction
This chapter gives an overview of different techniques used to study the structure of pro-
teins and biological matter, with emphasis on X-ray diffraction and X-ray absorption spec-
troscopy, which are the main techniques used in this work. A brief introduction to the
above mentioned X-ray techniques are given, focussing on the combination and synergy
between them, which is further described through selected examples of applications. Fi-
nally, an outline of the dissertation is presented.
1.1 Techniques used to study the structure of biological matter
Structures of proteins and biological soft materials are studied using many different tech-
niques. The more commonly used are summarized in Figure 1.1. The diversity among the
techniques is high and so are the types of structural information which can be obtained
from them. The appropriateness of each technique depends on the system, and many
techniques highly complement each other. One of the best examples of combining the
strengths of the different methods is the structure determination of the ribosome, which
awarded Ada E. Yonath, Venkatraman Ramakrishnan and Thomas A. Steinz the Nobel
Prize in Chemistry in 2009. Using a combination of high resolution methods to determine
the three-dimensional atomic structure of the subunits and low resolution techniques to
locate these subunits relative to each other resulted in a complete structure. A review on
the solution of the ribosome structure is presented by Moore (1998).
The three-dimensional structure of macromolecules is best determined by diffraction
techniques and nuclear magnetic resonance (NMR). A look in the protein data bank (PDB)
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Figure 1.1: Overview of the more commonly used techniques to provide structural information of
proteins and biomaterials.
reveals that 87.6 % of about 80,000 deposited structures are determined from X-ray diffrac-
tion (XRD), whereas NMR counts for 11.7 %. The importance of XRD and NMR structures
is primarily due to the high level of resolution provided by these techniques. XRD and
NMR are somewhat complementary, as NMR gives a picture of the protein in solution,
which better resembles its natural biological environment, in contrast to the ordered array
of molecules found in protein crystals. Another advantage of NMR is that no crystals are
needed. However, NMR is in practice only applicable for small proteins (< 30 kDa).
Similar resolution levels are obtained from neutron diffraction, which is complemen-
tary to X-rays as the scattering properties of neutrons and X-rays are different. Neutron ex-
periments are however time-consuming and expensive to perform and require very large
crystals, wherefore only about 50 neutron diffraction structures are found in PDB.
Lower resolution methods count small angle X-ray scattering (SAXS) and small an-
gle neutron scattering (SANS) in which the overall shape and size of the macromolecule
is determined. These techniques can be performed on dilute protein solutions and are
strong tools for studying assemblies and fibrils in combination with XRD structures of
the separate domains. Electron diffraction provides structural information of typically
20−3Å resolution from two-dimensional crystals, which may be the only obtainable crys-
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tals for membrane proteins. X-ray powder diffraction (XRPD) from micro crystals can be
obtained to resolutions of about 3 Å (von Dreele, 2005) and the structures can be refined
from Rietveld refinements, see Chapter 4 for further details. Microscopy covering cryo-
electron microscopy (cryo-EM), scanning tunnelling microscopy (STM) and atomic force
microscopy (AFM) is well-suited for studying larger proteins (≥ 100 kDa) and quarternary
structures of protein complexes, as the resolution typically is above 5 Å.
Spectroscopic methods generally provide information about the electronic structure.
Infrared (IR) and Raman spectroscopy probe the vibrations of the chemical bond and are
thereby used to fingerprint specific bond types. In proteins, α-helices and β-strands can be
distinguished and the distribution of secondary structure elements can be estimated from
these methods. Similar information are obtained from circular dichroism (CD), which is
used to classify the protein folding. As conjugated double bonds absorb electromagnetic
radiation in the ultraviolet (UV) and visible regions of the electromagnetic spectrum, UV-
vis spectroscopy provides information about aromatic residues (Tyr, Phe and Trp), and is
widely used for determination of protein concentration. Furthermore UV-vis is used to
obtain electronic information from metalloproteins as many d-d electron transitions have
energies in the visible region. Fluorescence spectroscopy is mostly used for imaging and
mapping. Distributions of proteins in cells and tissue is mapped by attachment of flu-
orophores to the peptides and the distribution of specific elements can be mapped with
X-ray fluorescence (XRF).
Structural information to very high resolution may be obtained by X-ray absorption
spectroscopy (XAS), which includes both extended X-ray absorption fine structure (EX-
AFS) and X-ray absorption near edge structure (XANES). XAS is element specific and
probes the three-dimensional structure within a radius of 5–6 Å around the specific ele-
ment, which makes the method well-suited for studying the local structure around the
metal centres in metalloproteins. Electron paramagnetic resonance (EPR) is another me-
thod providing information on metal sites, but only for paramagnetic ions, whereas XAS
is applicable for any metal.
1.2 Combination of XRD and XAS for metalloprotein studies
Metals play a central role in biological processes and over 30 % of the proteins known
are metalloproteins. To fully understand their role and the biological processes they are in-
volved in, it is important to know the three-dimensional structure, particularly in themetal
sites in which the reactions take place. Many of these reactions involves redox chemistry
where structural changes are very small (approx. 0.1 Å). Therefore it is important to obtain
high resolution structural information to study these subtle differences (Strange et al., 2005;
Strange & Feiters, 2008).
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X-ray diffraction and X-ray absorption spectroscopy belong to the techniques from
which three-dimensional structure can be determined at highest resolution. The entire
three-dimensional structure is obtained from XRD. However, only 2 % of the XRD struc-
tures in PDB are solved to resolution better than 1.2 Å, as crystals with high diffraction
power and high stability towards radiation damage and photoreduction during the data
collection are required (Ascone et al., 2005).
In contrast to XRD, XAS is applicable to metalloproteins only, and the structural infor-
mation is limited to a sphere of radius 5–6 Å around the absorbing metal atom. Hereby the
coordination of the metal (i.e. number and type of the neighbouring atoms) and the atomic
distances are determinedwith accuracies and precision comparable to those achieved from
small-molecule crystallography. XAS also provides information about the electronic struc-
ture of the absorbingmetal (i.e. oxidation state and spin state), and thereby offers a method
to characterize spectroscopically silent metals (Penner-Hahn, 2005). Another advantage of
XAS is that data can be collected on both aqueous and crystalline samples.
A major drawback of the method is that almost any model can be fitted to XAS data.
Therefore a priori knowledge about the system is highly required. A realistic startingmodel
may be provided from crystallography. Analysis of XAS data must be carefully performed
to avoid over determinacy in the refined models. Only parameters which significantly
contribute to the XAS signal must be included in the refinements.
Combination of medium resolution XRD and XAS may improve a structure to atomic
resolution accuracy in the metal centres as demonstrated by Hasnain & Hodgson (1999)
and Hasnain & Strange (2003). Likewise, XAS can be combined with NMR to determine
the metal coordination, which is not obtained from NMR (Banci et al., 2005). The output
from the XAS analysis can be directly used as geometrical restraints in the final refinement
of the entire protein structure from low and medium resolution XRD data. Simultaneous
collection of both XAS and XRD data provides an excellent opportunity to implement this
strategy, and is available at more beam lines, e.g. Proxima 1 at the SOLEIL synchrotron
radiation facility in France (Ascone et al., 2007).
1.3 Examples of applications of XRD and XAS
The majority of the XAS done on biological systems involves the 3d transition metals, since
they often constitute or are part of the active centre in metalloproteins, but metal centres
which have structural properties, as calcium, have also been studied. Since the develop-
ment of the modern XAS theory in the 1970’es, XAS has been found well suited for study-
ing the metal centres in metalloproteins (Sayers et al., 1975). A small selection of metal
centres studied by XAS is shown in Figure 1.2.
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Figure 1.2: Selected examples of metal centres in metalloproteins studied with X-ray absorption
spectroscopy. The figures are based on the PDB-coordinates stated. (a) The FeS4-cluster in rubre-
doxin, PDB-entry 5RXN (Watenpaugh et al., 1980). (b) The Fe-Mo cofactor MoFe7S9X, in nitroge-
nase, PDB-entry 2MIN (Einsle et al., 2002). (c) The haem-protein cytochrome c (PDB-entry 1HRC)
(Bushnell et al., 1990). (d) Binuclear Cu–Zn superoxide dismutase, PDB-entry 2C9V (Strange et al.,
2006). (e) Cu-nitrite reductase, PDB-entry 1OE1 (Ellis et al., 2003). (f ) Mn4Ca cluster in the oxygen-
evolving photosystem II, PDB-entry 3ARC (Umena et al., 2011). Carbon atoms are shown in black,
nitrogen in blue, oxygen in red, hydrogen in white, sulfur in yellow, calcium in light green, man-
ganese in purple, iron in brown, copper in dark blue, zinc in light blue and molybdenum in
turquoise.
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Rubredoxin was the first reported metalloprotein studied by EXAFS. Shulman et al.
(1975) studied the iron-sulfur cluster in rubredoxin, Figure 1.2(a), and showed that the
four Fe–S distances were equal in length in contrast to the XRD-structure available at that
time. Other more complex iron-sulfur clusters have been studied with XAS, for instance
the FeMo-cofactor (MoFe7S9X, where X is either C, N or O) in nitrogenase (Chen et al.,
1993; Corbett et al., 2005; George et al., 2008), see Figure 1.2(b). These XAS studies on the
FeK-edge and the MoK and L-edges highly complement the crystal structures, and have
provided supplementary electronic information about these clusters. Also haem-proteins
e.g. cytochrome c, Figure 1.2(c) have been studied with XAS (Cheng et al., 1999). The XAS
spectra of these porphyrin systems are highly influenced by multiple scattering (MS), see
Section 2.4.2. MS can be used to obtain information of not only the bond distances, but also
the angles between the ligands coordinated to the central iron atom. This is illustrated in a
recent study of different heam-complexes using both EXAFS and XANES data (D´Angelo
et al., 2008).
Superoxide dismutase (SOD) is a binuclear metalloprotein containing copper and zinc,
Figure 1.2(d). Oxidized and the reduced SOD have been studied by XAS performed on
both the Cu and ZnK-edges (Blackburn et al., 1984; Murphy et al., 1997), revealing a change
in coordination geometry around the copper ion upon reduction. This was not observed
in the first crystal structure of reduced SOD (Rypniewski et al., 1995), which illustrates
the difficulty in obtaining a particular oxidation state during XRD experiments. The XAS
studies thereby provides complementary information about oxidation state and detailed
coordination geometry.
Copper nitrite reductase (CuNiR) is another binuclear metalloprotein containing two
copper sites, respectively type I and type II copper, Figure 1.2(e). In general, proteins con-
taining more clusters with the same element, but with different coordination hereof, highly
increases the complexity of the XAS experiments. As XAS probes the average structure
around the absorbing metal, the XAS spectrum of CuNiR is an average of copper site I
and site II. To separate the different copper sites, Strange et al. (1999) recorded the EXAFS
spectrum of a type II depleted nitrite reductase (T2DNiR) containing less than 10 % type II
copper, whereafter the type I copper EXAFS spectrum was achieved from the difference
EXAFS between T2DNiR and CuNiR.
Following a reaction while it occurs is the ultimate goal to understand the function
of a protein and the biological system it is involved in. As the reactions may take place
within microseconds in situ XAS are challenging. Different methods to study biological
reactions by XAS are summarized by Haumann et al. (2005) and Westenhoff et al. (2010).
Freeze-quenching, in which the reaction is quenched at different stages, has been used to
slow down the reaction or trap intermediates, for instance in an XAS study of the ferritin
reaction between Fe2+ and O2 (Hwang et al., 2000). Rapid-scan XAS is another approach,
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in which the time resolution on the spectrometer is increased (Richwin et al., 2001). This is
required for the pump-and-probe experiments, where a reaction is initiated by photolysis,
as in a recent study of different intermediates of the Mn4Ca-cluster in the light sensitive
complex photosystem II (PSII), Figure 1.2(f ) (Haumann et al., 2005; Yano et al., 2006; Yano
& Yachandra, 2008).
1.4 Dissertation outline
The first part of this dissertation consists of two chapters introducing the theory and expe-
rimental principles behind XAS. Chapter 2 provides an introduction to the theory of X-ray
absorption spectroscopy, and defines the central terms used in XAS. The chapter covers ab-
sorption of X-rays and theory of EXAFS. Chapter 3 summarizes the most important issues
when designing XAS experiments and provides a brief introduction to the experimental
setup and acquisition of XAS data. The chapter is a supplement to the experimental de-
scriptions of XAS data collection procedures in the following chapters. The data treatment
and analysis procedures are described and different strategies used to analyse the XAS data
in this project are presented. Afterwards the results from the experimental work carried
out during this PhD study are presented. The work covers three areas:
I: Characterization of protein powder by XRPD
Chapter 4 summarizes the results from an XRPD study of protein powders. The focus is
on calculation of powder diffraction patterns where the contribution from the disordered
solvent are taken into account. The patterns are useful for identification and verification
of different crystal forms. The entire study is published in J. Appl. Cryst., (Paper I) and
Z. Kristallogr. Proc. (Paper II), which are included in Appendices A.1 and A.2, respectively.
Chapter 5 describes the experimental procedure by which protein XRPD-patterns can be
collected on in-house equipment at reasonable time scales. For this purpose different sam-
ple holders have been developed, which are described. A descriptive note of the final
sample holder design, which is also adaptable for XAS experiments, has been published in
J. Appl. Cryst., (Paper III) included in Appendix A.3.
II: XRD and XAS studies on hexameric insulin conformations
Chapter 6 contains an introduction to the structure of insulin with focus on the hexamer
conformations and their metal binding sites. Chapter 7 describes a study of three different
conformations (T6, T3R3 and R6) of hexameric zinc insulin from bovine pancreas. All three
structures are solved by single crystal XRD and the coordination of zinc in each of the con-
formers is studied by XAS, which include analysis of both EXAFS and XANES data. Based
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on this work, which illustrate the complementarity between XRD and XAS, a manuscript
has been prepared and submitted to Acta Cryst. D. Chapter 8 describes another XRD and
XAS study of T6 insulin hexamers containing iron, nickel and copper. Focus is particularly
on the metal coordination. A paper is currently in preparation.
III: Strontium for osteoporosis treatment and XAS studies on bones
Chapter 9 contains an introduction to bone physiology, osteoporosis and briefly summa-
rizes the mechanisms of renewal of bone tissue, which are involved in the uptake of stron-
tium in the bones. An overview of other XAS studies of bone and calcified tissue is further-
more presented. Chapter 10 presents the structure of polymorphs of strontium ranelate,
which is a medicament against osteoporosis. The content of water bound in the structure
is very dependent on temperature and relative humidity. The crystal structure of fully hy-
drated strontium ranelate is published in Acta Cryst. E, (Paper IV). A reprint is included
Appendix A.4. The other polymorphs, which occur upon dehydration, are studied by
XRPD and TGA. A manuscript has been prepared and will be submitted to Powder Diffrac-
tion. Chapter 11 describes an XAS-study of the localisation of strontium incorporated in
bone tissue on femur (thigh bones) and calvariae (skullcaps) from dogs treated with stron-
tium malonate. A linear combination of XAS spectra from reference samples are fitted
to the XAS spectra allowing estimation of the relative distribution of strontium in each
composite. Based on this work a manuscript has been prepared and will be submitted to
J. Bone Miner. Res.
Final conclusions about the techniques used as well as general conclusions are given in
Chapter 12. Furthermore, suggestions for future work are outlined.
Four appendices are included: Appendix A contains reprints of the scientific papers pub-
lished during this PhD study. Appendix B describe the structures of two insulin hexamers
crystallized with monovalent cations (rubidium and caesium). Appendix C describes the
EXAFS analysis on selected strontium salts used for reference compounds for the XAS
study of bone from dogs treated with strontium. Appendix D contains some initial results
from an EXAFS pre-study of strontium containing bone samples performed at room tem-
perature.
Throughout the thesis numerous figures are presenting structures and results. All protein
structures are created using PyMOL (DeLano, 2006), inorganic structures using ATOMS
(Shape Software, 2006) and all data curves are plotted using MATLAB (The Mathworks,
2008).
Chapter 2
Introduction to X-ray absorption
spectroscopy
Since the discovery of X-rays in 1895 by W. C. Röntgen (Röntgen, 1896), X-rays have been
used for obtaining information about the structure of matter. X-rays are high energy elec-
tromagnetic radiation with energies ranging from approximately 0.1 to 100 keV, with cor-
responding wavelengths between 100 and 0.1 Å. There are two fundamental physical phe-
nomena when the oscillating electric field of the X-rays interfere with matter: Photoelectric
absorption and scattering (inelastic and elastic). An introduction to X-ray absorption spec-
troscopy (XAS) is given in this chapter.
2.1 Historical background
X-ray absorption fine structure (XAFS) observed at energies above an absorption edge was
first discovered by Fricke (1920) and Hertz (1920). An early attempt to interpret the edge
region were done by Kossel (1920) and the first theories were suggested by Kronig (1931,
1932), but it took 40 years before the phenomenonwas correctly explained. The realization
that the fine structure could be used to obtain structural information led to the derivation
of the modern theory by Lytle, Stern and Sayers, (Sayers et al., 1971) in the beginning of the
1970’es. As synchrotron radiation sources have developed during the last 40 years, the XAS
theory has been further improved resulting in the curved-wave multiple scattering theory,
(Lee & Pendry, 1975; Ashley & Doniach, 1975; Gurman et al., 1984; Rehr & Albers, 1990),
which is implemented in modern XAS software. An in-depth review of the XAS theory
9
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and its development is produced by Rehr & Albers (2000). The principles of absorption
of X-rays and XAS are described in the following (Scott, 1985; Koningsberger et al., 1988;
Jalilehvand, 2000; Newville, 2004; Glatzel et al., 2011).
2.2 Absorption of X-rays in general
When X-rays pass through a sample of thickness x the intensity of transmitted photons,
I , is related to the incoming photon intensity, I0 by the inverse exponential power. This is
commonly referred to as the Beer-Lambert law:
I = I0 exp(−µ x) (2.1)
where µ is the X-ray linear absorption coefficient, and describes howmuch of the incoming
photon energy is absorbed by matter. µ depends on the energy of the incoming photons E
and the elemental composition of the sample.
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Figure 2.1: Electronic processes taking place during absorption of X-rays. (a) Excitation of core elec-
tron under ejection of photoelectron. (b) Fluorescence where the core hole is closed by an electron
in a neighbouring shell. (c) Emission of an Auger electron which is promoted to the continuum
from another core-level. Revised figure from Newville (2004).
During the absorption process the energy from the X-ray photons is transferred to the sam-
ple where it is used for excitation processes, under ejection of photoelectrons, Figure 2.1(a).
This photoexcitation is by far themost dominant mechanism for absorption of hard X-rays.
Any excess energy from the incoming radiation is given to the ejected photoelectron. The
energies required to eject deep core electrons from theK , LI, LII and LIII-shells to a contin-
uum fall in the X-ray regime and create corresponding core holes in the 1 s, 2 s, 2 p1/2 and
2 p3/2 orbitals, respectively. The atoms in excited states decays via competitive processes:
(i) Fluorescence, where an electron from a neighbour shell closes the core hole under emis-
sion of fluorescence, Figure 2.1(b). (ii) Secondary processes via the formation of Auger
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electrons, which are most distinct for lighter elements, Figure 2.1(c). For radiation in the
hard X-ray regime (E > 2 keV) fluorescence is the dominating decaying process. Fur-
thermore, scattering processes including both elastic (diffraction) and inelastic (Compton)
scattering also occur.
2.3 X-ray absorption spectroscopy
X-ray absorption spectroscopy constitutes the technique of measuring the variations of µ
as a function of energy, E, and the corresponding absorption spectrum is a plot of µ(E),
Figure 2.2(a). The energy at which a sharp increase in absorption is observed is referred
to as the absorption edge and corresponds to the energy required to eject a core electron
to the continuum, which increases with increasing atomic number, Z , for a given edge, Fi-
gure 2.2(b). This transition is associatedwith the absorption threshold and characterized by
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Figure 2.2: (a) Absorption coefficient µ as a function of the incoming photon energyE. The position
of the K-edge and the L-edges are indicated. Revised figure from Rehr & Albers (2000). (b)K and
LIII absorption edge energies as a function of atomic number, Z.
the energy E0, which theoretically indicates the energy available for photoelectric absorp-
tion via an open continuum channel. Experimentally,E0 is set as the energy corresponding
to the first inflection point of the first derivative below the edge. The exact determination
of E0 is however not possible because its position is influenced by the band-width of the
X-ray source, pre-edge structures and instrumental resolution. At energies above the ab-
sorption edge photoelectrons are ejected and the kinetic energies of these photoelectrons,
Ek, correspond to the excess energy Ek = E − E0.
Practically, the absorption coefficient µ(E) can be measured in two ways: (i) by trans-
mission, where the absorption is measured directly by measuring the number of photons
transmitted through the sample or (ii) by fluorescence, where the intensity of the emitted
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fluorescent X-rays, If , is measured, see Section 3.3. Since If is directly proportional to the
amount of absorbed X-rays in the sample, the fluorescence yield (If/I0) is proportional to
the absorption, µ.
The X-ray absorption fine structure (XAFS) is the modulation of µ at and above the
absorption edge. The XAFS spectrum can be divided into two different regions: X-ray ab-
sorption near edge structure (XANES) and extended X-ray absorption fine structure (EX-
AFS), Figure 2.3(a), which contain related, but slightly different information about the local
coordination and chemical state of an element.
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Figure 2.3: Fe K-edge X-ray absorption spectra of reduced horse heart cytochrome c, (Frankær,
2011). (a) Definition of the XANES and EXAFS regions. (b) Zoom of the regions close to the edge:
pre-edge, edge and near-edge. (c) Zoom of the pre-peak which occurs just below the edge.
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2.3.1 X-ray absorption near edge structure
The XANES includes the pre-edge, the edge region and the near-edge region from approx.
10 eV below E0 to 50 eV above, and contains informations about the local site symmetry,
charge state and orbital occupancy, Figure 2.3(b).
The pre-edge region is dominated by electronic transitions from the core levels to unoc-
cupied or partially occupied energy levels, and the spectral features are observed as small
so-called pre-peaks before the edge in the absorption spectrum, Figure 2.3(c). The energy
levels of the valence shells are determined by the geometric arrangement of atoms around
the absorbing atom. This means that the pre-edge region contains information about the
coordination geometry.
At the edge the energy matches the energy required for excitation of an electron to
the continuum, which is seen as an increase in absorption. The position of the edge de-
pends on the oxidation state of the absorbing atom and may be shifted by several eV per
unit change in oxidation state. On top of the absorption edge a so-called white-line is fre-
quently observed. The intensity of this sharp and intense peak depends on the electronic
structure and coordination geometry of the absorbing atom and originates from the fact
that the probability of absorption increases at the often closely spaced energy levels near
the continuum, mainly 2 p to n d transitions, (Koningsberger et al., 1988).
The near-edge region includes the energy range from a few eV to 50 eV above the
absorption edge. The term near edge X-ray absorption fine structure, (NEXAFS), is some-
times used to describe this region, but is most common for soft X-ray absorption spec-
troscopy (edge energies < 1 keV). The absorption features in this region originates from
the scattering of photoelectrons with relatively low kinetic energy. This includes contri-
butions from multiple scattering paths between the absorbing atom and its first shell and
sometimes also tightly bound second shell neighbour atoms.
Qualitatively, XANES can be used as a fingerprint for the structural arrangement of
atoms around the absorbing atom by comparing with model compounds. For a more
quantitative interpretation of the XANES recent developments by including full multiple
scattering theory (e.g. FEFF (Ankudinov et al., 1998)), and using finite difference methods
(e.g. FDMNES (Joly, 2001)) have allowed calculation of more realistic XANES spectra.
2.3.2 Extended X-ray absorption fine structure
The EXAFS extends from approx. 50 to 1000 eV above E0. The region is characterized
by the scattering of a photoelectron ejected from the absorbing atom by the photoelec-
tric effect, and is mostly dominated by single scattering events. The EXAFS contains in-
formation about the local structure, i.e. bond distances, number and type of neighbour
atoms. The modulations in the absorption arise from the interference between the outgo-
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ing and the backscattered photoelectron and depends on the kinetic energy of the photo-
electron. Recent development of data treatment software taking into account the contri-
bution from multiple scattering has permitted inclusion of the near-edge region data and
thereby ’stretched’ the EXAFS region into the XANES. The EXAFS is further described in
the following section.
2.4 Extended X-ray absorption fine structure theory
The fine structure originates from the interference between the photoelectron ejected from
the absorbing atom and the backscattered photoelectron from the surrounding atoms. The
photoelectrons are thereby very sensitive probes to the distribution of charge and the ar-
rangement of the neighbouring atoms. The interference is correlated to the probability
that the backscattered photoelectron returns to the absorbing atom in its excited state, i.e.
before the core hole is closed. As the released photoelectron only travels as long as the
core hole exists, the limitation for how far from the absorbing atom the structure can be
determined by EXAFS depends on the life time of the core hole.
(a) (b)
Figure 2.4: Interference between outgoing (dark grey) and backscattered photoelectron (light gray),
which is represented bywaves, and can either be constructive (a) or destructive (b). The interference
depends on distance between atoms and wavelength (i.e. energy) of the photoelectron.
Different ratios between the distance to the neighbour atom R and the wavelength of the
photoelectron λ leads to constructive and destructive interference between the outgoing
and backscattered photoelectron, Figure 2.4. Constructive and destructive interferences
respectively results in denser and lighter electron densities, which are seen as maxima and
minima in the absorption spectrum, respectively. The interference pattern, and thereby the
modulations in the absorption spectrum, contains information about the arrangement of
atoms around the absorbing atom.
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The fine structure modulation in absorbance as a function of energy, χ(E), is extracted
by subtracting the absorption for the isolated atom in the field of its neighbours, without
specific interactions, µ0(E), from the measured absorption, µ(E), and then normalizing to
one absorption event by dividing with µ0(E0):
χ(E) =
µ(E)− µ0(E)
µ0(E0)
(2.2)
Since EXAFS is an interference effect between the photoelectric waves, the absorption is
better represented as a function of photoelectronwave number k, rather than X-ray energy,
E. The conversion from E to k is:
k =
√
2 me (E − E0)
~2
(2.3)
whereme is the electron mass. The practical aspects of extraction of χ is further described
in Section 3.4
2.4.1 The EXAFS equation
The EXAFS contribution from each backscattering coordination shell j, including atoms
of a particular type and similar distances from the origin of the initial photoelectron, can
be approximated by a damped sine wave with amplitude, A, and phase, Ψ, characteristic
for the associated scattering path. Contracting all contributions into a sum of sine waves
results in the EXAFS equation (Sayers et al., 1971), by which the fine structure modulations,
χ(k), can be modelled:
χ(k) =
∑
j
Aj(k) sin(Ψij) (2.4)
χ(k) =
∑
j
Nj S
2
0(k)
k R2j
·
∣∣f effj (k)∣∣ · exp (−2 k2σ2j ) · exp
(
−2 R
Λ(k)
)
· sin (2 k Rj + φij(k)) (2.5)
Nj is the number of backscatterers in the jth shell.
Rj is the distance from the absorbing atom i to the backscatterer in the jth shell.
f effj (k) is the effective amplitude function.
S20(k) is the amplitude reduction factor.
2σ2j is the Debye-Waller term representing the mean-square disorder (static and thermal)
in the jth shell.
Λ(k) is the mean free path of the photoelectron.
φij(k) is the phase shift arising from the Coulomb potential between atom i and j.
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The amplitude of the EXAFS signal is proportional to the number of backscatters N
around the central atom Figure 2.5(a), whereas the phase contains information about the
bond distances from the central atom to the neighbouring atoms, R. As the photoelectric
wave must travel from the absorbing atom to the scatterer and back, the frequency of each
EXAFS wave is related to R, in a way that high frequencies corresponds to long distances
and vice versa, Figure 2.5(b).
The amplitude of each EXAFS wave further depends on the number and the backscat-
tering power of the neighbouring atoms. The backscattering power of an atom is described
by the effective amplitude function, f effj (k), which only depends on the nature of the
backscattering atom. The backscattering power is generally higher for heavier backscat-
ters, and the amplitude function f effj (k) takes maximum values at low k-values (3–4 Å
−1)
for light backscatterers (C, N, O etc.) and at higher k-values for heavier backscatterers, Fi-
gure 2.5(c). In modern curved wave theory, (in which the effect arising from the curvature
of the atoms is taken into account) f effj (k) also slightly depends on the distance to the cen-
tral atom, R. On the way the photoelectron will interfere with the Coulombic interactions
of the absorber, i, and the backscatterer, j. This results in a total phase shift, φij(k), which is
a sum of the k-dependent phase shifts the photoelectron experiences during the scattering
process: two from the absorber, 2δi, (both outgoing and incoming) and one from the scat-
tering δj . The k-dependence is shown in Figure 2.5(d). Calculations of both phase shifts
and amplitude functions are implemented in modern algorithms for ab initio calculations
of XAFS spectra, which use the methods described in Section 2.5.
The amplitude reduction factor, S20(k) mostly describes the reduction of signal due to
inelastic losses within the absorbing atom (intrinsic). Outer-shell electrons of the absorb-
ing atom may either be ejected to empty orbitals or to the continuum using the kinetic
energy of the photoelectron, (shake-up and shake-off processes, respectively). This energy
loss results in photoelectrons which EXAFS contributions are shifted in energy and phase,
and thereby reduces the total EXAFS amplitude. Also experimental factors influence on
S20(k), e.g. self absorption of highly absorbing samples where the fluorescence emitted is
absorbed by the sample itself, which for fluorescence measurements result in a reduced
intensity emitted from the sample. The contributions to S20(k) are difficult to quantify, and
S20(k) is in practise estimated from a standard sample of a well known structure. The fact
that the EXAFS phases are better determined than the amplitudes generally makes the
EXAFS-technique more accurate for bond distances than for coordination numbers.
The Debye-Waller term, exp(−2σ2j k
2), describes both the static and thermal disorder
effects. σ represents the half width at half maximum in a Gaussian distribution of dis-
tances. The distribution of distances is normally assumed to be symmetric around the
mean distance, but asymmetric distributions can be modelled by using expanded Debye-
Waller terms.
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Figure 2.5: The k-dependence of selected factors which are included in the EXAFS equation. (a)
The influence on the EXAFS signal of the number of backscatterers Nj within the jth shell. The
signal is amplified by more backscattering atoms. (b) The influence on the EXAFS signal of the
bond distance Rj to the jth shell. Long distances results in high frequencies and vice versa. (c) The
effective amplitude function, feffj (k) and (d) phase shifts φij calculated using Fe as absorber atom
for different backscatters at different distances: N at 1.99 Å, S at 2.30 Å and Fe at 2.46 Å. The position
of the maximum of feffj (k) in k-space increases with increasing atom number. The calculations are
done using FEFF8 (Ankudinov et al., 1998). (e) The Debye-Waller term exp(−2 σ2 k2) for different
values of 2 σ2. The damping effect increases with increasing 2 σ2-values. (f ) The mean free path
term exp(−2 Rj/Λ(k)) calculated using 2.46 Å Fe–Fe scattering path.
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Regarding the photoelectron scattering from an atom located at a mean distance R and
with a distribution of distances σ from the central atom, the backscattered contributions
will be slightly out of phase and thereby damping the EXAFS signal, in particular at high
k-values, Figure 2.5(e).
Inelastic scattering of the photoelectron involving ejection of valence electrons from the
neighbouring atoms (extrinsic) may also occur. These extrinsic losses will not contribute
to the interference between the outgoing photoelectric wave with backscattered wave, and
will thereby damp the EXAFS signal. Further the limiting life time of the core hole will also
damp the signal, as the backscattered photoelectronmust return to the core hole before the
excited state decays. To describe these losses a damped spherical wave which includes
the mean free path of the photoelectron, Λ, is used. The damping factor is plotted in Fi-
gure 2.5(f ). Λ describes the probability of how long the photoelectron is able to travel in
average and generally increases with increasing photoelectron energy. The mean free path
factor together with the 1/R2 dependence makes EXAFS a local atomic probe.
2.4.2 Multiple scattering
The sum over contributions in the EXAFS equation includes single scattering (SS) paths
from many shells of atoms, in which the photoelectron is travelling from the central atom
to the backscatterer and back again, Figure 2.6(a). But the contributions may also include
so-called multiple scattering (MS) paths in which the photoelectron is scattered by more
than one atom before it returns to the central atom, Figure 2.6(b).
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Figure 2.6: The definition of scattering pathways. (a) Single scattering events where the photoelec-
tron is only scattered once, nleg = 2. (b) Multiple scattering pathways where the photoelectron is
scattered by more atoms before returning to the absorbing atom for a three-leg pathway nleg = 3,
and a four-leg pathway nleg = 4. The angle α describing the deviation from linearity is indicated.
An MS pathway is characterized by its number of legs, nleg, which corresponds to the
number of distances the photoelectron travels before it returns to the absorber. Hence for
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single scattering pathways nleg = 2, whereas multiple scattering pathways have nleg ≥ 3.
MS pathways are always longer than SS pathways from the inner coordination shell, and
their amplitudes and phases are modified. MS becomes more important at low energies
(XANES region), which explains why the XANES regime is sensitive to the spatial arrange-
ment of atoms around the absorbing one relative to each other, and not only their radial
distances. This is illustrated in Figure 2.7. The effect from an MS pathway depends on the
angle α, describing the deviation from linearity of the atoms involved in theMS path, as de-
fined in Figure 2.6(b). The contribution is generally enhanced for linear systems (α = 0◦),
since the forward scattering from the intermediate atom is strong (nitrogen atom in Fi-
gure 2.6(b)). This is known as the focussing effect. The contribution will decrease with
increasing α.
EXAFS XANES
(b)(a)
Figure 2.7: (a) In the EXAFS part of an absorption spectrum, where the photoelectron has high
energy, single scattering dominates. (b) The XANES region is more sensitive to multiple scattering
events, as these occurs at lower photoelectron energies. Thereby EXAFS is a one-dimensional probe
determining bond distances R very accurately, whereas XANES is also sensitive to bond angles.
2.4.3 Fourier transformation
A Fourier transform of the EXAFS function in k-space, χ(k), results in a pseudo radial
distribution function, describing the electron density around the absorbing atom in a one
dimensional R-space.
For simplicity, the phase shift terms, φij , are normally omitted in the preliminary Fou-
rier transforms. As a consequence of not including these terms, the peak positions giving
the average absorber-backscatterer distances,Rj , are typically shifted by approx. 0.5 Å be-
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low their true values. The phases are however calculated in the fitting procedure to obtain
accurate values of Rj .1
The spatial resolution, δR, depends on the k-range used for the Fourier transform,∆k.
δR can be estimated by the following equation:
δR =
π
2∆k
(2.6)
Small k-intervals give broader peaks and thereby lower resolution. Often atomic shells of
similar distances can not be resolved and have to be modelled as one shell. In order to
avoid truncation effects χ(k)must take values close to zero in the end points. Convolution
of χ(k) with a window function, which is constant over the selected k-range, except at the
end point where it smoothly approaches zero is often used to obtain clean peaks in the
Fourier transform. During fitting analysis individual peaks in the Fourier transform can
be cut out and back-Fourier transformed in to k-space. This technique known as Fourier
filtering may help to identify different pathways, as they can be analysed individually.
2.5 Concepts on XANES calculation
For a quantitative interpretation of the XANES part of an absorption spectrum it is nec-
essary to calculate realistic spectra, which is often accompanied by heavy quantum me-
chanical calculations. Development of new methods providing short-cuts to these heavy
calculations has improved the quantitative interpretation of XANES.
In the one-electron approximation, in which only one electron is assumed to be ejected
during the excitation of the atom, the X-ray absorption coefficient µ is proportional to the
transition rate, which is given by Fermi’s golden rule:
µ(ω) ∝
∑
f
|〈ψf |p ·A(r)|ψi〉|
2 δ (Ef − Ei − ~ω) (2.7)
where ~ω is the energy and A(r) the vector potential of the electromagnetic field of the
incident light. p is the momentum operator and ψi and ψf are the wave functions corre-
sponding to the initial and final eigenstates with energies Ei and Ef , respectively. In the
one-electron approach ψi is a 1 swave function. It is calculated by solving the Schrödinger
equation for the initial state, which is relatively easy as the atom is in its ground state. Solv-
ing the Schrödinger equation for the final state, however, is very complicated as all elec-
trons in principle are involved, leading to many-body processes. The final state is strongly
dependent on the environment. To overcome calculation of ψf several approximations and
calculation strategies is used, which will be briefly described in the following:
1Plotting Fourier transforms without phase correction is common procedure in many programs (e.g.
WinXAS, (Ressler, 1998)).
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2.5.1 Muffin-tin approximation
As the ejected photoelectron propagates in the sample it moves in a potential. This poten-
tial determines the scattering strength at each site and must be as realistic as possible for
performing accurate calculations of spectra. The muffin-tin (MT) approximation, is called
so, as its profile resemble the shape of a muffin tin, and assumes non-overlapping spherical
scattering potentials centred on each atom and a constant value in the interstitial regions.
The calculations are eased by using this approximation, and it describes the actual poten-
tial very well near the centre of each atom. As the high energy photoelectrons are mostly
scattered from these inner regions, the MT-potential is highly adequate for most EXAFS
calculations. The shape of the potential in the outer edges of the atoms as well as the in-
teratomic potential however becomes more important in the near edge region, where the
photoelectron energies are lower. A more accurate description is often needed taking into
account the fact that the atomic potentials may overlap and that the charge distribution,
which is determined by the bonding properties in the material, is anisotropical.
2.5.2 Green’s formalism
In the Fermi golden rule the wave functions ψ can be substituted with Green’s functions,
which eases the calculations of the final states. The Green formalism has been essential for
the development of the multiple scattering theory and is implemented in many programs,
e.g. FEFF and FDMNES.
2.5.3 Finite difference methods
Finite difference methods, (Kimball & Shortley, 1934) is a general mathematical method to
solve differential equations by discretize them over a grid of points, and has been imple-
mented in FDMNES, (Joly, 2001). The Schrödinger equation has to be solved at each point
within a spherical volume which is centred on the absorbing atom. The radius of this
sphere defines the cluster size. The calculation time is strongly dependent on the cluster
size. The FDM is today the most precise approach to calculate XANES spectra (Jacquamet
et al., 2009a) as the method offers an approach to solve the Schrödinger equation in a free
shape potential, and thereby goes further than the muffin-tin approximation.

Chapter 3
Experimental X-ray absorption
spectroscopy
This chapter gives a brief introduction to experimental XAS including specifications of the
samples, the experimental setup, acquisition and treatment of XAS data, and is a supple-
ment to the experimental descriptions of XAS data collection procedures in the following
chapters. The two final sections respectively present an overview of the different strategies
used in this project to analyse the EXAFS data as well as quantitative analysis of XANES
data.
3.1 Availability of absorption edges
XAS experiments can be performed for almost any type of absorber atom in the periodic
table. For biological XAS studies hard X-rays (E > 2 keV) is mostly used, and the energy
available at synchrotron XAS beam lines typically range form 2 to 40 keV. In principal there
is no upper limit of Z , since elements with K-edges above the available photon energy
range, will have L-edges which fall within the available range, see Figure 2.2(b). The lower
level is around 2.5 keV, which corresponds to absorbers with atomic number Z ≥ 16,
(sulfurK-edge is 2472 eV). For energiesE < 2 keV absorption of the X-rays by air becomes
an important issue even with experiments performed in He-atmosphere.
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3.2 Sample specifications
XAS can be obtained from samples in any state, e.g. crystals, micro crystals, amorphous
solids, liquids, frozen solutions or solutions at room temperature or even directly from
tissue and cells. The technique is very sensitive wherefore it can be applied to study trace
metals and dilute samples. Obtaining useful XAS spectra highly depend on the sample
and the preparation hereof. Important issues about sample preparation are summarized
in the following points:
• The sample must be homogeneous. This is primarily an issue for solid material, e.g.
bone tissue, which must be carefully ground.
• The amount of absorbing atoms must be optimized to the experiment to obtain the
optimal signal-to-noise ratio. This is done by optimizing the sample thickness x
and/or the concentration for solutions. For fluorescence experiments on metallopro-
teins, the samples typically contain metal concentrations around 1 − 5 mM (Ascone
et al., 2003), but using specially designed setups high quality XAS data can be col-
lected on samples with metal concentrations down to 100 µM, (Ranieri-Raggi et al.,
2003).
• The sample must be stable during the entire measurement, meaning that photo-
reduction and degradation from radiation damage must be avoided. This is done by
cooling the samples in a liquid nitrogen or helium cryostat. Some systems are more
sensitive to photo-reduction. By performing faster scans and thereby collecting more
spectra allows for monitoring an eventual evolution caused by degradation. Moving
the beam position on the sample to an unexposed spot or changing the sample with
a freshly prepared one are strategies used to overcome this problem.
• For metalloproteins, excess amounts of the absorbing metal must be eliminated, (i.e.
metal atoms which do not coordinate to the protein, but can be present in the solu-
tion).
3.3 Experimental setup and data acquisition
A typical setup for an X-ray absorption spectroscopy experiment on a synchrotron facility
is shown in Figure 3.1.
As the absorption fine structure oscillations generally are weak signals (1–10 % of the
absorption coefficient), synchrotron radiation sources are required for performing XAS ex-
periments. Synchrotron radiation is generated in a high vacuum storage ring in which
electrons, accelerated to the speed of light, are injected. The storage ring is in principle a
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Figure 3.1: Schematic representation of an experimental arrangement for XAS. Synchrotron radi-
ation is generated from accelerated electrons in the storage ring. The monochromator provides a
monochromatic beam which can be tuned in energy. The intensities I0, I1 and I2 are measured in
the ion chambers before the sample, after the sample and after having passed a reference sample,
respectively. For transmission experiments the sample is aligned perpendicular to the beam. For
fluorescence experiments, the sample is rotated with an angle of 45◦ to both the incident beam and
the energy dispersive fluorescence detector, by which the intensity of the fluorescence is measured,
If .
polygon consisting of curved and straight sections which define the trajectory of the elec-
trons. The electrons are forced to follow the curvature of the ring by magnetic fields from
strong magnets. When the electrons hit the curved sections (bending magnets) they loose
energy which is emitted as electromagnetic radiation tangential to the ring. The energy of
the electrons can be tuned and modified in the straight sections by undulators and wig-
glers providing radiation with the wished characteristics. The emitted radiation is further
focussed and cut in the guide line leading the radiation from the ring to the experimental
hutch, by mirrors and slits.
The normal procedure for collecting XAS spectra is by collecting data points at dis-
crete photon energies, which is achieved by a scanning high-resolution monochromator.
The monochromator contains a pair of monochromator crystals, in which Bragg reflec-
tions from a certain diffraction plane is used to monochromatize the radiation. At beam
line 811 at MAX-lab interchangeable pairs of Si(111) and Si(311) crystals are used in the
monochromator to cover an energy range from 2.3 to 20 keV. By varying the angle between
the incident X-rays and the Bragg planes different energies can be sorted out.
XAS data can be collected in two different modes: Transmission and fluorescence.
Transmission experiments are conducted on concentrated samples, whereas fluorescence
experiments are more adequate for dilute samples used for biological applications where
the concentration of absorbing element typically is below 1 %, (Ascone et al., 2003).
In transmission experiments the sample is aligned perpendicular to the beam, and the
detector is placed behind. The absorption is obtained in analogy to optical spectroscopy
by measuring the intensities of the incident beam, I0, and the transmitted intensity, I1.
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The absorbance µ is calculated as log(I0/I1). The intensities I0, I1 and I2 are measured in
ion chambers. The ion chambers are filled with mixtures of inert gases (He, N2, Ne, Ar
or Kr), and a voltage is applied over the chambers. When the beam transverses through
the ion chamber, the gas is ionized, which is converted into an electrical signal. An op-
timal composition of the gas ionization chambers should provide an absorption of 20 %
of the incident beam in I0, and 20–40 % of the incident beam in I1. The gas mixture in I2
absorbs the majority of the remaining beam. As the absorption depends on the concentra-
tion of absorbing element and the thickness of the sample, the sample preparation must be
optimized with respect to sample thickness and concentration to obtain spectra with opti-
mal signal-to-noise ratios. Solid samples containing high concentrations of the absorbing
element are typically diluted with boron nitride.
In fluorescence experiments the optimal orientation of the sample is with an angle of
45◦ to both the incident beam and the fluorescence detector. The fluorescence emitted from
the sample If is detected by an energy-dispersive detector placed parallel to the beam, see
Figure 3.1. The fluorescence yield, which is proportional to the absorbance µ is calculated
as (If/I0).
A concurrent transmission experiment is conducted on a reference sample for internal
calibration of the spectra. The reference sample is typically a foil of pure metal of the same
type as the absorbing atom, and placed between ion chambers I1 and I2. The absorbance
µ is thus calculated as log(I1/I2).
3.4 Data treatment
The data treatment procedure of an experimental XAS spectrum is divided into several
steps. For extraction of XANES spectra only the first three steps are required, whereas
all steps are necessary for extracting the EXAFS oscillations χ(E). In this work the data
treatment was carried out inWinXAS, (Ressler, 1998).
Firstly, an experimental spectrum must corrected for background, which originates
from absorption by other atoms present in the sample, instrumental effects and absorption
by sample holder and surroundings. For transmission data the background is decreasing,
Figure 3.2(a), since the absorption of X-rays decreases with increasing energies, whereas
the opposite is observed for fluorescence experiments, Figure 3.2(b), as the fluorescence
increases with increasing energy. The background is empirically modelled by a smooth
polynomial (typically first order) which is fitted to the pre-edge of the spectrum and sub-
tracted.
Secondly, the experimental spectrum is normalized by scaling the height of the absorp-
tion step, µstep to unity, Figure 3.2(c). The concentration of absorbing atoms is proportional
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Figure 3.2: Extraction of the EXAFS oscillations χ(k) from raw spectra. (a) Transmission spectrum
of a zinc imidazole complex (Frankær, 2011) and (b) fluorescence spectrum of reduced horse heart
cytochrome c (Frankær, 2011) in which the backgrounds are modelled by a first order polynomial
fitted to the pre-edge (dashed lines) before subtraction. The background is generally decreasing in
transmission spectra (a) and increasing in fluorescence spectra (b). (c) Normalization is carried out
by scaling the absorption step µstep to unity. (d) After setting the threshold energyE0, the spectrum
is converted to k-space and an empirically modelled spline function, µ0(k) (dashed line), imitating
the absorption of the isolated atom in the field of its neighbours without specific interactions, is
subtracted. The EXAFS function χ(k) is obtained after normalization by µ0(k). (e) The k3-weighted
EXAFS function χ(k), amplifying the features at higher k-values. (f ) Fourier transformation of χ(k)
results in the radial distribution function.
to this step height and varies in different samples. A normalization allows EXAFS spectra
from samples with different concentrations of absorbing atom to be compared.
Thirdly, the spectrum must be energy calibrated by setting the threshold energy E0.
There is no simple way to determine E0 experimentally, wherefore the threshold energy
offset ∆E0 is refined upon model fitting to an EXAFS spectrum. However, when more
spectra are compared it is of utmost importance that the spectra are energy calibrated rela-
tively to each other. Therefore the spectra are calibrated by using a concurrently collected
spectrum from a well-characterized reference sample. A careful energy calibration is also
important when more experimental spectra are averaged.
For extraction of the EXAFS oscillations, it is convenient to convert the spectrum µ(E)
into a function of wave number µ(k) using Equation (2.3). The fine structure χ(k), is ex-
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tracted by subtraction of a spline µ0(k), which is an empirically determined background
function imitating the absorption for the isolated atom in the field of its neighbours, with-
out specific interactions, Figure 3.2(d). Division by µ0(k) normalizes the spectrum to a per
atom basis.
χ(k) =
µ(k)− µ0(k)
µ0(k)
(3.1)
The EXAFS function χ(k) can be kn-weighted in order to enhance the features at higher
k-values, Figure 3.2(e). For biological samples which primarily contain light backscatterers
n is typically 3. Finally, the EXAFS function is Fourier transformed resulting in the radial
distribution function, Figure 3.2(f ), as described in Section 2.4.3.
3.5 Model fitting to EXAFS spectra
The data analysis always involves some form of curve fitting of a model function to the ex-
perimental EXAFS spectra, thereby extracting structural and chemical information of the
samples. The theoretical model function is constructed by a sum of individual contribu-
tions as given in Equation (2.5). Backscattering amplitudes and atomic phase shifts are
obtained from ab initio calculations for selected pathways from the theoretical model. The
values of the parameters (distances Rj , number of backscatterersNj , Debye-Waller factors
σ2j and threshold energy offset ∆E0) are then adjusted and refined by a least-squares fit-
ting procedure. The final model includes all pathways which significantly contribute to
the experimental spectrum.
There are strong correlations between some of the parameters. As both Nj , and σ2j
influence on the amplitude of χ(k) these parameters usually correlates, whereas Rj and
∆E0 influence on the phase of χ(k) and correlate.
As the three-dimensional structure information obtained by EXAFS is decomposed into
a one-dimensional spectrum, the number of observables are limited and depends on the
data quality. The number of independent parametersNp can be estimated by:
Np =
2∆k∆R
π
+ 2 (3.2)
in which ∆k and ∆R and the k-range and Fourier filtering R-range, respectively. The
number of parameters to be refined can be limited by fixing the number of backscatterers
Nj , as they can be determined from other experiments (e.g. X-ray crystallography), and by
grouping similar distances Rj and Debye-Waller factors, σ2j . Three different approaches to
fit models to the experimental EXAFS spectra are illustrated in the work described in the
following chapters.
• The cluster approach, in which atoms within the same molecule are grouped. The
groups can be constrained by which each group is assumed to be rigid, or the groups
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can be imposed to geometrical restraints, which allows somemovement of the atoms
within the molecule (Binsted et al., 1992; Gurman, 1995). This approach was applied
in the study of hexameric insulin described in Chapter 7 and 8 using EXCURVE (Gur-
man et al., 1984, 1986; Binsted et al., 1991), which perform full multiple scattering
calculations. Thereby three-dimensional information is indirectly obtained from the
EXAFS. Using initial PDB-coordinates from crystal structures this approach, outlined
as 3D-EXAFS by Strange et al. (2005), is probably the best suited for metalloprotein
studies.
• The shell approach, by which atoms at equal distances from the absorbing atom are
grouped in shells. By the separate inclusion of pathways (both SS and MS pathways)
this approach is not the best suited for metalloproteins, as metal clusters in proteins
often contains many shells and thereby results in too many parameters. This ap-
proach was applied for strontium reference compounds in the study of bone tissue
using WinXAS, (Ressler, 1998). The EXAFS results of the reference compounds are
presented in Appendix C.
• A third approach, in which a linear combination of experimental EXAFS spectra from
model compounds are fitted to the experimental EXAFS spectrum, may be more ad-
equate for highly disordered structures. This approach was applied in the study of
strontium localisation in bone tissue described in Chapter 11 using the linear combi-
nation fit procedure included in ATHENA (Newville, 2001; Ravel & Newville, 2005).
All refinement evaluate the fit by a residual. The residuals are differently defined and
presented in the respective chapters.
3.6 Quantitative model fitting to XANES spectra
Advanced fitting algorithms against XANES spectra have recently been developed and im-
proved during the last decade (Benfatto et al., 2001; Smolentsev & Soldatov, 2006; Sarangi
et al., 2008; Jacquamet et al., 2009b). The main advantage of quantitative XANES analysis is
the possibility to obtain the information about three-dimensional environment of absorb-
ing atom. Unlike the EXAFS shell approach, which provides only the radial distribution of
atoms, the XANES enables to withdraw the bond lengths and angles.
For quantitative fitting of XANES spectra an initial model is required, where the coor-
dinates can be provided from a preliminary EXAFS analysis or an XRD structure. A few
structural parameters (typically two to four) can be varied and optimized by multidimen-
sional interpolation of calculated XANES spectra. The XANES fitting was applied in the
study of hexameric zinc insulin described in Chapter 7, using FDMNES (Joly, 2001) and
FitIt (Smolentsev & Soldatov, 2007).

Chapter 4
Characterization of protein powder
by XRPD
X-ray diffraction on single crystals is the preferable method to solve and characterize pro-
tein structures. The results are usually unambiguously clear, when the structure is re-
vealed. The need to find the right conditions for growing single-crystals of sufficient size
and quality is one of the major bottlenecks in this process, and being able to screen early
precipitates for crystals would save large amounts of time and efforts. Furthermore, as
structure based drug design is a growing field and drug candidates are more often proteins
themselves, the need for quick characterization and verification of protein polymorphs and
substrate-protein complexes is growing. X-ray powder diffraction (XRPD) offers a conve-
nient and quick way to characterize crystalline protein precipitate in the laboratory and
could thereby become a valuable tool for product characterization in the pharmaceutical
industry, as well as in the enzyme production industry.
For reliable identification of crystal forms, calculation of realistic protein powder pat-
terns based on for example Protein Data Bank (PDB) coordinate files are required. A pro-
cedure which includes straightforward corrections for background, unit cell parameters,
disordered bulk-solvent and geometric (Lorentz) factors has been developed and tested
with good agreements between measured and calculated patterns. A description of the
procedure has been summarized in this chapter and published in Paper I (Hartmann et al.,
2010) Appendix A.1 and Paper II (Hartmann et al., 2011) Appendix A.2.
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The calculation procedure have been testedwith tetragonal lysozyme and trigonal and
cubic insulin. In this chapter only the results from lysozyme are summarized. Further
details and the results from the two insulin crystal forms are found in Paper I, (Hartmann
et al., 2010) Appendix A.1.
4.1 Introduction
Metmyoglobin was the first protein structure to be refined from powder diffraction data
(von Dreele, 1999) by combining high-resolution diffraction data with restrained Rietveld
refinements. During the last decade X-ray powder diffraction has proven its ability for
solving and refining small protein structures such as insulin (von Dreele et al., 2000), lyso-
zyme (von Dreele, 2001, 2005; Basso et al., 2005) and SH3-ponsin domain (Margiolaki
et al., 2007b) from high resolution powder data using synchrotron radiation (von Dreele
et al., 2006; Margiolaki & Wright, 2008; Wright et al., 2008; von Dreele, 2009; Doebbler &
von Dreele, 2009).
Figure 4.1: High resolution powder diffraction patterns for tetragonal lysozyme recorded on beam
line ID31 at ESRF, Grenoble, France. Magnification of the high angle regions are shown in the insets.
This beam line provides data with extremely high angular resolution (FWHM of around 0.003◦ in
2θ) and is thus well-suited for protein powder diffraction experiments. Adapted from (Margiolaki
et al., 2007a) by permission from Oldenbourg Wissenschaftsverlag GmbH, ©2007.
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The critical point in refining protein structures from powder data is to obtain data with
resolution high enough to separate the diffraction peaks which otherwise overlap. How-
ever, even at specially designed beam lines using analyser crystals some peaks may still
be overlapping. A strategy in which diffraction peaks can be separated includes combina-
tion of more data sets collected at different conditions. In a study by (Basso et al., 2005) an
alteration of pH and temperature induced small systematic changes of the tetragonal unit
cell of lysozyme, which shifted the diffraction peaks. A high resolution powder pattern for
lysozyme is shown in Figure 4.1 Powder diffraction patternswith well resolved peaks have
also been collected on highly optimized laboratory equipment, (Margiolaki et al., 2007a),
but at the cost of longer data collection times.
Going from high resolution to medium resolution XRPD, a recent study using syn-
chrotron radiation demonstrated the ability to quickly and effectively distinguish between
different crystal forms of insulin in combination with multivariate data analysis (Norrman
et al., 2006). Based on these previous experiences the aim was to study whether protein
crystal forms could be sufficiently characterized and fingerprinted by using standard lab-
oratory diffractometers.
Collecting XRPD data with sufficient signal-to-noise ratios and calculation of realistic
powder patterns require special procedures compared to those used for small molecules.
Some challenges concerning sample handling and data treatment have been identified:
• The large unit cells result in Bragg peaks occurring at very low angles and at higher
angles the reflections are suffering from a severe peak overlap, which limit the data
resolution to about 4 Å (2θ =2–20◦ using Cu Kα1-radiation).
• The measured intensities fit poorly with those calculated from known structures.
Protein structures available from the PDB, do not include a description of the contri-
bution from the disordered solvent in the solvent channels, which is the major source
for this discrepancy.
• The measured peak positions sometimes deviate from those derived from the liter-
ature. In many cases this is due to a difference in data collection temperature, but
small differences in the amount of solvent and the exact composition of the solvent
may also slightly affect the unit cell parameters.
• Due to the large molecules and the high solvent content, protein crystals are soft
and in general poor scatterers. Combined with the non-Bragg scattering from the
surrounding mother liquor and the sample holder, it results in large background,
which must be subtracted manually.
• Working on laboratory sources relatively large amount of sample and/or measuring
time is needed.
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4.2 Experimental
4.2.1 Growing of lysozyme crystals
Tetragonal lysozyme crystals were grown using the vapour diffusion technique. Lyo-
philized lysozyme from chicken egg white, Gallus gallus (95 % Sigma Aldrich L-6876),
was dissolved in 0.02 M sodium acetate and the protein concentration was determined
to 13.8 mgml−1 using ε280 of 37470 M−1cm−1. The protein was equilibrated in a sitting
drop against a reservoir of 0.1 M HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid) and 0.8 M potassium sodium tartrate (KNaC4H4O6) at pH 7.5 (cf. Crystal Screen HR-
2-110 no. 29, Hampton Research). The drops were formed of 200 µl protein solution mixed
with 200 µl reservoir solution. The crystals were grown during three weeks, Figure 4.2
Figure 4.2: Crystals of tetragonal lysozyme.
4.2.2 X-ray powder diffraction
After crystallization excess mother liquor was removed and the wetted crystals were gen-
tly crushed to a concentrated suspension of protein powder. The diffraction experiments
have been carried out at an in-house Huber G670 diffractometer using Cu Kα1 radiation
(λ = 1.54059 Å). The samples were mounted in a specially designed sample holder (de-
scription of the design is reported in Section 5.2.1), which contains appr. 150 µl of the
powder suspension (corresponding to appr. 5 mg protein). The measurements were per-
formed on rotating samples at room temperature. Data were collected at room temperature
for 15×4 h. No indication of time decay was observed. The background was subtracted in
the program PROTPOW 1 by manually picking between 10 and 20 background points, fit-
1Available from http://www.xray.kemi.dtu.dk/English/Computer%20Programs/PROTPOW.aspx
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ting to a spline function and subtracting. Themanual procedure is necessary to distinguish
background from overlapping signal.
4.3 Calculation of XRPD patterns from PDB coordinates
A powder diffraction pattern of tetragonal lysozyme was calculated from the PDB-coordi-
nates of a lysozyme structure, which was refined from a crystal originating from the same
batch as the lysozyme powder (Hartmann, 2008; Hartmann et al., 2010). The resulting
structure factors, before and after corrections, were entered into PROTPOW for powder
diffraction pattern calculations. All corrections were carried out on the calculated patterns.
4.3.1 Optimization of unit cell parameters
It was necessary to optimize the unit cell parameters to get fully comparable powder pat-
terns. This could be due to differences in data collection temperatures (lysozyme powder
data were collected at room temperature while the single crystal data set was collected at
100 K) or variations in solvent concentrations. Optimization of the unit cell parameters
was done by a full-pattern profile fit. Optimized parameters describing the peak width
(FWHM) and peak shape of a pseudo-Voigt function are included in the pattern fit by
PROTPOW. A powder pattern was calculated in PROTPOW from the PDB coordinate file
using the optimized unit cell and peak profile parameters, Figure 4.3. In general the peak
positions fit well, but without taking into account the disordered bulk-solvent, the intensi-
ties fit poorly with the measured intensities, in particular at low 2θ.
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Figure 4.3: Calculated powder diffraction pattern for lysozyme before solvent correction (blue). An
experimental powder pattern (red) is included for comparison.
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4.3.2 Correction of disordered solvent
The contribution from the solvent was calculated in PHENIX (Adams et al., 2010) using
the flat bulk-solvent model (Phillips, 1980) where a constant level of electron density is
assumed in the voids between the macromolecule. The bulk-solvent model takes two pa-
rameters ksol defining the level of electron density and Bsol defining the steepness of the
border between the solvent and the macromolecular regions. The parameters are refined
in today’s single-crystal X-ray structure refinement software, but in case no other informa-
tion is available following average values can be used ksol = 0.35 e Å−3 and Bsol = 46 Å2
(Fokine & Urzhumtsev, 2002). The contribution from the solvent is added to the calculated
structure factors. The improved fit from the powder pattern based on calculated structure
factors is seen on Figure 4.4.
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Figure 4.4: Calculated (blue) and experimental (red) powder diffraction patterns for lysozyme. The
calculated pattern is corrected for bulk-solvent.
4.3.3 Other factors
As the conventional Lorentz correction tends to infinity when approaching 2θ = 0◦ a re-
vised geometrical intensity correction factor has been derived. Applying this improved
geometrical factor gave a minor, but, significant improvement to the fit in the low angle
region.
Protein structures available from the PDB do not generally contain hydrogen positions.
Including calculated hydrogen positions did not improve the overall fit and was aban-
doned. Further details are reported in Paper I (Hartmann et al., 2010).
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4.4 Discussion
The combined effects from applying background subtraction, optimizing the unit cell pa-
rameters and bulk-solvent correction are seen in Figure 4.4. The agreement between the
experimental and the corrected calculated patterns are generally very good. Even in the
region where 2θ = 12 − 20◦ the agreement is good, meaning that for well diffracting crys-
tals it is possible to detect the detailed diffraction pattern down to resolutions of 4 Å on
in-house equipment. However, there still remain minor disagreements between the calcu-
lated and experimental patterns, which have not been accounted for. Some of the factors
which may influence on the experimental data are:
• Preferred crystal orientation which causes a non-random distribution of reflecting
planes.
• Insufficient or excess background correction. The overlap problem may result in a
background subtraction which also includes some of the signal.
• Despite solvent corrections the structural model may still be deficient.
4.5 Concluding remarks
Using a standard in-house X-ray powder diffractometer, powder patterns up to 4 Å resolu-
tion were collected fromwell-diffracting powder samples of lysozyme. Calculated powder
patterns were generated from PDB coordinate data. By performing corrections for back-
ground, unit cell parameters, disordered bulk-solvent and geometrical factors the agree-
ment between the experimental and the calculated patterns is generally very good. The
key factor to bring the calculated patterns in agreement with the observed patterns is the
bulk-solvent correction.

Chapter 5
Practical aspects and sample handling
for in-house XRPD studies of protein
A procedure by which protein XRPD-patterns can be collected on in-house equipment at
reasonable time scales has been developed. For this purpose two sample holders have
been designed and described in this chapter. The final design furthermore supports the
sample holder to be adaptable for XAS experiments, and has been used for the insulin
study described in Chapter 7 and 8. A descriptive note of the final sample holder design
has been published in Paper III (Frankær et al., 2011) Appendix A.3.
5.1 Introduction
Obtaining powder diffraction patterns with sufficient signal-to-noise ratios (S/N ) from
protein powders on in-house X-ray sources requires careful design of the sample holders
and collimators. Some general issues concerning the design are mentioned here:
• As protein crystals contain 30–80 % of disordered solvent they must be prevented
from drying out by keeping them in their the mother liquors in sealed sample cham-
bers.
• The geometry of the sample chamber: To expose as many crystallites to the X-ray
beam as possible a large surface area is required. However, the sample volumen
must be minimized in order to minimize the sample amount.
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• The sample should be easy to mount in the holder.
• Rotation should be applied to avoid sedimentation on the windows and walls of the
sample chamber and so avoid multiple layers of powder.
• The background should be minimized by optimizing the collimation of the radiation
using pinholes and slits.
• Cryo-cooling can improve the signal, but will require a thorough optimization of the
cryo-protectant. Furthermore, successful cryo-coolong depends on the geometry of
the sample holder in order to maintain a laminar flow of cold nitrogen.
5.2 Sample holder designs
Two sample holders designs were developed for the Huber G670 diffractometer equipped
with a flat powder specimen holder, which allows the samples to be rotated around an
axis χ orthogonal to the detector. To collect as much signal as possible on the in-house
X-ray sources, the general principle behind the designs is to support a thin film of protein
crystallites with a relatively large surface area. Drawings and photographs of the sample
holders are seen in Figure 5.1. These designs, however, obstruct cooling of the samples as
turbulence from the cryo-stream will form when hitting the flat holder.
For capillary measurements a lead shield was designed to offer a simple and efficient
way to ensure reproducible collimation and significant background reduction. A photo-
graph is seen in Figure 5.2. For an effective sample cooling a laminar cryo-flow can be
maintained using capillaries.
Approaching very small sample volumes a loop, similar to those used for single crystal
protein crystallography, has been tested with 1.0 µl of protein powder suspension on a
micro-source diffractometer. Dimensions and sample volumes of all sample holders are
listed in Table 5.1.
Table 5.1: Dimensions of the sample chambers of the different sample holders. All sample cham-
bers are cylindrical (except the loop which is assumed spherical), hence the dimensions are given
by a height and a diameter.
Model 1 Model 2a Model 2b Capillary Loop
Diameter (mm) 10 4.5 3.0 0.5 1
Height/thickness (mm) 1.5–2.0 1.0 1.0 25 –
Sample chamber volume (µl) 120–150 16 7 5 1
Powder suspension needed (µl) 120–150 16 7 15 1
Rotation around χ χ χ ϕ ϕ
Cooling Ineffective Ineffective Ineffective Possible Required
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5.2.1 XRPD sample holder, model 1
The first sample holder model, encases a thin layer of protein powder wetted by its mother
liquor. The protein powder film is approximately 0.5–1.0 mm thick allowing the diffrac-
tometer to work in transmission mode. It consists of a rubber O-ring between two iron
discs with circular windows (6.5 mm in diameter), Figure 5.1(a) and 5.1(b). Due to the
Guinier geometry of the powder diffractometer the profile of the inner edge has been cut
in a 45◦ angle to prevent shielding of the incoming X-rays. The discs are plated with a thin
layer of gold for increased corrosion resistance. Two pieces of mylar foil are placed be-
tween each disc and the O-ring so they cover the windows. The mylar windows have low
absorption of X-rays, the scattering from the material gives an amorphous and relatively
low contribution to the background and the strong and non-permeable material is able to
endure the pressure that occurs when the sample holder is assembled. Three screws and
appertaining nuts keep the device assembled. Each disc is supplied with an engraved cir-
cular furrow matching the diameter of the O-ring and when assembled the O-ring presses
against the foil and provides for a tight fit.
5.2.2 XRPD sample holder, model 2
The improved sample holder consists of a 1.0 mm thick polycarbonate plate with a hole,
(either 4.5 mm or 3.0 mm in diameter, creating sample chamber volumes of 16 and 7 µl,
and referred to as model 2a and 2b, respectively). Further dimensions are specified in
Figure 5.1(c) and 5.1(d). Metal-free polycarbonate was chosen to avoid fluorescence signal
from the sample holder which for XAS experiments would conflict with the fluorescence
signal from metalloproteins. Small holes have been drilled so the holder fits the cryostat
(Oxford Instruments, ITC503) available at the 811 XAS beam line at the synchrotron at
MAX-lab, Lund, Sweden. The sample holder takes a small cylindrical volume of protein
powder wetted by its mother liquor, and with a sample thickness of 1.0 mm this holder
still allows the diffractometer to work in transmission mode. The sample is sealed by two
pieces of mylar foil which are glued to the polycarbonate plate with either epoxy glue or
double-sided adhesive tape. For powder diffraction a lead plate with a pinhole matching
the diameter of the sample chamber is glued on top of the assembled holder and serves
for efficient shielding of the background scattering. The inner edge profile of the lead plate
has been cut in a 45◦ angle to prevent shielding of the incoming X-ray beam. The pinhole
plate fits exactly into the flat powder specimen holder at the Huber G670 diffractometer,
allowing the sample to be centred in the beam. The relatively compact shape of the sample
chamber, compared to the first model, eases mounting of the sample.
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Figure 5.1: Drawings and photographs XRPD sample holders for Huber G670 diffractometer. The
dimensions are specified on the drawings. (a) and (b) model 1. (c), (d) and (e) model 2.
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5.2.3 Lead shield for capillaries
The lead shield was made from a 1.0 mm thick lead plate (16 mm × 30 mm) with a slit
(1 mm × 11 mm) and was designed to be mounted on the capillary sample holder at the
Huber G670 diffractometer, Figure 5.2. Whenmounted on the sample holder the slit is cen-
tred 5 mm from of the capillary and efficiently shields the scattering from the background.
Figure 5.2: Capillary mounted on a goniometer with the lead shield seen in the background.
5.3 Experimental
The sample holders were tested with powder of tetragonal lysozyme crystals which were
grown according to the procedure described by Section 4.2.1. After crystallization excess
mother liquor was removed and the wetted crystals were gently crushed to a concentrated
suspension of protein powder.
5.3.1 Sample preparation and data collection in sample holders
The sample holders were loaded by filling the partly assembled holder with protein pow-
der suspensions. Amounts of concentrated protein suspension are listed in Table 5.1. The
top parts of the sample holders were carefully put in place in order to avoid trapping air
bubbles in the sample chambers. The sample holders were mounted on the flat powder
specimen holder at the Huber G670 diffractometer and rotation around χ was applied to
the samples. Data were collected for 4 h at room temperature using Cu Kα1 radiation
(λ=1.5406 Å).
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5.3.2 Sample preparation and data collection in capillaries
Glass capillaries with an inner diameter of 0.5 mm were packed with 15 µl suspension of
protein powder in its mother liquor by centrifugation (4×3 min at 7500 rpm). The packing
efficiency after centrifugation increased 2–3 times resulting in sample volumes of 3–5 µl
densely packed powder. For low temperature experiments with cryo-protection glycerol
was added to the suspensions resulting in final concentrations of 15–30 vol.%. After sed-
imentation the capillaries contained 15–25 mm high columns of densely packed crystals.
The capillaries were then sealed with epoxy glue and mounted on a goniometer head fit-
ting the capillary powder sample holder at the diffractometer. The sample holder was
further equipped with the lead pinhole for capillaries. Rotation around an axis ϕ perpen-
dicular to the beam and parallel to the capillary was applied, and data were collected for
4 h using Cu Kα1 radiation both at room temperature and at 120 K using a cryo-stream of
nitrogen (Oxford Cryosystems).
5.3.3 Sample preparation and data collection in loops
A commercial loop (Hampton Research) with a diameter of 1.0 mm was loaded with ap-
proximately 1.0 µl of protein powder suspension. The loop was mounted on a diffrac-
tometer with micro-source beam: GeniX beam delivery system 50 kV, 50 W generating
Cu Kα-radiation (λ=1.5418 Å). The beam is focussed on the sample with a spot size of
230 µm. The samples were cooled to 130 K to prevent them from drying out and data
were collected for 15 and 45 minutes on a Rigaku R-AXIS IV++ 2D-detector in a single
frame covering ∆ϕ of 90◦. Distance to detector was 400 mm. The 2-dimensional powder
patterns, (Figure 5.3) were integrated to one dimension using FIT2D ((Hammersley, 1998;
Hammersley et al., 1996). The beam stop was masked out and the tilting of the detector
and the position of the direct beam was optimized using the signal from the hexagonal ice
as an internal standard.
5.4 Results
5.4.1 Performance of the sample holders
The background intensity levels and the signal-to-noise ratios, which are somehow in-
terrelated, were estimated by looking at the raw lysozyme powder patterns presented in
Figure 5.4. The patterns for all X-ray tube source experiments are directly comparable, as
the data collection times are similar, whereas for the micro-source, the integrated signal
was simply scaled to the model 2a sample holder pattern. Note that the peaks for the cold
samples are slightly shifted towards higher 2θ-values as a result of the contracted unit cell.
Separating background from diffraction is however not straightforward due to the heavy
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(a) (b)
Figure 5.3: X-ray powder diffraction rings collected at 130 K on an in-house X-ray micro-source
diffractometer for 1 µl samples of lysozyme powder. Data collection times of (a) 15 min and (b)
45 min. The intensities are scaled relatively to each other.
peak overlap. An estimation of the background intensity was therefore done by scaling a
calculated pattern to the experimental. Prior to the calculation of a powder pattern unit cell
and peak shape parameters were optimized using the procedure described in Section 4.3.
The background level, BG, was evaluated as a sum of intensities I in the 2θ-range 2–20◦
by the following equation:
BG =
∑
IBackground∑
(IBragg + IBackground)
=
∑
(ITotal + IBragg)∑
ITotal
(5.1)
where IBragg was evaluated from a calculated pattern that was scaled to the experimental
using PROTPOW. The background levels are presented in Table 5.2.
Table 5.2: The performance of the different sample holders evaluated as the background
level, BG.
Temperature (K) BG (%)
Model 1 293 90.2
Model 2a 293 87.4
Model 2b 293 92.3
Capillary 293 88.3
Capillary 120 89.3
Loop (15 min) 130 90.5
Loop (45 min) 130 82.2
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Figure 5.4: XRPD patterns of tetragonal crystals of hen egg white lysozyme prior to background
subtraction. The data collection time was 4 h for sample holder model 1, 2a, 2b and capillaries,
and 15 or 45 min for the loop. The powder patterns for the loop has been converted to Cu Kα1
radiation (2θ = 1.5406Å) and the intensities scaled relative to the other patterns. A pattern has been
calculated using the unit cell and peak shape parameters, optimized from the model 2a powder
pattern, and is shown for comparison (bottom).
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With the improved sample holder (model 2) the minimum amount of sample has been
reduced by an order of magnitude resulting in 7–16 µl, which is similar to the amounts
required for capillary samples. Furthermore the new design eased the sample prepara-
tion. Rotation of the sample was shown to be important for these relatively thick samples.
Without rotation the crystallites may sediment on the windows and walls of the sample
chamber and result in multiple layers of powder.
The S/N -ratios and the background levels depend on the collimation of the beam.
Pinholes, which are integrated in the flat specimen sample holder designs, ensure that
the beam only hits the homogeneous part of the sample and reduce the background, in
particular at low 2θ-angles. After an optimization of the beam stop position, it is possible
to measure reflections down to 2.0◦ on the Huber G670 diffractometer. For capillaries the
lead slit seen in Figure 5.2 has reduced the background level by a factor of two, resulting
in S/N -ratios similar to the flat specimen holders. In general the background level, which
primarily originates from themother liquor, seems to have reached a constant level around
90 % independent on which sample holder is used, and may lead to the conclusion that
the upper limit of what can be measured on an in-house powder diffractometer using a
standard X-ray tube as source has been reached, provided that other post-crystallization
treatments such as dehydration of the crystals as described by (Heras & Martin, 2005) are
not taken into account.
5.4.2 Comments on micro-source
A micro-source diffractometer, generating a smaller beam with a higher photon flux (2 ×
108) ph/s), permits that powder patterns with S/N comparable with the previous results
can be obtained in only 15 minutes for 1.0 µl droplets of samples supported by a loop and
flash-cooled. The high collimation of the micro-source beam obviates the need for pinholes
and a lower background was observed (82.2 %). With the 2D-detector reflections occurring
at 2θ-angles down to 1.0◦ was measured. Collecting the entire Debye-Scherrer rings gave
a better average and smoother patterns. At the micro-source diffractometer the beam is
focused on the sample, which results in less resolved peaks compared to the dedicated
powder diffractometer, where the beam is focused on the detector.
5.4.3 Comments on cryo-protecting protein powder
For this system, no radiation damage was observed for the room-temperature samples.
Cooling the crystals would, in principle, reduce the thermal motions and thereby increase
the crystal order and improve the S/N . However, the cooling process may also induce
stress and disorder in the crystal, making it diffucult to predict whether the net diffrac-
tion quality will increase or decrease (Juers & Matthews, 2004). Comparing the two cap-
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illary patterns a slightly higher background was observed for the cold sample. It is pos-
sible to protect the crystallites with a cryo-protectant (Jenner et al., 2007), wherefore a pre-
experiment was carried out where different concentrations of glycerol was added to the
powder suspension. The crystallites were partly dissolved wherefore more sample was re-
quired, and a decreased S/N with increasing glycerol concentrations was observed. Most
likely the glycerol slightly etches the surface of crystals, which is not noticeable when treat-
ing large single crystals. However, for a powder sample the crystallite size is significantly
reduced or even dissolved, requiring that the cryo-protection condition are even better
optimized for powder samples than for single crystals.
5.5 Concluding remarks
Optimizing the collimation by pinholes the sample holder design has been improved to op-
erate with sample volumes down to 7 µl which is comparable with capillaries, but easier
to prepare. The improved sample holder design has been successfully applied to samples
used for both powder diffraction and XAS experiments. Capillary samples are generally
more cumbersome to prepare, but may with suitable collimation produce useful diffrac-
tion patterns for tests prior to synchrotron experiments. Using an in-house micro-source
diffractometer an acceptable powder pattern can be collected in 15 minutes from 1.0 µl
of powder suspension. Working with in-house X-ray sources cooling is not necessary to
avoid radiation damage and it does not significantly improve the scattered intensity at
the low angles of interest. Adding cryo-protectant requires thorough optimization, and
may complicate the experiments unnecessarily. However, cooling is needed for samples
mounted in loops to prevent them from drying out.
Chapter 6
Introduction to the insulin structure
and its conformations
A general introduction to insulin with emphasis on its structure is given in this chapter.
Divalent cations play a special role in the formation and stabilization of insulin hexamers,
which are believed to be involved in the storage and release mechanisms of insulin into
the blood stream. The insulin structure is therefore described with special emphasis on the
hexamer assembly and its metal ion binding sites, which are studied with XRD and XAS
and reported in the following two chapters.
6.1 Introduction
Since the biological function of insulin was discovered by Banting & Best (1922), insulin
has been extensively studied. The protein is mainly known for its regulation of the sugar
level in the blood and is given to patients suffering from diabetes, which is a still increas-
ing global public health problem. The World Health Organization (WHO) estimates that
346 million people worldwide have diabetes, and that the number of diabetes death will
double between 2005 and 2030 (World Health Organization, 2012).
6.2 Biosynthesis of insulin
Insulin is a protein hormone produced in the endocrine β-cells located in the islets of
Langerhans in the pancreas. Insulin is first synthesized as pre-proinsulin containing three
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domains (chain B, C and A) and an N-terminal signal peptide of 24 amino acid residues
(see Figure 6.1). The signal peptide is required for transporting the peptide across the
membrane of the endoplasmatic reticulum (Steiner et al., 1967), and is later removed by
a post-translational process. The resulting proinsulin is transported into the Golgi appa-
ratus, where it assembles into hexamers in presence of zinc (Emdin et al., 1980; Huang &
Arvan, 1995), and stored in vesicles to protect the protein from enzymatic degradation. The
β-cells contain high concentrations of zinc, which indicates the importance of this element
for the storage and secretion of insulin. Two endopeptidases are responsible for a prote-
olytic cleavage, which converts proinsulin into insulin by removing the C-chain (Davidson
et al., 1988). As the solubility of insulin is lower compared to the proinsulin, the insulin
hexamers start to form micro-crystals in the β-granules. This compact organization allows
the insulin to be tightly packed and furthermore serves for protection against proteolytic
degradation (Halban et al., 1987). When insulin is secreted into the blood stream vessels
by exocytosis (Howell, 1984) the zinc concentration is lowered and the micro-crystals ex-
perience a jump in pH from approx. 5.5 inside the storage vesicles to 7.4 in the blood. This
have a destabilizing effect on the hexamer which rapidly disintegrates into monomers, see
Section 6.6.
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Figure 6.1: Schematic overview of the biosynthesis of insulin. Proinsulin is formed from pre-
proinsulin by cleavage of the N-terminal signal peptide. Insulin is formed from proinsulin by pro-
teolytic cleavage of the C-chain. The residues are represented by circles, and the disulfur bridges
which connect the insulin A- and B-chain are included.
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6.3 The insulin structure
After the insulin amino acid sequence was determined (Ryle et al., 1955), the first three-
dimensional structure of porcine insulin was solved from X-ray diffraction to 2.8 Å resolu-
tion by Adams et al. (1969). Since then, the number of insulin structures has increased and
today more than 150 insulin structures from XRD and NMR are deposited in the Protein
Data Bank originating from different source organisms, mutants and in different confor-
mations.
6.3.1 The insulin monomer
The insulin molecule is built up of a 21-residue A-chain and a 30-residue B-chain which
are connected by two interchain disulfide bonds (CysA7–CysB7 and CysA20–CysB19) and
an intrachain disulfide bond in the A-chain (CysA6–CysA11) (Blundell et al., 1972). The
conservation of the amino acid sequence is high for mammals. The sequence of porcine
insulin differs from bovine insulin at two residues A8 and A10 (respectively Thr and Ile
in porcine → Ala and Val in bovine) and from human insulin by one residue B30 (Ala in
porcine→ Thr in human). The sequence of bovine insulin is shown in Figure 6.2(a).
The tertiary structure of the molecule is maintained by a hydrophobic interior and
the overall folding is shown in Figure 6.2(b). The folding of the A-chain is shown in Fi-
gure 6.3(a) and consists of two antiparallel α-helical segments (A1–A8 and A13–A19) con-
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Figure 6.2: (a) Schematic drawing including the sequence of bovine insulin. (b) The tertiary folding
of insulin including the disulfide bondings (yellow spheres). The figure is based on the atomic
coordinates from the Zn T6 insulin presented in Chapter 7. The A-chain is shown in orange and the
B-chain in blue.
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nected by a loop (A9–A12). The intrachain disulfide bond A6–A11 stabilizes the loop. The
N- and C-terminal are brought together and further stabilized by van der Waals contact
between IleA2 and TyrA19. The B-chain consists of a central α-helical segment (B9-B19)
flanked by two extended regions, see Figure 6.3(b). The two interchain disulfide bonds
linking to the A-chain are located at each end of the central α-helix. In presence of phe-
nolic derivates and high lyotropic anion concentrations the N-terminal extended part (B1–
B8) can adopt different conformations where it is partly or entirely curled up in an α-helix
resulting in the formation of a 19-residues long helix. These conformations are further
described in Section 6.5.
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Figure 6.3: The tertiary folding of the insulin A-chain (a) and B-chain (b). The figure is based on the
atomic coordinates from the Zn T6 insulin presented in Chapter 7.
6.3.2 The insulin dimer
The surface of the insulin monomer has two extensive non-polar regions, which play an
essential role for the contacts formed under aggregation of the monomers into both dimers
and hexamers. The two insulin molecules in the dimer are related by a local approxi-
mate two-fold rotation axis. The strongest monomer-monomer contact involves residues
from the central B-chain α-helix and from the B-chain C-terminal, as seen in Figure 6.4.
The dimer is further stabilized by a hydrogen bonding network, where an antiparallel β-
pleated sheet structure is formed involving the residues B23–B28 from each molecule. The
two PheB25 residues in the centre of the β-sheet are located directly opposite to each other.
In order to avoid clash these residues are forced to adopt an asymmetric conformation
(Figure 6.4), which breaks down ideal two-fold symmetry. The smallest possible asym-
metric unit is thus constituted by the dimer. Generally, the region of contacts between
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the monomers has a high population of aromatic residues (PheB24, PheB25 and TyrB26),
which stabilize the dimer further by hydrophobic interactions and forms a non-polar core
in the centre of the dimer (Blundell et al., 1972).
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TyrD26
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PheB24
TyrB16
TyrD16
Figure 6.4: The dimer and its interactions between the aromatic residues in the antiparallel β-sheet
and around a local approximate two-fold axis. The figure is based on the atomic coordinates from
the Zn T6 insulin presented in Chapter 7.
6.3.3 The insulin hexamer
Insulin forms hexamers in presence of salt and divalent metal ions (typically Zn2+). The
six insulin molecules compose a hexamer with an overall torus shape of approx. 35×50 Å.
A schematic representation of the hexamer is seen in Figure 6.5.
The hexamer can be regarded as a trimer of dimers where the 3-fold axis (Q) generates
the hexamer from the dimers. In rhombohedral crystals the three-fold axis is coinciding
with the crystallografic c-axis. A pseudo two-fold axis P relates the two monomers of the
dimer, as described in Section 6.3.2. As a consequence of the three-fold symmetry, another
pseudo two-fold rotation axis P’ is generated perpendicular to Q and 60◦ to P. This axis
relates one insulin molecule to another one in its neighbour dimer. The contact surface
between two dimers at P’, includes non-polar residues from the central B-chain α-helix,
the B-chain N-terminal and the A-chain interhelical region, as seen in Figure 6.6.
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Figure 6.5: Schematic representation of the insulin hexamer, (a) seen perpendicular to the three-
fold axis, (b) seen from the side. The pseudo two-fold axis P relates the two monomers of the dimer
and P’ relates two dimers to each other. The two metal sites located on the three-fold axis Q are
separated by approx. 15.8 Å and shown in orange.
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Figure 6.6: The surface interactions between two adjacent dimers (i.e. around the local two-fold axis
P’). The figure is based on the atomic coordinates from the Zn T6 insulin presented in Chapter 7.
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6.4 Metal ion binding in the hexamer
The hexamer is a zinc insulin complex, where each hexamer binds two Zn2+-ions. The zinc
ions are located on the three-fold rotation axis approx. 8 Å above and below the centre of
the hexamer, Baker et al. (1988). Each zinc ion is coordinated to the Nǫ2 atoms of three
symmetry related HisB10 residues, and can be either octahedrally- or tetrahedrally coor-
dinated, Figure 6.7. Octahedral coordination is fulfilled by further coordination of three
water molecules, and tetrahedral coordination is fulfilled by coordination of one lyotropic
anion (typically chloride), which is also located on the three-fold symmetry axis.
(a) (b)
Figure 6.7: Possible coordination geometries of the hexameric insulin zinc sites. Both ions are lo-
cated on a three-fold symmetry axis going through the hexamer and coordinate to three symmetry-
related histidine Nǫ2 atoms. (a) Octahedral coordination is fulfilled by further coordination of three
water molecules. (b) Tetrahedral coordination is fulfilled at both Zn-sites by coordination of one
lyotropic anion, (e.g. chloride), which is also located on the three-fold symmetry axis. The atoms
are coloured according to their type, carbon is black, nitrogen is blue, oxygen is red, chlorine is
green and zinc in light blue.
Hexamers containing more than two zinc ions have also been observed (Emdin et al., 1980).
At higher zinc concentrations additional off-axial binding sites are formed in which zinc
is tetrahedrally coordinated to Nǫ2 atoms of a HisB10 residue in another conformation, a
HisB5 residue from the neighbour dimer and two anions or water molecules (Bentley et al.,
1976; Smith et al., 1984).
The presence of divalent metal has for a long time been known to be crucial for the
hexamer formation (Scott, 1934; Scott & Fisher, 1935). Zn2+ has the best affinity to stabilize
the hexamer, but hexamers can be well stabilized by other divalent metal ions, e.g. Mn2+,
Fe2+, Co2+, Ni2+, Cu2+ and Cd2+ (Schlichtkrull, 1956). These metals have unoccupied 3 d-
orbitals and are thus better suited for spectroscopy, which have been used to study confor-
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mational changes of hexameric insulin (Roy et al., 1989; Brader et al., 1992; Bloom et al., 1997;
Brader et al., 1997; Kadima, 1999). The crystal structure of human insulin has recently been
solved for hexamer complexes containing manganese (PDB-entry 2R34) (Sreekanth et al.,
2009), cobalt (PDB-entry 1M5A) (Nicholson et al., 2006), nickel (PDB-entries 3EXX, 2R36
and 3INC) (Prugovecˇki et al., 2009; Sreekanth et al., 2009), copper (PDB-entries 3TT8 and
3IR0) and strontium (PDB-entry 3ILG).
6.5 Hexamer conformations
In its hexameric form insulin is an allosteric complex and exists in different conformations.
The conformations are distinguished by the secondary structure of the first eight residues
of the B-chain, and are presented in Figure 6.8. The residues B1 to B8 can either adopt an
extended conformation, which is denoted as tensed (T), Figure 6.8(a), or adopt a relaxed
conformation (R), Figure 6.8(c), where the central B-chain α-helix is continuous from B1
to B19 (Kaarsholm et al., 1989). A third conformation in which the continuous α-helix is
limited to residues B4 to B19, while the residues B1 to B3 adopt extended conformation
has been reported as the frayed R-conformation, denoted Rf (Ciszak et al., 1995), see Fi-
gure 6.8(b). A fourth conformation, where the PheB1 residue is extended thereby forming
a conformation between pure R- and Rf -conformation, has been observed for one out of
six molecules in a hexamer in monoclinic R6 insulin structures (Smith et al., 2000). This
conformation will be denoted Rg in the following.
The insulin hexamer has been observed in three different conformations, as seen in
Figure 6.9. Using the T/R-nomenclature introduced by Kaarsholm et al. (1989), where a
(a) (b) (c)
Figure 6.8: Different conformations of the insulin B-chain. (a) Tensed state (T), where the residues
B1–B8 adopt an extended structure. (b) Relaxed and frayed (Rf ), where the residues B1–B3 are
extended and B4–B19 form an α-helix. (c) Relaxed (R), where the α-helical structure is adopted
throughout the entire N-terminal (B1–B19).
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number in the subscript refers to the number of monomers present in each conformation,
the T6 denotes the conformation where all six monomers adopt a T-conformation. This
conformation was earlier reported as 2Zn-insulin due to the two zinc ions bound in the
structure (Adams et al., 1969; Blundell et al., 1971; Dodson et al., 1979; Baker et al., 1988).
(a) (b) (c)
Figure 6.9: Different conformations of the insulin hexamer viewed along the 3-fold axis (top) and
perpendicular to the 3-fold axis (bottom). (a) T6, where both molecules in the dimer adopt T-
conformation. (b) T3Rf3 , where one insulin molecule in the dimer adopts T-conformation and the
other Rf -conformation. (c) R6, where both molecules in the dimer adopt R-conformation. The
figure is based on atomic coordinates from PDB-entries 1MSO (Smith et al., 2003), 1TRZ (Ciszak &
Smith, 1994) and 1EV3 (Smith et al., 2000), respectively.
It is often useful to consider the hexamer as a dimer of trimers, where each trimer contain
one zinc ion. In the T3R3 conformation one of the two trimers will adopt the helical R-
conformation while the other will remain tensed. The conformation of B1 to B3 in the three
monomers constituting in the R3 trimer were later concluded to be frayed, why this con-
formation was renamed T3R
f
3
(Ciszak et al., 1995). However, the T3R3 notation can still be
used when the conformation of the B1–B3 segment is unspecified. The T3R
f
3
conformation
was first seen in the crystal structure of 4Zn-insulin (Bentley et al., 1976), which had been
known from chemical analyses to contain four zinc ions per hexamer (Schlichtkrull, 1958).
The T3R
f
3
conformation has later been observed in hexamers which only contain two zinc
ions (Ciszak & Smith, 1994), wherefore it seemed reasonable to name the hexamer species
by their conformation rather than their zinc content.
The R6 conformation contains six insulin monomers all adopting the R-conformation,
and was first observed in the structure determined from monoclinic crystal form (Dere-
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wenda et al., 1989). The structure has later been solved from rhombohedral crystal of R6
insulin (Smith & Dodson, 1992; Smith et al., 2000).
Spectroscopic and structural studies of the allosteric property of the insulin hexamer,
demonstrate that it exists in a state of dynamic equilibrium, following the reaction scheme:
T6 ⇋ T3R3 ⇋ R6
The T6 state is obtained at low concentration of anions and in the absence of phenol
derivates (Baker et al., 1988; Smith et al., 2003). Shifting the equilibrium from the T6 state
to the T3R3 state is done by addition of inorganic lyotropic anions such as chloride or thio-
cyanide in high concentrations (Whittingham et al., 1995). These anions bind at the zinc
site and stabilize helix formation of the residues B4 to B8 in the Rf
3
-trimer (Ciszak et al.,
1995). The increased lyotropic anion concentration can only stabilize helix formation in
one of the two trimers.
Besides the presence of lyotropic anions, shifting the equilibrium to the R6 state re-
quires addition of phenol or phenol derivates. Addition of phenol-like molecules creates
two hydrophobic phenol binding sites, located at each dimer-dimer interface, and fully
stabilizes the helix formation of the first eight N-terminal residues of the B-chains in both
trimers (Derewenda et al., 1989; Smith & Dodson, 1992). The phenolic compounds bind in
these hydrophobic pockets, and form hydrogen bonds between the hydroxyl group of the
phenol and the carbonyl oxygen of CysA6 and the backbone nitrogen atom of CysA11.
Rhombohedral crystals were first obtained by Abel (1926), and were found to belong
to the space group R3 by X-ray crystallographic measurements (Crowfoot, 1938). Today
rhombohedral crystals have been obtained from all three conformations and crystal struc-
tures belonging to the space group R3 have been solved. As the trimers undergo a con-
formation from T3 to R3, the length of the hexamer slightly increases along the three-fold
symmetry axis which is coincident with the crystallographic c-axis. A systematic increase
in the unit cell c-axis from 34.0 Å in T6, to 37.6 Å in T3R
f
3
and 40.4 Å in R6 has been observed
and has earlier been used for characterization of 2Zn-insulin and 4Zn-insulin (Harding
et al., 1966; Bentley et al., 1978).
6.6 Hexamer assembly and stability
The formation of hexamers has been proposed to occur by the formation of a dimer from
two monomers, which then interacts with a second dimer forming a tetramer and finally
completed by interaction with a third dimer. As the associative forces between the dimers
are not as strong as between the two monomers of the dimer, divalent metal ions are re-
quired to stabilize the hexamer assembly. The stability formed by binding Zn2+ in these
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sites may overcome the repulsion forces of the close lying GluB13 residues in the hexamer
centre, and complete the hexamer formation. (Hill et al., 1991)
The different allosteric states are thought to be involved in the zinc uptake and release,
which respectively stabilizes and destabilizes the hexamer, and thereby play an important
role in the storage and release of insulin.
In the T6 state, the extended conformation of the N-terminal B-chains forms a wide
cleft leading into the zinc ions and exposes them to the surrounding solvent, Figure 6.9(a).
The T3 sites provides room for an octahedral coordination geometry where three water
molecules fulfil the coordination. The zinc ions exchange on a time scale of seconds, and
may thereby easily diffuse from the hexamer. As the N-terminal B-chain helices are sta-
bilized the channel leading into the zinc site is closed and the zinc ions become shielded
from its surroundings. Also the coordination of zinc is affected in these R3 sites. R3 zinc
sites are more compact, compared to those found in T3 sites due to the three helical N-
termini are closer to each other. Thereby R3 zinc sites only leaves room for tetrahedral
coordination. The stability of the hexamer conformations has been verified from spectro-
scopic studies (Rahuel-Clermont et al., 1997), which showed that R6 is themost stable of the
three conformations and that T3R3 is more stable than T6. This high stability of R6 led to
increased interest in co-crystallizing insulin with phenol derivates, e.g. m-cresol, resorci-
nol (Smith et al., 2000), 4’-hydroxyacetanilide (Smith & Ciszak, 1994), 4-hydroxybenzamid
(Smith et al., 1996), methylparaben (Whittingham et al., 1995) to produce R6 crystals for
long term acting insulin formulations.
The stability of the hexamer is also pH dependent. A stabilizing hydrogen bonding
network involving six glutamate residues (GluB13) is observed in the centre cavity of the
hexamer. At pH around 6.0 the glutamate residues are hydrogen bonded to each other.
When pH exceeds 7.0 the carboxylic acids are deprotonated, and the hexamer assembly
becomes destabilized by repulsive forces, from the six negative charges in the core of the
hexamer. At the pH of blood 7.4, these interactions are increasingly disfavoured and co-
ordination of zinc ions are essential to overcome their repulsive forces. When insulin are
secreted into the blood stream, the dilution of zinc ions in the serummeans that the zinc ion
coordination can not bemaintained, and the hexamer rapidly disintegrates intomonomers.
The important role of GluB13 was studied by mutating the glutamate to glutamine.
This recombinant insulin mutant was shown to form stable hexamers in absence of Zn-ions
at pH 7.0 (Bentley et al., 1992), and the hexamer from this mutant would presumably not
be able to disintegrate into monomers upon secretion of insulin from the storage vesicles
into the blood stream.

Chapter 7
XRD and XAS studies of T6, T3R3 and
R6 bovine insulin with Zn
The work presented in this chapter illustrates the complementarity between X-ray diffrac-
tion and X-ray absorption spectroscopy. These techniques have been used to study hex-
americ bovine insulin in the three different conformations T6, T3R3 and R6, with emphasis
on the zinc ion binding sites. Based on this work a manuscript has been written and sub-
mitted.
7.1 Introduction
In hexameric insulin crystallized in the rhombohedral space group R3, unstructured elec-
tron densities around the zinc ions bound in T3 binding sites are often observed among
the structures deposited in the Protein Data Bank, in particular for the low resolution
structures (Harding et al., 2010). These electron densities may be modelled with atoms
at chemically unreasonable bond distances. For instance a tetrahedrally coordinated Zn–O
distance of 1.18 Å is observed in a T3 binding site in the structure of an insulin analogue
to 2.0 Å resolution (PDB-entry 6INS) (Derewenda et al., 1991). A bovine insulin structure
to 2.56 Å resolution (PDB-entry 2ZP6) contains T3-sites where both tetrahedral and octa-
hedral coordination geometry of zinc are observed, and Zn–O distances up to 2.63 Å.
Possible explanations for these unstructured densities include radiation damage, which
is a general problem for single crystal XRD, due to the high energy load per volume of
sample. Metal containing proteins, in particular, suffer from radiation damage as pro-
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tein crystals with heavy atoms generally absorb more radiation and thereby have shorter
lifetimes (Holton, 2009). Furthermore, artefacts from data truncation (so-called Fourier rip-
ples) occurring around heavy scatters or artefacts generated from the three-fold symmetry
axis, on which the zinc ions are located, may affect the electron densities at these zinc sites.
Such problems are avoided by X-ray absorption spectroscopy, which also provides a lower
energy load per sample. This technique may thus be better suited for studying the zinc
coordination in hexameric insulin.
The structures of all three conformations of bovine insulin have been solved by sin-
gle crystal XRD, and corresponding samples have been studied by XAS. The single crys-
tal structures of T3R3 and R6 are new, as for bovine insulin only the structure of T6-
conformation has hitherto been solved (Smith et al., 2005). The developed procedure for
verification of crystal forms by XRPD has been applied to characterize the insulin sam-
ples before the XAS experiments. Despite the fact that insulin is a well studied protein
only one EXAFS study of the zinc sites in a single conformation of hexameric insulin has
been reported (Bordas et al., 1983), and modelling performed using only single scattering
paths. This study has been updated using both XANES and EXAFS, including full multi-
ple scattering. Finally, the XAS results are compared with what has been observed in small
molecules with similar coordination geometries, as well as in other insulin structures to
evaluate the accuracy of XAS.
7.2 Experimental
Lyophilized insulin from bovine pancreas, Bos taurus, was purchased from Sigma Aldrich
(I-5500). Other reagents used were stock chemicals, analytical grade.
7.2.1 Growth of single-insulin crystals
After several crystallization trials it was found that full control of the concentration of Zn2+
was crucial for the growths of single crystals large enough for XRD analysis. As the insulin
contains approximately 0.5 %(w/w) zinc, the zinc ions were removed from the insulin be-
fore use. Metal-free insulin was prepared by chelating using the method of Coffman &
Dunn (1988). 20 mg insulin was suspended in 1 mL ultra-pure water (18.2MΩ·cm, milli-
Q, Millipore) and dissolved by raising the pH to 10.5 with 1 M NaOH. 360 mg Chelex100
resin was added and pH adjusted to 8.7 with 1 M HCl and the suspension was stirred for
2 h while maintaining the pH at 8.7. In additional 150 mg Chelex100 resin was added to
ensure complete metal chelation and the resin was separated from the insulin solution by
syringe filtration (0.22 µm). Following the solution was diluted with milli-Q water. All
concentrations were determined by UV-vis spectrophotometry using an extinction coeffi-
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cient at 280 nm, ε280, of 5960 M−1cm−1, which was estimated by ProtParam (Gasteiger et al.,
1995).
For the growth of T6 and R6 insulin crystals, the vapour diffusion technique was used.
2 µl of a solution containing 5mgml−1 insulin adjusted to pH 6.8 using HCl(aq) wasmixed
with 2 µl reservoir solution and equilibrated in a hanging drop against 1 ml reservoir with
a composition given in Table 7.1. After 7 days 200–500 µm large crystals were observed,
Figure 7.1.
Table 7.1: Reservoir composition for single crystal growth of T6 and R6 insulin using the
vapour diffusion technique.
T6 insulin R6 insulin
Sodium citrate (M) 0.05 0.12
Zinc acetate (mM) 0.5 17
Acetone (vol.%) 15 22
m-cresol† (vol.%) – 0.5
NaCl (M) – 1.67
pH 7.2 8.4
† m-cresol was dissolved in the acetone before addition.
T3R3 insulin was crystallized using the batch crystallization technique. The crystalliza-
tion procedure is described in Section 7.2.2.
Single crystals with dimensions of 300–500 µmwere soaked in cryo-protective solution
containing 15 vol.% PEG 400, 25 vol.% glycerol and 60 vol.% mother liquor (Smith et al.,
2001, 2003) and stored in liquid nitrogen until diffraction analysis.
(a) (b)
Figure 7.1: Single crystals of (a) T6 and (b) R6 insulin.
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7.2.2 Preparation of insulin micro-crystals
Micro-crystal samples of the three conformations were used for X-ray absorption spec-
troscopy measurements. All three conformations were prepared using the batch crystal-
lization technique. The compositions of the crystallization solutions are given in Table 7.2
as the concentration for each compound in the final crystallization solution. The crystal-
lization compounds were added in the order given in the table.
Table 7.2: Crystallization conditions for preparation of micro-crystals of T6 T3R3 and
R6 insulin by batch crystallization. The compositions are given as the concentration for
each compound in the final crystallization solution.
T6 insulin T3R3 insulin R6 insulin
Insulin (mgml−1) 5.0 6.5 5.0
HCl (M) 0.01 0.01 0.01
Zinc acetate (mM) 5.0 7.0 7.5
Sodium citrate (M) 0.02 0.05 0.05
Acetone (vol.%) 15 15 20
KSCN (M) – 0.2 –
m-cresol† (vol.%) – – 0.5
NaCl (M) – – 1.0
pH 6.0 6.4 8.2
† m-cresol was dissolved in the acetone before addition.
T6 insulin microcrystals were obtained using a slightly modified procedure of the method
by Schlichtkrull (1956). The crystallization solution was warmed to 323 K and pH was
adjusted to 6.0 withHCl. The solutionwas allowed to cool to room temperature andmicro-
crystals were precipitated during 24 h under agitation. The micro-crystals were saved by
filtration using an Ultra-free-MC centrifuge filter (Amicon/Millipore), with a pore size of
0.22 µm. Excess zinc was removed by re-crystallization under analogue conditions, but
with exclusion of zinc acetate, resulting in stochiometric ratios between insulin and zinc.
T3R3 insulin crystals were grown with thiocyanate using a slightly modified proce-
dure of the method by Whittingham et al. (1995). After the crystallization solution (Ta-
ble 7.2) was prepared pH was subsequently raised to 8.0 with 1 M NaOH. The solution
was warmed to 323 K to ensure complete solution and maintained at approximately 323 K
while pH was lowered to 6.4 with 1 M HCl. The solution was placed in an incubator at
323 K and cooled to room temperature over a period of four days. The crystallization re-
sulted in a few 500 µm large crystals and several smaller rhomboid shaped crystals. The
crystals were recovered by filtration on a centrifuge filter. A large crystal was saved for sin-
gle crystal XRDwhile the rest were gently smashed to a powder. The powder was washed
three times with a solution of 0.04 M sodium citrate, 12 vol.% acetone and 0.2 M KSCN,
pH = 6.0 to eliminate excess zinc in the sample.
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R6 insulin was co-crystallized with the phenol derivative m-cresol using a crystalliza-
tion solution with an analogue composition to that from the procedure by Smith et al.
(2000), see Table 7.2. pH was raised to 9.4 with 1 M NaOH to ensure complete solution.
After adjusting the final pH to 8.2 the solution was placed in an incubator at 277 K and
after two days micro-crystals were observed. The crystals were separated by filtration on
a centrifuge filter and excess zinc was eliminated by washing three times with a zinc free
solution containing 0.035 M sodium citrate, 23 vol.% acetone, 0.3 %m-cresol and 1MNaCl.
For all three samples the correct crystal form was verified with XRPD.
7.2.3 Single crystal diffraction
Single crystal diffraction data were collected at MAX-lab, Lund, Sweden, on beam line
911-2, MAX-II using a MarResearch CCD detector. Data collection and data processing
statistics for all three crystals are summarized in Table 7.3. The data were processed and
scaled using the programs XDS and XSCALE (Kabsch, 1993). As twinning previously has
been observed for hexameric insulin crystals (Knudsen, 2011), the processed data were
tested for twinning using the on-line merohedral twin detector algorithm by Padilla &
Yeates (2003). The structures were refined using the programs REFMAC5 (Murshudov
et al., 1997) included in the CCP4 suite (Collaborative Computational Project, Number 4,
1994) and PHENIX (Adams et al., 2010). The model building and editing were carried out
usingWinCoot (Emsley & Cowtan, 2004), whereas ordered solvent was modelled using the
auto insertion procedure in PHENIX, followed by a manual inspection to remove insignifi-
cant water molecules. For each data set a random 5 % subset of all reflections was reserved
for validation. The structures were validated using PROCHECK (Laskowski et al., 1993),
WHAT_CHECK (Hooft et al., 1996) and the STructure ANalysis server STAN (Kleywegt &
Jones, 1996). Refinement and validation statistics are listed in Table 7.4.
The residue numbers are assigned according to the nomenclature used by Smith et al.
(2000, 2001), in which the decimal portion refers to the monomer number in the dimers. In
the deposited coordinates A, C, E, G, I, K, M, O, Q, S, U, W, Y, 1, 3 and 5 refer to A-chains
and B, D, F, H, J, L, N, P, R, T, V, X, Z, 2, 4 and 6 to B-chains. For instance, PheB1.3 designates
the first phenylalanine residue in the B-chain of insulin monomer 3, which corresponds to
PheF1 in the deposited PDB-file.
T6 insulin
The structure was refined using the peptide chain from the 1.0 Å structure of human T6 in-
sulin, PDB-entry 1MSO (Smith et al., 2003). Two zinc atoms were inserted, and the residues
specific for bovine insulin were mutated. The N-terminal of the B.2-chain (PheB1.2 to
GlnB4.2) was remodelled and the side chains of residues ValB12.1, LeuB17.1, CysA11.2 and
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Table 7.3: Data collection parameters and processing statistics. All data were collected at beam line 911-2,
MAX II, MAX-lab, Lund, Sweden.
T6 insulin T3R3 insulin R6 insulin
Data collection
Wavelength (Å) 1.04002 1.03914 1.04002
Temperature (K) 100 100 100
No. of frames 180 200 180
Oscillation range (◦) 1 0.5 1
Exposure time per frame (s) 8 10 10
Detector distance (mm) 80 70 120
Resolution collected (Å) 1.30 1.21 1.70
Data processing
Resolution (Å) 20.78–1.40 (1.50–1.40)† 21.27–1.23 (1.30–1.23)† 28.88–1.80 (2.00–1.80) †
No. of reflections 86987 (16137)† 70690 (7380)† 365308 (96841)†
No. of unique reflections 15790 (2963)† 23527 (3060)† 64897 (17655)†
Redundancy 5.51 (5.45)† 3.00 (2.41)† 5.63 (5.49)†
Completeness (%) 98.1 (99.8)† 93.0 (79.0)† 97.5 (97.9)†
Rsym (%)‡ 4.2 (60.8)† 4.6 (41.4)† 7.1 (50.1)†
〈I/σ(I)〉 19.28 (2.62)† 14.68 (3.52)† 11.65 (2.95)†
Space group R3 R3 R3
No. of molecules per asu 2 2 16
a (Å) 80.98 79.20 156.24
c (Å) 33.49 37.22 78.88
Average mosaicity (◦) 0.72 0.37 0.42
Solvent content§ (%) 33.2 37.2 39.1
† Values in parentheses are for the outermost resolution shell.
‡ Rsym is defined as
∑
hkl
∑
i |Ii(hkl) − 〈I(hkl)〉| /
∑
hkl
∑
i Ii(hkl), where 〈I(hkl)〉 is the mean intensity of
a set of equivalent reflections.
§ Estimated by the programMatthews (Kantarjieff & Rupp, 2003).
LeuB17.2 were modelled in two alternating conformations. A total of 84 water molecules
were inserted. Restrained refinement was carried out in PHENIX and hydrogen atoms
were included. The two zinc ions were modelled by anisotropic refinement and the pep-
tide chain by a combination of TLS refinement and isotropic refinement. The TLS domains
were chosen in a way that each secondary structure element constitute a TLS domain re-
sulting in seven domains in total: Residues 1–8 and 13–19 in A-chains, 9–18 in the B-chains
and a group containing the residues 23–27 of two adjacent B-chains. Other were refined
isotropically. Validation showed that only one residue SerA9.1 fell into the outlier region
in the Ramachandran plot using the regions defined by Kleywegt & Jones (1996).
T3R3 insulin
The structure was refined using the peptide chain from the structure of human T3R3 in-
sulin co-crystallized with 4-hydroxybenzamide, PDB-entry 1BEN (Smith et al., 1996). Two
zinc ions and one molecule of thiocyanate were included. The refinement procedure is
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Table 7.4: Data-refinement and validation statistics.
T6 insulin T3R3 insulin R6 insulin
Resolution cut (Å) 1.40 1.30 1.80
No. of atoms in the model
Total non H-atoms 903 897 6816
Total H-atoms 787 750 0
Total protein atoms 1604 1544 6218
Total ordered water molecules 84 98 454
Total ligand atoms 0 3 136
Total Zn2+-ions 2 2 8
B-factors§
Overall (Å2) 32 27 41
Main chain (Å2) 26 20 36
Side chains and water molecules (Å2) 34 29 45
M2+-ions (Å2) 16 11 24
RMS deviation from ideal
Bonds (Å) 0.013 0.008 0.007
Angles (◦) 1.449 1.038 0.982
Ramachandran plot‡
In core regions (%) 98.9 98.8 98.4
Outliers (%) 1.1 1.2 1.6
R-factors†
R 0.1938 0.1439 0.2088
Rfree 0.2285 0.1794 0.2717
§ The analysis ofB-factors was done using BAVERAGE included in CCP4 (Collaborative Compu-
tational Project, Number 4, 1994)
† R and Rfree =
∑
||Fobs| − |Fcalc|| /
∑
|Fobs|, where Fobs and Fcalc are the observed and calcu-
lated structure-factor amplitudes, respectively. Rfree was calculated with a random 5 % subset
of all reflections excluded from the refinement.
‡ The definition of the Ramachandran plot regions according to Kleywegt & Jones (1996).
analogue to the one for T6 insulin. The residues PheB1.2, LysB29.2 and AlaB30.2 were dis-
ordered and could not be modelled. The final structure contained 98 water molecules and
the side chains of residues GlnA5.1, LeuA16.1, GluB13.1, and SerB9.2 were modelled with
alternating conformations. Hydrogen atoms were included and anisotropic refinement of
the atomic displacement factors was applied. Validation showed that only one residue
SerA9.1 fell into the outlier region in the Ramachandran plot.
R6 insulin
The structure was solved by molecular replacement using an entire insulin hexamer gen-
erated from the structure from human R6 insulin, PDB-entry 1EV3 (Smith et al., 2000), as
template. Molecular replacement was carried out using Phaser (McCoy et al., 2007) which
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found two hexamers in the asymmetric unit. According to the doubling of cell parameters
when compared to the other conformations, 16 insulin molecules were expected to consti-
tute the asymmetric unit. Anothermolecular replacement was performed on the difference
map using an insulin dimer as template. This revealed another two dimers located close to
the three fold rotation axis generating two hexamers with their symmetry-related dimers.
The asymmetric unit was thus found to contain a total of 16 insulin molecules distributed
as two hexamers (insulin momomers 1–6 and 7–12) and two dimers (monomers 13–14 and
15–16). A schematic overview of all insulin molecules in the R6 conformation is shown in
Figure 7.2(a).
The electron difference density maps clearly revealed the zinc sites and showed tetra-
hedral coordination, wherefore eight chloride ions were further included in the model.
The residues specific for bovine insulin were changed and 16 molecules of m-cresol were
inserted in the binding pocket located next to the CysA6 backbone oxygens. The two C-
terminal residues LysB29 and AlaB30 in all monomers were disordered and were not mo-
delled. Special attention was made to model the phenylalanine residues at the N-terminals
of all B-chains, as they were found to adopt different conformations in the different chains,
see Figure 7.2. Alternate conformations were assigned to the residues AsnB3.1, ValB18.1,
ValB18.2, GlnB4.3, ValB18.4, ValB18.6, LeuB17.7, AsnB3.10, SerA9.12, ValB18.12, AsnB3.14,
LeuB17.16 and ValB18.16 with occupancies refined in PHENIX (the minimum occupancy
was found to be 0.33). 454 water molecules were included in the structure and the atomic
displacement factors were refined by a combination of TLS refinement and isotropic re-
finement using seven TLS domains per dimer in analogy to the T6-structure, resulting in
56 domains in total. All other atoms were refined isotropically. Validation showed that
11 ValB2 residues in monomers 3, 4, 5, 7, 8, 9, 11, 12, 13, 15 and 16 fell into the outlier
region in the Ramachandran plot.
7.2.4 X-ray powder diffraction
The micro-crystal samples for XAFS analysis were analysed with X-ray powder diffraction
(XRPD) before and after the XAFS experiment to verify the conformation and to monitor
eventual degradations of the samples. Small amounts (5–7 µl) of wetted insulin micro-
crystals samples were mounted in a 1 mm thick sample holder for XRPD as well as XAS
(Frankær et al., 2011), as described in Chapter 5. Using the procedure to calculate XRPD
patterns from PDB coordinates described in Chapter 4, the conformations were verified in
30 minutes on a Huber G670 diffractometer using CuKα1 radiation (λ = 1.5406 Å). XRPD
data was furthermore collected for R6 insulin at 120 K and RT for 64 and 16 h, respectively.
These R6-samples were mounted in capillaries in order to apply a laminar flow of nitrogen
for cooling (Oxford Cryosystems).
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Figure 7.2: (a) Schematic representation of the over all packing of the eight dimers constituting the
asymmetric unit, with the different conformations of PheB1 schematically drawn. The N-terminal
residues B1–B4 are shown in reality: (b) for the site where monomers 4 and 7meet and (c) for the site
where monomers 1 and 8meet. Orderedwater molecules are shown as red spheres. (d) The B-chain
N-terminal for Rf -conformation (green) seen in R3-sites of T3R3 insulin (e.g. PDB-entry 1BEN), the
new conformation (blue), seen in monomers 2–9, 11–13, 15 and 16 and the pure R-conformation
(orange), seen in monomers 1, 10 and 14.
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7.2.5 X-ray absorption spectroscopy
Data collection
XAFS measurements at the Zn K-edge were carried out on beam line 811 at the syn-
chrotron at MAX-lab, Lund, Sweden using a Si(111) double-crystal monochromator. The
storage ring was operating with ring currents between 150 and 300 mA, and harmonics
were suppressed by detuning the peak intensity by 60 % at 10660 eV.
XAS data for the insulin samples as prepared for XRPD were collected in fluorescence
mode. A photograph of a mounted insulin sample is shown in Figure 7.3. XAS data were
also collected for two model compounds representing respectively octahedrally and tetra-
hedrally coordinated Zn: The six-coordinated zinc in hexakisimidazolezinc(II) chloride
(Sandmark & Brändén, 1967) and the four-coordinated zinc in bisimidazolezinc(II) chlo-
ride (Edsall et al., 1954). The model compounds were diluted with boron nitride in the
ratio 1:6 to avoid self absorption and measured in transmission mode.
Figure 7.3: XAS sample of insulinmounted at the cryostat holder on beam line 811, MAX-lab, Lund,
Sweden.
The samples were kept at 100 K in a liquid nitrogen cryostat. Transmission data were col-
lected using ion chambers and fluorescence data were collected with a PIPS (Passivated
Implanted Planar Silicon) detector equipped with solar slits and a copper filter to surpress
non-Zn fluorescence scattering. Data were collected in the region 9510–10660 eV in follow-
ing intervals: Pre-edge data (150–30 eV before the edge) were collected in steps of 5 eV
for 1 s, the edge (from 30 eV before to 30 eV above the edge) in steps of 0.3 eV for 1 s,
and the EXAFS (30–1000 eV above the edge, corresponding to 16 Å−1 in k-space) in steps
of 0.05 Å−1 for 1–15 s. Three to four spectra were collected for each sample to ensure
reproducibility and that no radiation damage of the sample had taken place.
XAS data reduction
The spectra were deglitched, averaged, energy calibrated, background corrected and the
EXAFS function χ(k) extracted using WinXAS (Ressler, 1998), as described in Section 3.4.
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The energy calibration was carried out using a simultaneous XAFS transmission spectrum
of a Zn reference foil. The first inflection point of the foil spectrum was assigned to the Zn
K-edge (9659 eV).
EXAFS analysis
Simulations of the calibrated, averaged and background corrected EXAFS, χ(k), were car-
ried out using EXCURVE (Gurman et al., 1984, 1986; Binsted et al., 1991). Potentials were
calculated using the relaxed approximation and phase shift by the Hedin-Lundqvist me-
thod. The startingmodels, consisting of atomswithin a radius of 5.6 Å from the zinc atoms,
(which thereby includes the Cβ atom of the histidine residues) were taken from the crystal
structures described in Section 7.2.3.
Multiple scattering, which occurs in the imidazole and the linear thiocyanate molecule,
in particular, was included throughout all refinements. The amplitude reduction factor, S20 ,
was set to 0.95 due to a relatively low self absorption caused by the low zinc concentrations.
The models were refined by first a constrained and later a restrained refinement (Binsted
et al., 1992). In the constrained refinement E0, distances and Debye-Waller factors were
refined iteratively where each histidine is assumed to be rigid and refined by only one
distance and one angular parameter, (Binsted et al., 1992). The number of refineable pa-
rameters was kept low by grouping Debye-Waller factors of atoms with similar distances
to the central atom (e.g. the Cε1 and Cδ2 in the histidine residue). During refinement,
the ordered water molecules included in the crystal structures in the outer coordination
shells were stepwise included in the model, and justified only if the fit-index, ǫ2v, decreased
by more than 5 % (Joyner et al., 1987). The fit index taking account of the degree of over
determinacy in the system is given as:
ǫ2v =
1
Nind −Np
Nind
N
N∑
i
1
σ2i
(
χexp(ki)− χteo(ki)
)2 (7.1)
in which N is the number of data points, Nind is the number of independent data points
and Np is the number of parameters. 1/σi is a normallization term used for simplifying
the numerical methods employed in the algorithm and is further defined in Binsted et al.
(1992). The fit was evaluated by a residual, Rexafs, defined as (Binsted et al., 1992):
Rexafs =
N∑
i
1
σi
(∣∣χexp(ki)− χteo(ki)∣∣) · 100% (7.2)
Hereafter restrained refinement was performed in which the restraints were set up for the
histidine residue restraining the imidazole and the Cβ atom as defined by Engh & Huber
(1991) and shown in Figure 7.4. The geometric restraints and the EXAFS were weighted by
50 % each.
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Figure 7.4: Ideal bond lengths of the histidine residueused in restrained refinement (Engh&Huber,
1991). Dashed lines indicates ’secondary’ bond distances which are used to define the angles.
XANES analysis
For XANES analysis the calibrated, averaged and background corrected experimental spec-
tra, given as a function of energy, µ(E), are compared with other experimental XANES
spectra (qualitative analysis) and calculated XANES spectra (quantitative analysis). Cal-
culation of XANES spectra were performed using the FDMNES code (Joly, 2001), which
perform full potential calculations using finite difference methods (FDM).
For quantitative fitting of XANES spectra the coordinates optimized from the EXAFS
analysis were used as starting models. Full multiple scattering calculations were per-
formed at the Zn K-edge using the FDMNES-code (Joly, 2001) testing both the muffin-tin
(MT) approximation and the FDM approach. A cluster with a radius of 4.5 Å from the Zn-
ion was found suitable to reproduce the features of the XANES spectra still minimizing
the calculation time. The calculated spectra were convoluted with an energy-dependent
broadening using an arctangent function to account for inelastic processes, and with a
Gaussian function to simulate the experimental energy resolution of the instrument. For
the fitting procedure geometrical transformations were decomposed into parameters and
selected by the criterion that each parameter must have a significant influence on the
XANES spectra. Four structural parameters (two ligand-zinc distances and two angles)
have been chosen for T6 and R6 insulin conformers. All geometry transformations and
FDM calculations were carried out and the structural parameters were optimized by mul-
tidimensional interpolation of calculated XANES spectra by FitIt (Smolentsev & Soldatov,
2007). The best fit was found by finding a suitable interpolation polynomial and a XANES
spectrum of the optimized geometry was calculated for verification. The fit between cal-
culated and experimental spectra is evaluated with an R-factor, given as:
Rxanes =
N∑
i
∣∣µexp(Ei)− µcalc(Ei)∣∣
µexp(Ei)
· 100% (7.3)
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7.2.6 Comparison analysis
An analysis of Zn-coordination in other insulin structures was carried out by searching
the Protein Data Bank (PDB). 67 X-ray structures of hexameric insulin (including mutant
proteins) containing Znwere found. Structures solved at non-cryogenic temperatureswere
discarded and only the structures with a resolution of 2.00 Å or better were included in
the analysis since the geometrical restraints are tighter for low resolution structures. This
resulted in a total of 31 structures. The Zn sites in these structures were classified as either
a T3-site or an R3-site and the bond distances from Zn to its inner coordination sphere
ligands were extracted.
Zn-coordination in small molecules were analysed by searching the Cambridge Struc-
ture Database (CSD) among structures solved at temperatures below 200 K containing zinc
which coordinates to three monodentate ligands through sp2-hybridized nitrogen atoms.
For the T3-site and the R3-site, respectively, only structures containing Zn coordinated to
six atoms (3 nitrogen ligands and 3 other atoms) and Zn coordinated to four atoms (3
nitrogen ligands and 1 chloride) were included in the analysis. Among the structures con-
taining hexa-coordinated zinc only Zn–O-distances were included in the analysis besides
the three Zn–N-distances.
7.3 Results
7.3.1 Single-crystal X-ray diffraction structures
General conformation
The conformations of the B-chain N-terminals, which determine the overall insulin confor-
mation, have been verified in all three structures: Both insulinmolecules in the T6-structure
adopt tensed conformation in which the backbone of residues B1–B8 is extended. In the
T3R3-structure the insulin molecule present in the T3-trimer also adopts extended confor-
mation, whereas for the molecule involved in the R3-trimer an Rf conformation was ob-
served in analogy to what has been observed for human and porcine T3R3 insulin (Smith
et al., 2001; Whittingham et al., 1995). In the R6 insulin structure pure R-conformation,
where all residues in the range B1–B18 take part of an α-helix, was only observed in
monomers 1, 10 and 14 (see Figure 7.2(a)–(c). The three first residues B1–B3 in the rest of
the 16 insulin molecules were neither observed to adopt a pure R- nor an Rf -conformation,
but something in between, where the PheB1 residue is extended, Figure 7.2(d). This con-
formation will be designated Rg in the following. As a consequence the ψ and ϕ-torsion
angles of ValB2 take values around −89◦ and +50◦, respectively which are found to be lo-
cated at the border to the allowed regions in the Ramachandran plot, thereby justifying the
outliers of the ValB2 residues. The PheB1 residues are located on the protein surface and
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are thereby involved in the hexamer packing. The backbone orientation of the two hexam-
ers and the two dimers, respectively, were observed to differ by a rotation of 9◦ about an
axis parallel to the c-axis, see Figure 7.2(a).
Geometry of Zn-sites
The coordination of the zinc sites are presented in Figure 7.5 and 7.6. For the T6-conforma-
tion, octahedral coordination geometry was verified at both Zn-sites, fulfilled by three
symmetry related water molecules at 2.29 Å on average from the Zn-atom. As the Zn-
sites in T6 insulin are exposed to the solvent, a large electron density was observed above
the Zn-ion, Figure 7.5(a), which was best modelled by water molecules connected by a
hydrogen bonding network. The Zn-sites in R6 insulin, Figure 7.5(b), are not exposed to
the solvent. They are encased by the helix formation of the N-terminal of the B-chains, and
thereby only allowed room for a tetrahedral coordination with a chloride ion completing
the coordination. The Zn–Cl distances ranged from 2.07 to 2.40 Å, throughout the eight
Zn-sites, with an average of 2.21±0.10 Å.
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Figure 7.5: (a) Octahedrally coordinated Zn in the 1.4 Å T6 insulin structure, where the electron
density has been modelled with four symmetry related water molecules, of which one is located on
the three-fold axis (O2). (b) Tetrahedrally coordinated Zn in the 1.8 Å R6 insulin structure, in which
the LeuB6 residues encase the metal site. Distances to the first coordination sphere as determined
by single crystal X-ray diffraction are shown. As the T6 and R6 insulin respectively contain two
and eight Zn per asymmetric unit, the distances shown are the average of the different Zn-sites in
each structure. The σA-weighted 2Fo − Fc maps have been contoured at 1.0 σ.
In the T3R3-structure both Zn-site geometries were observed, Figure 7.6. One thiocyanate
ion fulfils the tetrahedral Zn-site coordination, Figure 7.6(a), as observed earlier for the
porcine T3R3-structure (Whittingham et al., 1995). A clear octahedral Zn coordination was
observed at the other Zn-site, and the electron density was modelled by water molecules
at a distance 2.47 Å from the Zn-atom, Figure 7.6(b).
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Figure 7.6: Zn coordination in the 1.3 Å T3R3 insulin structure. (a) A thiocyanate fulfils the tetrahe-
dral coordination and the site is further encased by LeuB6 residues in analogy to the Zn-sites in R6
insulin. (b) Octahedrally coordinated Zn where the electron density has been modelled with three
symmetry related water molecules. Distances to the first coordination sphere as determined by
single crystal X-ray diffraction are shown. The σA-weighted 2Fo − Fc maps have been contoured
at 1.0 σ.
7.3.2 X-ray powder diffraction
Using the procedures described in Chapter 4 the crystal forms were verified from the pow-
der patterns. The unit cell parameters were determined from a full pattern profile fit and
listed in Table 7.5. The unit cell parameters are different for the different conformations,
e.g. the unit cell parameter c is increased by approximately 3 Å for each trimer undergoing
a T to R conformational change. This systematic variation of unit cell parameters is thereby
the primary factor for the identification of the conformations. Experimental and calculated
patterns of all three insulin conformations are seen in Figure 7.7.
Table 7.5: Unit cell parameters determined by XRPD from full pattern profile fits.
Identification Phase analysis
T6 insulin T3R3 insulin R6 insulin R6 insulin R6 insulin
Temperature (K) RT RT RT RT 120
Data collection time (h) 0.5 0.5 0.5 16 64
a (Å) 82.86 80.99 80.39 80.02 156.49
c (Å) 33.96 37.45 40.27 40.11 78.53
Rp (%) 0.83 1.09 0.94 0.79 0.22
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Figure 7.7: Experimental (red) and calculated (blue) XRPD patterns of (a) T6 , (b) T3R3 and (c) R6.
The verification of the crystal formswas done from experimental data collected in 30 minutes. Unit-
cell and peak shape parameters were optimized from full pattern profile fits, and solvent correction
using average values of ksol = 0.35 eÅ
−3 and Bsol = 46 Å
2 was applied prior to calculation of the
powder patterns.
In order to detect whether the R6 insulin undergoes a phase transition when cryo-cooled,
powder patterns with longer data collection times were collected at RT and at 120 K. The
unit cell doubling observed in the single crystal experiment was detected from the XRPD
patterns, as well, by looking at the low angle region (2θ = 3 − 5◦) in the powder patterns,
where the peaks are better resolved. In the cold pattern, reflections which are not in agree-
ment with the non-doubled unit cell are observed, for instance the reflection at 3.25◦, which
is pointed out on Figure 7.8(a) can only originate from a large unit cell. Analogously, from
the powder pattern collected at RT all reflections are in accordance with the non-doubled
unit cell, Figure 7.8(b).
7.3.3 Qualitative XANES spectroscopy
In Figure 7.9 XANES spectra of the three insulin conformations T6, R6 and T3R3, having re-
spectively six-coordinated zinc, four-coordinated zinc and a mixture hereof, are compared
with the two model compounds. The octahedrally coordinated zinc complexes with six
ligands give strong white lines (> 1.5) with normalized edge steps, whereas tetrahedrally
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Figure 7.8: XRPD patterns of R6 insulin collected at 120 K (a) and RT (b). Insets: magnification of
the low angle region (2θ = 3 − 5◦) and the positions of the Bragg peaks for the large (a ≈ 160 Å,
c ≈ 80 Å) and small (a ≈ 80 Å, c ≈ 40 Å) unit cell, respectively. The peak pointed out at 3.25◦ in
the cold spectrum indicates that the cold phase must have doubled unit cell parameters.
coordinated zinc complexes give white lines (< 1.5) with normalized edge steps (Feiters
et al., 2003). The medium intensity of the white line for the T3R3-conformation indicates
coordination of both octahedral and tetrahedral character, which is in agreement with the
dual coordination observed in the crystal structure.
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Figure 7.9: Energy calibrated XANES spectra of the three protein samples and the two reference
compounds: Hexakisimidazolezinc(II) chloride, T6 insulin, T3R3 insulin, R6 insulin, bisimidazolez-
inc(II) chloride. The location of theK-edge of metallic zinc (9659 eV) is pointed out.
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7.3.4 EXAFS spectroscopy
The extracted k3-weighted EXAFS spectra and the modulus of the phase-corrected Fou-
rier transforms of the three insulin conformations are presented in Figure 7.10. The major
single peak in the radial distribution function is observed around 2.0 Å and corresponds
to the inner coordination shell which is mostly dominated by the three imidazole nitro-
gen atoms and common for all three conformations. The shells occurring around 3 and
4 Å verifies the imidazole coordination of histidine in all conformations. The imidazole
coordination can also be directly identified from the ’camel-back’ feature around 4–5 Å−1
which originates from the interference between the backscattered electron waves from the
first, second and third shell atoms of the imidazole ring (Bordas et al., 1983).
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Figure 7.10: (a) k3-weighted EXAFS spectra and (b) radial distribution functions calculated as the
modulus of the phase corrected Fourier transforms of the three protein samples: T6 insulin, T3R3
insulin and R6 insulin.
By comparing the k3-weighted χ(k) at low k-values (approx. 3–7 Å−1) the T3R3-conforma-
tion have character of both T6 and R6 which is in agreementwith the dual tetrahedral/octa-
hedral coordination of the zinc ions as seen from the crystal structure and the XANES
spectra. An indication for coordination of thiocyanate in the T3R3-conformation is seen
as a slightly more intense and complex peak around 4.5–5.0 Å in the radial distribution
function whereas the chloride which is fulfilling the tetrahedral coordination in the R6-
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conformation is seen as a more intense and slightly more broadened inner coordination
shell peak at 2.0–2.2 Å.
The optimized distances and Debye-Waller factors are presented in Table 7.6 and the
best fits are shown in Figure 7.11 (dashed lines). Due to the complexity of the double
cluster necessary for modelling the T3R3-conformation restrained refinement resulted in
too many refineable parameters, and was therefore abandoned. Restrained refinement for
T6 and R6-conformations gave the best fits where residuals down to 11–15 %were reached.
Further EXAFS refinement statistics are summarized in Table 7.7.
The distances to the inner coordination sphere as determined by EXAFS were used
as restraints for refinement of the T6- and R6 insulin XRD-structures. The EXAFS dis-
tances were given as the ideal distance and the uncertainty as the standard deviation σ in
PHENIX. Slightly increasedRfree were observed for both T6- and R6 insulin, when applying
the restraints from the EXAFS model.
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Figure 7.11: k3-weighted EXAFS (top) and radial distribution functions calculated as the modulus
of the phase-corrected Fourier transform (bottom) of the three insulin conformations: (a) T6 (b)
T3R3 and (c) R6. Experimental spectra are shown in blue and simulated in red (dashed), using the
parameters from the restrained refinement given in Table 7.6 for T6 and R6, and parameters from
the constrained refinement for T3R3 given in Table 7.6.
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Table 7.6: Zn-coordination distances as refined from EXAFS of T6-, R6- and T3R3 insulin compared
to crystallographic values. T6 and R6 have been refined with restrained refinement, while T3R3 has
been refinement using constrained refinement.
T3-sites
T6 insulin T3R3 insulin
XRD Restrained EXAFS XRD Constrained EXAFS
〈R〉§ (Å) R (Å) 2σ2 (Å2) 〈R〉§ (Å) R (Å) 2σ2 (Å2)
Nε2 (HisB10) 2.10 2.074(3) 0.012(1) 2.07 2.025(11)† 0.014(1)
Cε1 3.03 3.07(4)‡ 0.020(3) 3.05 2.84 0.018(1)
Cδ2 3.13 3.05(3)‡ 0.020(3) 3.05 3.16 0.018(1)
Nδ1 4.17 4.22(2)‡ 0.017(3) 4.16 4.03 0.028(4)
Cγ 4.26 4.22(3)‡ 0.017(3) 4.20 4.21 0.028(4)
Cβ 5.69 5.55(5)‡ 0.017(3) 5.61 5.66 0.030(3)
Ow1 2.29 2.135(11) 0.030(1) 2.47 2.289(15) 0.035(5)
Ow2 (axial) 3.09 2.88(3) 0.021(10)
R3-sites
R6 insulin T3R3 insulin
XRD Restrained EXAFS XRD Constrained EXAFS
〈R〉§ (Å) R (Å) 2σ2 (Å2) 〈R〉§ (Å) R (Å) 2σ2 (Å2)
Nε2 (HisB10) 2.08 2.001(4) 0.007(1) 2.02 1.987(11)† 0.014(1)
Cε1 3.09 2.98(2)‡ 0.010(2) 2.99 2.99 0.018(1)
Cδ2 3.04 3.04(2)‡ 0.010(2) 3.03 2.96 0.018(1)
Nδ1 4.18 4.15(1)‡ 0.012(2) 4.10 4.09 0.028(4)
Cγ 4.19 4.14(2)‡ 0.012(2) 4.16 4.11 0.028(4)
Cβ 5.60 5.53(3)‡ 0.012(2) 5.58 5.52 0.030(3)
O (LeuB6) 4.87 4.90(5) 0.020(9)
Cl (axial) 2.21 2.218(3) 0.006(1)
NSCN (axial) 1.83 1.802(9) 0.014(1)
CSCN 2.98 2.96 0.018(1)
SSCN 4.72 4.69 0.017(3)
† The rotation angle of the histidine unit around an axis orthogonal to the imidazole plane going
through the Nε2 was included in the refinement.
‡ The φ-angle (polar coordinates) was refined in order to allow some movement of the atoms in
the restrained imidazole ring.
§ Average distances of all Zn-sites in the structure. The standard deviations among the different
sites are below 0.03 Å for T6 insulin and below 0.1 Å for R6 insulin.
7.3.5 Quantitative fitting of XANES spectra
Quantitative fitting of XANES spectrawas possible for T6 and R6 insulin and the calculated
XANES spectra are shown in Figure 7.12 for both conformations before and after the fitting.
FDM calculation of a XANES spectrum using a 4.5 Å cluster took 1–2 days on the high
performance computer available at the Technical University of Denmark.
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Table 7.7: EXAFS refinement statistics. T6 and R6 have been refined with restrained
refinement, while T3R3 has been refinement using constrained refinement.
T6 insulin R6 insulin T3R3 insulin
Ef (eV) −3.31 −5.47 −2.366
ǫ2v 0.4127 0.1920 3.1572
Rexafs (%) 14.09 10.17 22.53
Rdist (%) 1.14 0.65
Rtotal (%) 15.23 10.82
Np 19 19 14
k-range (Å−1) 2.8–14.3 2.8–13.3 2.8–14.3
wdist 0.5 0.5
Using the MT-approach a XANES spectrum could be calculated in minutes on a standard
PC, but matches the observed poorly, as seen in Figure 7.12, whereas the spectra calculated
by the FDM approach are in better agreement with the experimental spectra.
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Figure 7.12: XANES calculated on a 4.5 Å cluster around each Zn-atom of (a) T6 insulin, and (b)
R6 insulin. Calculation were done on the input model (EXAFS model) using both the MT approx-
imation (green) and FDM approach (red), and on the model optimized by FitIt (XANES model)
using the FDM approach (blue). The calculated spectra are compared with experimental XANES
(dashed). The offset of the energy scale is 9659 eV corresponding to theK-edge position of metallic
zinc.
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The XANES technique is more sensitive to bond angles among the used techniques.
Besides the distances to the inner coordination sphere, two angles were found to have a
significant influence on the XANES spectra: ∠(Zn–Nε2–Cε1) for both conformations and
∠(Nε2–Zn–Ow1) for T6 and ∠(Nε2–Zn–Cl) for R6. The geometrical parameters, P1–P4, var-
ied during the quantitative fit, are visualized in Figure 7.13 and their values are listed in
Table 7.8 together with the Rxanes for the fits.
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Figure 7.13: The 4.5 Å cluster used for calculation of XANES spectra of (a) T6 and (b) R6 insulin.
The parameters which were varied during the quantitative fit P1–P4 are visualized.
Table 7.8: Quantitative XANES fit parameters andR-factors for the initial model (EXAFS
model) and the model optimized by Fit-It (XANES model).
T6 insulin Input model Optimized model
(EXAFS model) (XANES model)
P1: Zn–Nε2 (HisB10) 2.07 Å 2.08 Å
P2: Zn–Ow1 2.14 Å 2.13 Å
P3: ∠(Zn–Nε2–Cε1) 127◦ 119◦
P4: ∠(Nε2–Zn–Ow1) 166◦ 173◦
Rxanes 3.7 % 2.5 %
R6 insulin Input model Optimized model
(EXAFS model) (XANES model)
P1: Zn–Nε2 (HisB10) 2.00 Å 2.00 Å
P2: Zn–Cl 2.22 Å 2.24 Å
P3: ∠(Zn–Nε2–Cε1) 130◦ 141◦
P4: ∠(Nε2–Zn–Cl) 109◦ 107◦
Rxanes 3.4 % 2.4 %
Regarding the inner coordination sphere of Zn, the XANES analysis of T6 insulin shows
a more regular octahedrally coordinated Zn than determined from the XRD, as the angle
Nε2–Zn–Ow1 was optimized from 166◦ to 173◦. The tetrahedral Zn-site in R6 insulin, was
7.4. Discussion 83
verified without significant optimizations, meaning that the initial R6-model from the EX-
AFS optimized XRD structure was better than the T6-model. However, in-plane rotation
of the histidines was optimized from 130◦ to 141◦ with significant influence on the shape
and the intensity ratio of the main double peak of the spectrum, see Figure 7.12(b). The
optimized models from XANES were used for another round of EXAFS analysis, which
gave fits of similar quality as the initial.
7.3.6 Comparison with other reported Zn-site geometries
The result of the analysis of bond distances involved in the zinc coordination observed in
other insulin structures, as well as in small molecules with similar coordination geometries,
is summarized Table 7.9. The Zn–N bond distances for the R3-sites amongst the insulin
structures are plotted as a function of the resolution, Figure 7.14.
Table 7.9: Average bond distances and statistical standard deviations for Zn bonds to its inner
sphere ligands among 31 insulin structures deposited at PDB and 39 small molecule structures
with similar Zn coordination.
PDB-analysis T3-sites R3-sites
Number of Zn-sites 25 42
Zn–Nε2 (Å) Zn–Ow1 (Å) Zn–Nε2 (Å) Zn–Cl (Å)
All structures 2.06(5) 2.41(17) 2.02(10) 2.18(9)
XRD this work† 2.10(1) 2.29(3) 2.08(5) 2.21(10)
EXAFS this work† 2.07 2.14 2.00 2.22
CSD-analysis Octahedral Zn (3N+3X) Tetrahedral Zn (3N+1Cl)
Number of structures 26 13
Zn–N(sp2) (Å) Zn–O (Å) Zn–N(sp2) (Å) Zn–Cl (Å)
2.16(3) 2.16(4) 2.01(2) 2.26(3)
† Only distances for the T6 and R6 insulin are presented.
7.4 Discussion
7.4.1 Single crystal XRD structures
The three conformations of bovine insulin were crystallized in the space group R3, and
data were collected to 1.40 Å, 1.30 Å and 1.80 Å resolutions for T6, T3R3 and R6 insulin,
respectively. The structures of bovine insulin in the T3R3 and R6 conformations have
not been solved before. In analogy to what has been observed for an earlier reported
bovine T6 insulin structure (Smith et al., 2005) the structural consequences of the sequence
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Figure 7.14: Zn–N distances as a function of resolution among 42 R3-sites deposited in PDB. In-
sulin structures inH3 are distinguished from other space groups. Furthermore the Zn–N distances
from the XRD-structures presented in this work, the Zn–N distance in R6 insulin as determined by
EXAFS and the average Zn–N distance among tetrahedral Zn-sites in small molecules are included.
change at A8 and A10 were not significant in any of the three conformations. However
there are some differences to previously reported structures. The structures presented
here were superposed with other structures deposited in the Protein Data Bank. Inde-
pendent T2, TR and R2 dimers in T6, T3R3 and R6 insulin, respectively, were superposed
using a least-squares procedure using SUPERPOSE (Krissinel & Henrick, 2004), where
the displacements of Cα-atoms of all residues in common were minimized, and the root
mean squares (RMS) were calculated. The T6-structure shows a high resemblance to the
previously published bovine structure (RMS= 0.282 Å, PDB-entry 2A3G), (Smith et al.,
2005), and the porcine structure (RMS= 0.239 Å, PDB entry 4INS), (Baker et al., 1988). A
somewhat larger discrepancy to the human (RMS= 1.013 Å, PDB-entry 1MSO), (Smith
et al., 2003) may be explained a difference of the conformation of the B1.2–B4.2 chain. The
T3R3 insulin structure is in close resemblance with the porcine structure (RMS= 0.377 Å,
PDB-entry 2TCI), (Whittingham et al., 1995), which was also crystallized with thiocyanate.
The bovine R6-structure displays a eight-fold cell doubling compared to the human R6-
structure (PDB-entry 1EV3), (Smith et al., 2000). This means that the asymmetric unit con-
tains 16 monomers, whereof themajority (13 out of 16 monomers) of the B-chain N-termini
are found to adopt Rg-conformation. Excluding PheB1 and ValB2 from the superposition
resulted in RMS displacement of Cαs of 0.413 Å. The Rg conformation has previously been
observed for one out of six molecules in a hexamer in monoclinic R6 insulin structures
(Smith et al., 2000). Together with the observed rotation of adjacent hexamers/dimers
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along the c-direction by 9◦, the conformational variation of the B-chain N-termini explain
the eight-fold doubling of the unit cell. Using powder diffraction a phase transition was
observed for the R6-conformation when cooled, in analogy to what has been seen in the hu-
man T3R3-structure by Smith et al. (2001) with the large unit cell being the low temperature
structure.
Both Zn-sites in T6 insulin structure are octahedral and coordinate three water mole-
cules at similar, however long, distances to what has been observed in the other T6-structu-
res (Baker et al., 1988; Smith et al., 2003, 2005). For the T3R3, Zn sites, the three water
molecules which fulfil octahedral coordination are clearly observed at the T3-site, in con-
trast to the porcine (Whittingham et al., 1995) and the human (Smith et al., 2001) struc-
ture, where tetrahedral coordination fulfilled by respectively a single water molecule and
chloride ion, has been modelled. The R3-sites in both the T3R3 and R6 conformations are
however always tetrahedral, as one lyotropic anion fulfils the coordination geometry.
7.4.2 XAS
Using EXAFS the inner coordination sphere distances are more accurately determined
(down to 0.005 Å), whereas distance to outer shells are determined with accuracies around
0.01–0.05 Å. Comparing XAS with XRD the level of accuracy obtained by these two meth-
ods is still intensely discussed, but it certainly depends on the actual resolution of the XRD
structure, and the inner coordination sphere distances must be significantly better deter-
mined by XAS. Not surprisingly, the results demonstrate that the technique is best for
mononuclear metalloproteins or metalloproteins containing several metal clusters that all
have identical coordination geometry. Samples having different coordinations of the same
metal, as in the T3R3-conformation, highly increase the complexity of data treatment and
reduce the amount of structural information which can be resolved. It was clearly demon-
strated that the FDM-methods reproduce the XANES spectra quite well. The coordination
geometry of the zinc sites (bond angles in particular) was optimized from XANES. How-
ever, very good quality of the EXAFS spectra (high signal-to-noise ratios for data up to
k = 13 − 14 Å−1) allowed the initial structural model to be quite accurate. Therefore only
subtle adjustments of the coordination geometries were possible with quantitative XANES
fitting. The optimized bond distances were in agreement with EXAFS, and thereby XANES
serves as tool for cross-validation. Furthermore qualitative comparison of XANES spectra
is a powerful tool for identification and verification of coordination geometry.
7.4.3 Comparison with other reported Zn-site geometries
The data base search for small-molecule structures with a geometry that resembles the T6
geometry revealed only a small number of structures with Zn coordinated to three nitro-
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gen and three oxygen ligands with facial isomerism. Therefore the three ligands besides
nitrogen were unspecified in the search. For the T3-site Zn–N distances there is a good
agreement between the mean XRD and the EXAFS results. The small molecule search
shows a somewhat longer distance, maybe due to the difficulty to find matching struc-
tures. For the Zn–O distances, however, EXAFS clearly gives a distance much closer to the
small-molecule structures, while XRD gives a too large number and a very large standard
deviation. A brief look at some difference maps for insulin structures on PDB containing
T3-sites (including the XRD structure presented here) often reveals unstructured densities,
modelledwith watermolecules and at chemically unreasonable bond lengths, in particular
in structures with lower resolution.
For the R3-sites the Zn–N distance found by the EXAFS study is closer to the Zn–N
distance found by averaging all the PDB-structures than to the structure determined in
this paper. The broad spread amongst the distances found by XRD is seen in Figure 7.14. It
is clear that the high-resolution structures show a very good agreement with results from
the small-molecule survey and with the EXAFS result.
An explanation for the quite large discrepancy between the XRD structures and the
EXAFS results could be the difference in X-ray dose imposed on the samples. The doses
for the two experiments were estimated using the photon energy and flux specifications
for beam line 911-2 and 811 as well as the sample size and exposure time. The estimation
shows a higher dose by more than two orders of magnitude (2.6 · 109 Gy) for the single
crystal used for XRD compared to the XAS sample (2.5 · 107 Gy), wherefore it must be
assumed that the single crystals suffer from a higher degree of radiation damage. It is also
reasonable to assume that radiation damage influences the loosely bound water molecules
in the T3-site more severely than the tightly bound chloride ion in the R3-site.
7.5 Conclusive remarks
The structures of all three conformations (T6, T3R3 and R6) of bovine insulin were solved
by single crystal XRD, whereof two of the structures are new (T3R3 and R6). The developed
procedure for verification of crystal forms by XRPD was successfully applied to character-
ize the insulin samples before the XAS experiments. For R6 insulin, XRPD was also used
to identify a phase transition, in which the unit cell volume is eight-fold doubled when
cooled.
The distances between the zinc and its ligands were very accurately determined with
EXAFS (within 0.01 Å), in particular those in the first coordination sphere. The EXAFS
determinations are in agreement to what has been observed among small molecules with
similar coordination geometries, as well as other high resolution insulin structures. These
observations may be coupled to a lower radiation dose for XAS experiments. EXAFS may
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thus be better suited for studying metal sites in proteins, which are sensitive to radiation
damage. Using XANES the coordination geometry was verified by qualitative compari-
son with reference compounds and realistic XANES spectra were calculated using finite
difference methods.
This study on hexameric bovine insulin highly illustrates the complementarity between
XRD and XAS for studying metals in proteins.

Chapter 8
XRD and XAS studies of T6 insulin
with Fe, Ni, and Cu
Hexameric insulin is stabilized by other divalent cations than zinc. In this chapter a study
of T6 insulin with iron, nickel and copper is presented, with particular focus on the metal
coordination. This work further illustrates the complementarity between X-ray absorption
spectroscopy and diffraction. Hexameric insulin can also be stabilized by some mono-
valent cations. Insulin structures with rubidium and caesium are solved and briefly pre-
sented in Appendix B.
8.1 Introduction
Metal ions are known to play a key role in the storage, release and conformations of insulin
(Emdin et al., 1980; Sudmeier et al., 1981). The type of metal that binds to insulin influence
on the stability of the hexamer, as well as on the conformation and coordination geometry,
and it has therefore been suggested that different intermediates in the T6 to R6 pathway
could be trapped by crystallizing with different metals (Sreekanth et al., 2009).
Metal ions are also known to play a role in amyloid fibrillation, by which peptides con-
vert into insoluble aggregates. The mechanisms behind fibrillation are poorly understood,
but studying formation of fibrils is important as fibrils are known to be involved in many
diseases also counting type II diabetes. As already mentioned, zinc plays an important
role in the stabilization of the insulin hexamer, thereby inhibiting the formation of insulin
fibrils. Likewise, copper is known to bind to the fibrils and is believed to be involved
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in Alzheimer’s disease. Insulin structures containing other divalent transition metal ions
are therefore relevant for studying the hexamer stability. These studies can furthermore
be complemented by spectroscopy, as the metals have unoccupied 3 d-orbitals, which are
spectroscopically active.
Hexameric insulin containing copper, nickel and iron has been studied with single
crystal diffraction and XAS, with emphasis on conformation and metal coordination. To
support the interpretation of the XAS data, ab initio Hartree-Fock calculations have been
carried out evaluating energies of copper clusters with different geometries.
8.2 Experimental
8.2.1 Growth of insulin single crystals
Crystallization experiments of hexameric insulin with Mn2+, Fe2+, Co2+, Ni2+ and Cu2+
were carried out. As the affinity to insulin decreases through the series from Zn to Mn,
insulin single crystals were only obtained with Ni2+ and Cu2+. Insulin crystals containing
Fe2+ were grown from zinc contaminated media by using insulin solutions where the zinc
was not chelated and removed prior to the crystallization experiments.
For the growth of nickel and copper insulin single crystals, excess zinc ions were re-
moved from the insulin before use using the procedure described in Section 7.2.1. The
insulin solution was diluted with milli-Q water and pHwas adjusted to 2.0 using HCl(aq).
The concentration was determined to 7.5 mgml−1 by UV-vis spectrophotometry. Nickel
and copper insulin crystals were grown using the vapour diffusion technique. 2 µl of the
metal free insulin solution was mixed with 2 µl reservoir solution and equilibrated in a
hanging drop against 1 ml reservoir with a composition given in Table 8.1. After 5 days
200–300 µm large single crystals were observed. The crystals resembled those from T6 Zn
insulin in size and shape. Single crystals with dimensions of 200 µmwere soaked in cryo-
protective solution containing 15 vol.% PEG 400, 25 vol.% glycerol and 60 vol.% mother
liquor (Smith et al., 2001, 2003) and stored in liquid nitrogen until diffraction analysis.
For the growth of iron insulin single crystals, lyophilized insulin (Sigma Aldrich, I-
5500) was dissolved in 0.02 M HCl and pH was carefully raised with NaOH until all pro-
tein was re-dissolved at pH around 7.0. The protein concentration was determined to
5.2 mgml−1. The crystals were grown using the vapour diffusion technique. 3 µl of the
insulin solution was mixed with 2.4 µl reservoir solution and equilibrated in a hanging
drop against 1 ml reservoir with a composition given in Table 8.1. After 2 months small
crystals with dimensions of 60–80 µmwere observed, Figure 8.1(a).
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(a) (b)
Figure 8.1: (a) Single crystals of T6 insulin crystallized with Fe2+. (b) Preparation of micro-crystal
samples of Mn2+, Fe2+, Co2+, Ni2+ and Cu2+ insulin for XAS experiments.
8.2.2 Preparation of insulin micro-crystals
Micro-crystal samples of Mn2+, Fe2+, Co2+, Ni2+ and Cu2+ insulin were prepared for
X-ray absorption spectroscopy measurements using the batch crystallization technique,
Figure 8.1(b). Solutions containing 5 mgml−1 metal free insulin, 0.01 M HCl, 5 mM M2+
acetate, 0.02 M sodium citrate and 15 vol.% acetone were mixed in acid washed tubes.
The crystallization solutions were hereafter treated as in the preparation of Zn2+ T6 micro-
crystals, described in Section 7.2.2. The samples were analysed with XRPD, which showed
that T6 insulin micro-crystals only were obtained for preparations with Ni2+ and Cu2+.
8.2.3 Single crystal diffraction
Single crystal diffraction data were collected at MAX-lab, Lund, Sweden, on beam line
911-2, MAX-II using a MarResearch CCD detector. The scattering properties generally
improved after annealing the crystals a few times. Data collection and data processing
statistics for all crystals are summarized in Table 8.2. The structures were refined using
Table 8.1: Reservoir compositions for single crystal growth of nickel, copper and iron
insulin using the vapour diffusion technique.
Ni2+ insulin Cu2+ insulin Fe2+ insulin†
Sodium citrate (M) 0.05 0.05 0.054
M2+ acetate (mM) 15 7.5 8
Acetone (vol.%) 15 15 25
pH 7.4 6.8 8.3
† Fe2+ insulinwere grown using insulin solutions where the zinc was not chelated and
removed prior to the crystallization experiments.
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the peptide chain from the T6 Zn insulin structure described in Chapter 7 and validated as
described in Section 7.2.3. Refinement and validation statistics are listed in Table 8.3.
Table 8.2: Data collection parameters and processing statistics. All data were collected at beam line 911-2,
MAX II, MAX-lab, Lund, Sweden.
Ni2+ insulin Cu2+ insulin Fe2+ insulin
Data collection
Wavelength (Å) 1.040 1.040 1.038
Temperature (K) 100 100 100
No. of frames 107 180 180
Oscillation range (◦) 1 1 1
Exposure time per frame (s) 10 10 10
Detector distance (mm) 95 85 120
Resolution collected (Å) 1.45 1.35 1.78
Data processing
Resolution (Å) 16.78–1.50 (1.54–1.50)† 16.87–1.45 (1.49–1.45)† 24.3–1.82 (1.92–1.82)†
No. of reflections 41817 (1946)† 35631 (2614)† 42583 (6175)†
No. of unique reflections 12710 (752)† 14336 (1069)† 7368 (1086)†
Redundancy 3.29 (2.59)† 2.49 (2.45)† 5.8 (5.7)†
Completeness (%) 97.6 (79.7)† 98.1 (100.0)† 99.9 (100)†
Rsym (%)‡ 3.9 (13.7)† 5.0 (45.6)† 6.4 (75.4)†
〈I/σ(I)〉 19.21 (10.45)† 14.00 (2.52)† 14.4 (2.2)†
Space group R3 R3 R3
No. of molecules per asu 2 2 2
a (Å) 80.85 81.36 81.01
c (Å) 33.36 33.40 33.61
Average mosaicity (◦) 0.52 0.29 0.42
Solvent content§ (%) 32.8 33.7 34.0
† Values in parentheses are for the outermost resolution shell.
‡ Rsym is defined as
∑
hkl
∑
i |Ii(hkl) − 〈I(hkl)〉| /
∑
hkl
∑
i Ii(hkl), where 〈I(hkl)〉 is the mean intensity of
a set of equivalent reflections.
§ Estimated by the programMatthews (Kantarjieff & Rupp, 2003).
T6 Ni insulin
Two nickel atoms were inserted. The side chains of residues GlnB4.1, ValB12.1, LeuB17.1,
CysA11.2 and GlnB4.2 weremodelled in two alternating conformations. A total of 80 water
molecules were inserted. Restrained refinement was carried out in PHENIX and hydrogen
atoms were included. The atomic displacement factors for the peptide chain were refined
by a combination of TLS refinement and isotropic refinement, using the TLS domains de-
scribed in Section 7.2.3. Other were refined isotropically. Validation showed that only one
residue SerA9.1 fell into the outlier region in the Ramachandran plot using the regions
defined by Kleywegt & Jones (1996). This residue is involved in a hydrogen bonding to a
HisB5.2 in a neighbouring hexamer.
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Table 8.3: Data-refinement and validation statistics.
Ni2+ insulin Cu2+ insulin Fe2+ insulin
Resolution cut (Å) 1.50 1.45 1.90
No. of atoms in the model
Total non H-atoms 906 922 826
Total H-atoms 792 793 0
Total protein atoms 1616 1615 792
Total ordered water molecules 80 98 32
Total M2+-ions 2 2 2
Type of M2+ siteI/siteII Ni/Ni Cu/Cu Zn/Fe
B-factors§
Overall (Å2) 29 24 38
Main chain (Å2) 23 19 35
Side chains and water molecules (Å2) 32 26 41
M2+-ions (Å2) 14 15 22
RMS deviation from ideal
Bonds (Å) 0.016 0.014 0.008
Angles (◦) 1.484 1.469 1.007
Ramachandran plot‡
In core regions (%) 98.9 98.9 98.9
Outliers (%) 1.1 1.1 1.1
R-factors†
R 0.1819 0.1686 0.1952
Rfree 0.2243 0.2044 0.2525
§ The analysis ofB-factors was done using BAVERAGE included in CCP4 (Collaborative Compu-
tational Project, Number 4, 1994)
† R and Rfree =
∑
||Fobs| − |Fcalc|| /
∑
|Fobs|, where Fobs and Fcalc are the observed and calcu-
lated structure-factor amplitudes, respectively. Rfree was calculated with a random 5 % subset
of all reflections excluded from the refinement.
‡ The definition of the Ramachandran plot regions according to Kleywegt & Jones (1996).
T6 Cu insulin
Two copper atoms were inserted. The side chains of residues GlnB4.1, ValB12.1, LeuB17.1,
CysA11.2 and ValB12.2 were modelled in two alternating conformations. 98 water mole-
cules were inserted in total, and hydrogen atomswere included. The refinement procedure
of coordinates and atomic displacement factors is hereafter analogue to the one for T6 Ni
insulin. Validation showed that only one residue SerA9.1 fell into the outlier region in the
Ramachandran plot.
T6 Fe insulin
Initially, two iron atoms were inserted in the structure. The iron atom placed in site I did
not account for all the density, as seen in Figure 8.5(a), wherefore this site was remodelled
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as a Zn-site, Figure 8.5(b). Residue AlaB30.1 and the side chains of LysB29.1 and LysB29.2
were disordered and could not be modelled. Two alternating conformations were model-
led in the side chains of residues GluB13.1. In total 32 water molecules were inserted. The
atomic displacement factors were refined isotropically. In the Ramachandran plot residue
SerA9.1 fell into the outlier region.
8.2.4 X-ray absorption spectroscopy
Fluorescence XAS data were collected for Ni and Cu insulin at the Ni and Cu K-edges
respectively, on beam line 811 at the synchrotron at MAX-lab, Lund, Sweden. The data
collection and following analysis were carried out using the procedure described in Sec-
tion 3.4.
8.2.5 Energy calculations on Cu sites
The 3 d9 electron configuration of Cu2+ will predict a tetragonal Jahn-Teller distortion for
six-coordinated copper, (Cotton et al., 1995). As this geometry is inconsistent with the C3
symmetry of the T3 metal site, in which the metal ions normally are coordinated by six
ligands, ab initio Hartree-Fock (HF) calculations were performed on a tetrahedral and an
octahedral Cu cluster, shown in Figure 8.2. The HF calculations were performed using
SPARTAN’10 (Shao et al., 2006) A hydroxide ion was chosen in the tetrahedral cluster in-
stead of a water molecule to maintain the C3-symmetry. The most stable conformation of
each cluster was found by energy minimizing calculations using the HF method with the
basis set 6-31G*. The energy of the individual components (Cu(imz)3, 3 H2O and OH−)
Cu Cu
(a) (b)
Figure 8.2: Cu clusters for Hartree-Fock calculations (a) A copper atom octahedrally coordinated
to three imidazole and three water molecules. (b) A copper tetrahedrally coordinated to three im-
idazole molecules and one hydroxide ion. The hydroxide ion, which is isoelectronic with a water
molecule, was chosen to maintain the C3 symmetry. Carbon is shown in black, nitrogen in blue,
oxygen in red, hydrogen in white and copper in dark blue.
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were hereafter calculated and the energy differences between the complex and the sum of
individual components were compared.
8.2.6 Comparison analysis
Searching the PDB reveals hexameric insulin structures crystallized with other metals than
zinc. The structure of human insulin with both nickel (PDB-entry 3EXX), (Prugovecˇki et al.,
2009) and copper (PDB-entry 3TT8), have been solved to quite high resolutions 1.35 Å and
1.12 Å, respectively. These structures are compared with the bovine insulin structures
presented here.
Nickel and copper coordination in small molecules were analysed by searching the
CSD among structures containing nickel or copper coordinating to three monodentate lig-
ands through sp2-hybridized nitrogen atoms. For the nickel sites, only structures contain-
ing Ni coordinated to six atoms (3 nitrogen ligands and 3 oxygen atoms in facial isomerism)
were included in the analysis. For copper, structures containing Cu coordinated to respec-
tively four (3 nitrogen ligands and 1 oxygen atom in tetrahedral geometry) and six atoms
(3 nitrogen ligands and 3 oxygen atoms) were included in the analysis. The isomerism
among all six-coordinated copper structures were meridonial.
8.3 Results
8.3.1 Single-crystal X-ray diffraction structures
An extended conformation of the backbone of residues B1–B8 was observed in all three
structures, which thereby adopt the T6-conformation. The electron densities around resi-
dues B1.2–B3.2 were weak in all structures, but it was possible to trace the benzene ring of
the PheB1.2, Figure 8.3, which resulted in a conformation of the N-terminal similar to the
one observed in the T6 zinc structure.
PheB1.2
ValB2.2
AsnB3.2
Figure 8.3: N-terminal of the B-chain in monomer 2 of Cu insulin structure. The electron density
in the region is poor, but the location of the benzene ring in PheB1.2 is clear. The σA-weighted
2Fo−Fc maps have been contoured at 1.0 σ. Carbon is shown in black, nitrogen in blue, oxygen in
red and hydrogen in white.
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The coordination geometries of each metal site are shown in Figure 8.4 for Ni and Cu
insulin and in Figure 8.5 for Fe insulin.
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2.12 Å
O1
HisB10
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2.04 Å
2.23 Å
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HisB10
O3
O1 O1
O2
O3
Cu
HisB10
2.11 Å
2.25 Å
O1
HisB10
O2 O3O3 O3
O1O1
O4 O4 O4
Cu 2.09 Å
2.67 Å
O1
HisB10
HisB10
O2 O2 O2
(a)
(b)
(c)
(d)
Figure 8.4: (a) Nickel site I and (b) nickel site II in the 1.50 Å Ni insulin structure. Ni2+ is octahe-
drally coordinated to three HisB10 and three water molecules (red) in both sites. (c) Copper site I
and (d) copper site II in the 1.45 Å Cu insulin structure. Cu2+ is octahedrally coordinated in site I
and tetrahedrally coordinated in site II. Distances to the first coordination sphere as determined by
single crystal X-ray diffraction are shown. The σA-weighted 2Fo − Fc maps have been contoured
at 1.0 σ. Carbon is shown in black, nitrogen in blue, oxygen in red, hydrogen in white, nickel in
turquoise and copper in dark blue.
All metal ions bound in the structures are located on the three-fold rotation axis and coor-
dinate to three Nε2-atoms of the three symmetry-related HisB10 residues. In all structures,
electron densities were observed above the metal-ions, which are exposed to the solvent in
these open T3-sites. These densities weremodelled with water molecules connected by hy-
drogen bonding networks, resulting in different coordination geometries for the different
insulin derivatives.
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In the nickel insulin derivative octahedral coordination geometry was observed at both
Ni-sites, fulfilled by three symmetry relatedwatermolecules at respectively 2.12 and 2.23 Å
from the Ni-atoms in the two sites, Figure 8.4(a) and (b). Copper was observed to adopt
both octahedral (site I) and tetrahedral (site II) coordination geometry in the Cu insulin
with Cu–O distances of 2.25 and 2.67 Å, respectively, Figure 8.4(c) and (d). Tetrahedral
coordination of the metal in a T3-site has been observed in other insulin structures at PDB,
predominantly among low resolution structures, e.g. in the bovine T6 insulin structure at
2.56 Å resolution (PDB-entry 2ZP6).
Fe
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O1O1
O3 O3
O2 O2
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HisB10
HisB10
2.00 Å
2.24 Å
(a) (b) (c)
Figure 8.5: Iron and zinc coordination in the 1.90 Å Fe insulin structure. An octahedral coordination
was observed in metal site I, which has been modelled with (a) Fe2+ and (b) Zn2+. (c) Metal site II
contains tetrahedrally coordinated Fe2+. The σA-weighted 2Fo − Fc maps have been contoured at
1.0 σ and the difference Fo − Fc maps at 3.0 σ. Carbon is shown in black, nitrogen in blue, oxygen
in red, hydrogen in white, iron in bronze and zinc in light blue.
Also in the Zn/Fe insulin a dual octahedral/tetrahedral coordination was observed. The
zinc ion located in site I is octahedrally coordinated fulfilled by three water molecules
2.41 Å from the zinc ion, Figure 8.5(b). In site II tetrahedral coordination is observed with
Fe–O distance of 2.24 Å, Figure 8.5(c).
8.3.2 X-ray absorption spectroscopy
The extracted k3-weighted EXAFS spectra and the modulus of the phase-corrected Fourier
transforms of Ni and Cu insulin are presented in Figure 8.6. It is seen that the shape of
the k3-weighted χ(k) for Ni insulin has a high resemblance with that of T6 Zn insulin
indicating an octahedral coordination, whereas for Cu insulin the spectrum have more
similarity to that of the R6 Zn insulin, see Section 7.3.4. The distances and Debye-Waller
factors were optimized from a restrained refinement, and are presented in Table 8.4. Both
octahedral and tetrahedral models were tested. The best fit of the Ni insulin were obtained
from a model with an octahedral geometry (R = 17.30 %), whereas a tetrahedral model
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gave the best fit for Cu insulin (R = 19.45 %), as shown in Figure 8.6. Further EXAFS
refinement statistics are summarized in Table 8.4.
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Figure 8.6: k3-weighted EXAFS (top) and radial distribution functions calculated as the modulus
of the phase-corrected Fourier transform (bottom) of (a) T6 Ni insulin and (b) T6 Cu insulin. Expe-
rimental spectra are shown in blue and simulated in red (dashed), using the parameters from the
restrained refinement given in Table 8.4.
XANES spectra calculated by the FDMmethod for nickel and copper insulin are shown in
Figure 8.7. The nickel spectrumwas calculated using the coordinates from the model opti-
mized by EXAFS. As seen in Figure 8.7(a) there is a good agreement between experimental
and calculated spectra, (Rxanes = 3.20 %), and the XANES spectrum is similar to what has
been observed for six-coordinated nickel, (Colpas et al., 1991).
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For copper insulin, XANES spectra were calculated for both tetrahedral and octahedral
coordination with Cu–O distances of 2.18 Å. The weak white line observed in the experi-
mental spectrum suggests a tetrahedral coordination of copper, Figure 8.7(b). In analogy to
zinc, the XANES for six-coordinated copper gives stronger white lines, (Manceau & Maty-
nia, 2010), which is in agreement with the calculated XANES for the octahedral cluster, see
Figure 8.7(c). The discrepancy between experimental and calculated spectra for the tetra-
hedral copper is however larger than for nickel insulin (Rxanes = 5.65%), Figure 8.7(b), due
to a shoulder occurring at 8981–8984 eV. This shoulder originates from a peak located at
8983 eV, which can be assigned to the 1 s→ 4 p electronic transition of copper in oxidation
state +I, (Kau et al., 1987). The copper in the sample is thereby partly reduced. Examina-
tion of the raw data did not reveal any differences nor indication of evolution among the
averaged raw XAS spectra. However, comparison with a fast scan spectrum collected just
after mounting in the beam did not show any peak at 8983 eV, meaning that the sample
was reduced at the beam line.
Table 8.4: Distances and Debye-Waller factors of Ni and Cu coordination in T6 insulin as refined
from EXAFS. The distances are compared to crystallographic values.
Ni insulin Cu insulin
XRD Restrained EXAFS XRD Restrained EXAFS
〈R〉§ (Å) R (Å) 2σ2 (Å2) 〈R〉§ (Å) R (Å) 2σ2 (Å2)
Nε2 (HisB10) 2.07 2.079(7) 0.004(1) 2.11/2.09 1.984(5) 0.010(1)
Cε1 3.02 3.06(4)‡ 0.011(2) 3.01/3.00 2.93(2)‡ 0.011(5)
Cδ2 3.09 3.05(3)‡ 0.011(2) 3.16/3.14 3.08(3)‡ 0.011(5)
Nδ1 4.15 4.20(3)‡ 0.016(4) 4.17/4.16 4.05(4)‡ 0.025(6)
Cγ 4.21 4.21(3)‡ 0.016(4) 4.26/4.24 4.20(3)‡ 0.025(6)
Cβ 5.65 5.59(4)‡ 0.016(4) 5.68/5.67 5.64(6)‡ 0.030(8)
Ow1 2.18 2.09(2) 0.015(3) 2.25/–
Ow2 (axial) 3.40 2.82(4) 0.020(9) 3.23/2.67 2.18(3) 0.030(11)
Ef (eV) −0.50 0.08
ǫ2v 0.5598 0.6951
Rexafs (%) 16.28 18.28
Rdist (%) 1.02 1.17
Rtotal (%) 17.30 19.45
Np 21 19
k-range (Å−1) 2.8–14.3 2.8–13.5
wdist 0.5 0.5
§ Average distances of both Ni2+-sites in the XRD structure.
† Distances to copper in Cu site I and Cu site II, respectively, in the XRD structure.
‡ The φ-angle (polar coordinates) was refined in order to allow some movement of the atoms in
the restrained imidazole ring.
§ Average distances of both Ni2+-sites in the XRD structure.
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Figure 8.7: XANES calculated on a 4.5 Å cluster around each metal atom in (a) octahedrally coor-
dinated nickel, (b) tetrahedrally coordinated copper and (c) octahedrally coordinated copper. FDM
calculations were done on the coordinates from the EXAFS model for octahedral nickel and tetra-
hedral copper, and on an octahedral copper cluster fulfilled by three oxygen atoms located 2.18 Å
from the Cu-atom. The calculated spectra are compared with experimental XANES (dashed). A
peak located at 8983 eV indicates the presence of copper in oxidation state +I (Kau et al., 1987).
8.3.3 Energy calculations on Cu sites
The energy minimization of the octahedral complex resulted in unreasonable long Cu–O
distances (4.32 Å), whereas a Cu–O distance of 2.10 Å were found in the tetrahedral com-
plex. This indicates that the octahedral geometry is disfavoured. The energy differences
between the energy optimized complexes and the sum of individual components showed
that the octahedral complex is not significantly stabilized, whereas the tetrahedral complex
is stabilized by 6.6 eV.
8.3.4 Comparison with other reported M2+-site geometries
The bond distances involved in the nickel and copper coordination observed in the high
resolution structures of human Ni and Cu insulin, as well as in small molecules with sim-
ilar coordination geometries are summarized in Table 8.5. The distances are compared to
those from the XRD structures and EXAFS analysis. The results for the Zn T6-structure
is furthermore included for comparison. The CSD analysis of copper included both tetra-
hedral and octahedral copper coordination. For the octahedrally coordinated copper a
tetragonal Jahn-Teller distortion was observed in all of the 5 structures found. Expanding
the search to include polydentate ligands resulted in 163 structures. Most of these struc-
tures had meridonial isomerism and were tetragonally distorted. Only 3 structures had
non-distorted facial isomerism, which was maintained by chelation from their polyden-
tate ligands.
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Table 8.5: Metal coordination geometries and distances to inner sphere ligands in each of the two
metal sites for Ni, Cu and Zn insulin. Distances from the XRD structures and the EXAFS analysis
are compared to human M2+ insulin structures deposited in PDB and small molecules with similar
coordination geometries in CSD.
Insulin structures (PDB) Resolution Geometry† M2+–Nε2 (Å)† M2+–Ow1 (Å)†
Nickel sites
XRD this work 1.50 Å oct/oct 2.10/2.04 2.12/2.23
Human Ni insulin‡ 1.35 Å oct/oct 2.05/2.06 2.15/2.18
EXAFS this work oct 2.08 2.09
Copper sites
XRD this work 1.45 Å oct/tet 2.11/2.09 2.25/2.67
Human Cu insulin† 1.12 Å oct/oct 2.04/2.06 2.08/2.24
EXAFS this work tet 1.98 2.18
HF-calculation this work tet 2.18 2.10
Zinc sites
XRD this work 1.40 Å oct/oct 2.09/2.10 2.31/2.27
Human Zn insulin† 1.00 Å oct/oct 2.09/2.10 2.22/2.23
EXAFS this work oct 2.07 2.14
Small molecule structures (CSD) Number of structures M2+–N(sp2) (Å) M2+–O (Å)
Octahedral Ni (3N+3O) 6§ 2.09(3) 2.11(3)
Tetrahedral Cu (3N+1O) 7 2.01(4) 2.36(16)
Octahedral Cu (3N+3O) 5* 2.02(2) 2.29(24)
Octahedral Zn (3N+3X) 26 2.16(3) 2.16(4)
† Metal coordination geometry and M2+–Nε2 distances in site I and site II, respectively.
‡ Best resolution structures of human insulin with Ni, Cu and Zn deposited in the PDB. PDB
entries 3EXX, 3TT8 and 1MSO, respectively.
§ Only Ni-complexes with facial isomerism are included.
* All Cu-complexes showed tetragonal Jahn-Teller distortion and had meridonial isomerism.
8.4 Discussion
Hexameric insulin was successfully crystallized with divalent cations of nickel, copper and
iron, and the structures were solved. The affinity of insulin to nickel and copper is large
enough to crystallize hexamers with Ni2+ or Cu2+ in both metal sites, which was seen in
the presented structures. The affinity to iron is lower and crystals with Fe2+ in both metal
sites could not be obtained. Instead, crystals containing one Fe2+ and one Zn2+ was grown
in presence of small amounts of zinc. Moreover, a site selectivity among the Fe2+ and
Zn2+ ions is shown by the crystal structure. Furthermore, T6 insulin micro-crystals were
obtained with nickel and copper. The low affinity metals (cobalt, iron and manganese) are
removed by the recrystallization procedure used, by which excess metal was eliminated in
these XAS samples.
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8.4.1 Conformation
T6-conformation was observed in all structures, and the structures were compared with
the zinc T6-structure and other structures in PDB by superposing independent T2 dimers
in SUPERPOSE (Krissinel & Henrick, 2004) in which the Cα-displacements were mini-
mized and the RMS calculated. All structures show high resemblance with the zinc T6-
structure presented in Chapter 7 as well as the bovine T6 deposited in the PDB, (Smith
et al., 2005) with root mean squares below 0.4 Å. In analogy to the bovine zinc T6-structure,
comparison with the structures of human Ni and Cu insulin show larger discrepancies
(RMS=1.345 Å and RMS=1.290 Å, for Ni and Cu respectively), due to a different conforma-
tion observed for the B1.2–B3.2 chain. The weak determination of the B1.2–B3.2 residues
may be a consequence of a partially disordered N-terminal of the B-chain, and may in-
dicate that the insulin partially undergoes conformational change. The dihedral angle
A6Cβ–A6Sγ–A11Sγ–A11Cβ of the disulfide bridge CysA6–CysA11 is close to +100◦ when
the monomer adopts T-conformation and close to −90◦ in R-conformations (Engels et al.,
1992). Based on these angles the double conformations of CysA11.2 in the Ni, Cu and Zn
structures result in T/R ratio of approx. 70/30 %. For the iron insulin the resolution was
not good enough to model alternate conformation for residue CysA11.2. Modelling of an
alternate conformation of the entire B-chain N-termini in these structures was attempted,
but could not be traced in the electron density. The partial disorder of these residues may
be a consequence of the cooling process (Smith et al., 2003), which is in agreement with
the enhanced scattering properties of the crystals after annealing. According to Sreekanth
et al. (2009) different conformations can be trapped by the binding different metals to in-
sulin. This has been studied using a human Arg-insulin, in which an arginine has been
attached to the N-terminal of the A-chain. These Arg-insulin structures were compared
with other structures of human insulin and showed different conformations of the B-chain
N-terminal. The data collection temperature and the crystallization conditions of the com-
pared structures were however not analogous, wherefore the influence from these factors
can not be ruled out.
8.4.2 Metal binding
For nickel insulin an octahedral coordination fulfilled by threewater molecules is observed
in both of the open T3-sites. The nickel coordination is generally in very good agreement
with the human Ni insulin structure (Prugovecˇki et al., 2009) and other octahedrally coor-
dinated Ni structures deposited in the CSD. The Ni–Ow distances as determined by EX-
AFS are slightly shorter than those from the XRD structure, and thereby reveals an almost
undistorted octahedral coordination of nickel, which has been verified by an FDM calcu-
lation of the XANES spectrum.
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For copper insulin a dual octahedral/tetrahedral coordination of copper was observed
in the XRD structure, whereas both copper sites are octahedral in the human Cu insulin
structure (PDB-entry 3TT8). In general, regular octahedral coordination of Cu2+ is not
chemically favoured, since the 3 d9 electron configurationwill predict six coordinated Cu2+
to be tetragonally distorted by the Jahn-Teller effect. Furthermore such distortions will
obstruct the three-fold symmetry. The result from the EXAFS analysis, in which both oc-
tahedral and tetrahedral models were tested, supports a tetrahedral coordination, which
is also predicted to be more energetic favourable by the HF-calculations. The coordina-
tion geometries of Ni and Zn in the other insulin structures have hitherto been verified
by XANES calculations. For Cu, XANES spectra calculated for both geometries further
confirmed the tetrahedral coordination. A feature in the XANES spectra revealed that re-
duction of Cu2+ to Cu+ had taken place. Copper in oxidation state +I does not show any
Jahn-Teller effect due to its 3 d10 electron configuration, and is usually tetrahedral (Cot-
ton et al., 1995), which is in agreement with the EXAFS results. Thereby copper insulin is
more sensitive towards radiation damage compared to nickel and zinc. As concluded in
Chapter 7 the radiation doses are about two orders of magnitude lower for the absorption
experiments compared to the diffraction experiments, meaning that it is highly possible
that copper is reduced in the single crystals used for XRD, as well.
There is a good agreement between the Cu–Nε2 distances as determined from EXAFS
and Cu–N distances in tetrahedrally coordinated copper among small molecule structures
in the CSD. Compared to the Ni and Zn T6-structures, the Cu–Nε2 are smaller and re-
semble the Zn–Nε2 distances observed in the R6 structure, in which zinc is tetrahedrally
coordinated, see Chapter 7. This further confirms the tetrahedral geometry.
8.5 Conclusive remarks
The structures of hexameric bovine T6 insulin with nickel, copper and iron were solved
from XRD data collected to 1.50 Å, 1.45 Å and 1.90 Å, respectively. Trapping different con-
formations with different metal ions were not observed for the bovine structures presented
here, as all structures adopted T6-conformation similar to that of zinc T6 insulin.
A dual octahedral/tetrahedral coordination of zinc and iron, respectively, was ob-
served in the XRD structure of iron insulin. In analogy to zinc T6 insulin, octahedral coor-
dination of nickel was observed in the XRD structure and verified by a calculated XANES
spectrum. Distances to nickel were refined from EXAFS showing a very regular octahedral
coordination. The XRD structure of copper insulin revealed a dual octahedral/tetrahedral
coordination of copper in the twometal sites. According to the EXAFS analysis copper was
determined to be tetrahedrally coordinated fulfilled by one water molecule, which is fur-
ther supported by Hartree-Fock calculations and calculated XANES spectra. The XANES
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spectrum further revealed that reduction of Cu2+ to Cu+ has taken place. The coordina-
tion distances as determined by EXAFS are generally similar to what is observed among
small molecules with similar coordination geometries.
Chapter 9
Introduction to bone physiology and
osteoporosis treatment with Sr
This chapter gives an introduction to bone physiology, osteoporosis and the treatment
hereof with strontium containing medicaments, among these strontium ranelate, which
is one of several drugs used for treatment of osteoporosis. The mechanism by which stron-
tium is incorporated in bone tissue is not fully understood, but considering the physico-
chemistry of the bone composites possible locations of strontium have been suggested, and
are described in this chapter. X-ray absorption spectroscopy is a well-suited technique for
studying the strontium locations and thereby provide information on the incorporation of
strontium. The final section presents an overview of X-ray absorption studies performed
on bone material. The experimental work is reported in the following two chapters: The
crystal structures of polymorphs of strontium ranelate (SrR) are presented in Chapter 10,
and the localisation of strontium in bone samples from dogs treatedwith strontium is stud-
ied by XAS and is presented in Chapter 11.
9.1 The structure of bones
Bones have biomechanical and metabolic functions as they both provide structural sup-
port to the weight of the body, attachment points for mussels and tendons and make up a
natural reservoir for many ions e.g. calcium and phosphate. More detailed information on
the function, composition and structure of bone can be found in the reviews by Weiner &
Wagner (1998); Seeman & Delmas (2006); Launey et al. (2010).
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The hierarchically organized structure of bone, as seen in Figure 9.1, provides the ma-
terial to be stiff in order to carry the weight from the body without breaking, and at the
same time flexible to absorb energy by deforming rather that cracking. On the macro-scale
bone tissue is classified as either cortical (compact) bone, which is found on the surface of
all bones, and trabecular (spongy) bone, which fills the inside of many bones. The com-
pact bone varies in thickness and is present in bone types where an increased strength is
important, e.g. the femur bone. The spongy bone is found, where its flexible properties
are needed, e.g. in vertebrae and femur neck. Many bones are composed of both types, for
instance the skull cap which consists of a layer of trabecular bone between two layers of
cortical bone. Such architecture minimizes the total weight of the skeleton, without loosing
strength.
The compact bone is composed of osteons which have a concentric lamellar structure
and surrounds the Haversian channels, in which blood vessels are protected. The lamellae
are composed of sheets of differently orientated fibres, which are made up by linked colla-
gen fibrils. Each fibril is made up of tropocollagen filaments and 50×25 nm plate-shaped
crystals of calcium hydroxyapatite arranged in a geometrical pattern (the quarter-stagger
model) and make up the basic building block in the bone structure. The tropocollagen con-
sists of three peptide chains, each forming a helix, which coil up in a coiled-coil structure.
9.2 Composition of bones
The mineralized collagen fibrils are the basic building block in bone tissue and primar-
ily consists of three components: Collagen, calcium hydroxyapatite and water, which are
described in the following.
9.2.1 Collagen
The collagen in bone tissue is primarily of Bornstein & Traub type I and constitutes approx.
90 % of the proteins present in bone. The sequence of the collagen is made up by amino
acid triads often following the patterns Gly–Pro–X or Gly–X–Hyp, in which X is an amino
acid other that glycine, proline and hydroxyproline (Hyp). The high fraction of glycine in
the sequence facilitates the formation of a left-handed helical structure. Tropocollagen is
composed of three helical strands twisted together in a right-handed coiled-coil structure,
which further stabilizes the protein. (Miller, 1984) The overall length of each tropocolla-
gen filament is approx. 300 nm and the width is 1.5 nm. In the fibrils, the tropocollagen
molecules are lined up head to tail in long rows with a gap of approx. 40 nm. Adje-
cent rows of tropocollagen are shifted by an offset of 68 nm, known as the quarter-stagger
model (Hodge & Petruska, 1963), and the gaps are filled up by small crystals of CaHA,
which highly increases the strength and toughness of the material.
9.2. Composition of bones 107
Tropocollagen
Hydroxyapatite
Tropocollagen
~300 nm
Mineralized 
collagen fibril 
~1 µm
68 nm ~300 nm
Fibril arrays 
~10 µm
Lamella of fibres 
~50 µm
Osteons 
~0.1 mm
Trabecular 
bone tissue 
~0.5 mm 
Bone tissue 
~10 cm
Lacuna with 
osteocytesHaversian 
channels
Type I collagen
Cortical 
bone tissue
~0.5 mm 
Figure 9.1: The hierarchically organized structure of bone. Bone is classified in twomain categories:
Cortical (compact) bone and trabecular (spongy) bone. The compact bone is built up of concentric
lamellar structures of differently oriented fibres. Each fibre consist of an array of fibrils. Each fibril
is composed of mineralized collagen in which tropocollagen and 50×25 nm plate-shaped crystals
of calcium hydroxyapatite are systematically arranged. Three collagen molecules coil up to form
the tropocollagen. Figure modified from (Launey et al., 2010) using Servier Medical Art (Servier,
2012).
9.2.2 Calcium hydroxyapatite
Calcium hydroxyapatite (CaHA) has the stoichiometric formula Ca5(PO4)3OH, but is often
written as Ca10(PO4)6OH2, as there is two formula units in the crystallographic unit cell.
CaHA forms hexagonal crystals belonging to the space group P63/m, (Kay et al., 1964).
The structure is seen in Figure 9.2 and contains two crystallographic different calcium sites,
denoted Ca(I) and Ca(II), respectively. Four of the ten calcium ions in the unit cell are
located in site I and the remaining six in site II.
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The structure can be described as a hexagonal stack of PO3−
4
groups. Each phosphor
atom coordinates four oxygen atoms in a tetrahedral arrangement, and the phosphate
tetrahedra create two different tunnels parallel to the crystallographic c-axis. Ca(I) ions
are surrounded by nine oxygen atoms and occupy the sites in the first tunnel, which is
coinciding with the c-axis. Ca(II) ions are surrounded by seven oxygen atoms, and are
arranged around the second channel, which is occupied by hydroxide ions. More infor-
mation on biological apatites can be found in the extensive review by Wopenka & Pasteris
(2005).
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Figure 9.2: The structure of calcium hydroxyapatite viewed along the crystallographic c-axis. The
PO3−4 groups are represented by orange tetrahedra. The OH
− ions (dark red) are located on the
ternary axis and surrounded by six Ca(II) ions (light green), which accounts for six out of the ten
calcium sites in the unit cell. The remaining four calcium Ca(I) (dark green) are located in a channel
parallel to the crystallographic c-axis. Figure is drawn from the coordinates by Kay et al. (1964).
The calcium ions in the apatitic structure can be substituted by other divalent cations such
as Sr2+, Mg2+, Fe2+, Zn2+ and Pb2+. For substitution of calcium by strontium the unit
cell parameters increase linearly with increasing strontium amounts, and the doping level
can be estimated from the cell parameters (O´Donnell et al., 2008). A preferential occu-
pation among the two crystallographic sites upon substitution of Ca2+ by other cations
depends on the size of the cation, (Tamm & Peld, 2006). Sr2+ preferentially occupies site I
when present in low doping levels (< 1 atom %), whereas an ideal and equal distribu-
tion (Sr(I):Sr(II) = 4:6) is observed at doping levels around 5 %, (Bigi et al., 2007; Terra
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et al., 2009). For higher degree of Sr-substitutions the Sr2+ preferably occupies the site II
(O´Donnell et al., 2008).
Also the anions can be substituted in the apatitic structure. The hydroxide can be re-
placed by fluoride, which better fits the size of the anion channel position. Fluorapatite
occurs in high amount in tooth enamel, where it is advantageous, as it is less soluble than
hydroxyapatite in acidic environments. Bone apatite contains approx. 7 %(w/w) carbon-
ate, but the incorporation in apatite is still not fully understood. However, it seems to
be generally accepted that CO2−
3
substitutes at the phosphate sites in biological apatites.
(Wopenka & Pasteris, 2005)
9.2.3 Serum
Water is present between the triple helical molecules and fill up the gaps within and be-
tween the collagen fibrils and fibres. Water has an important role on the mechanical prop-
erties of bone, which are different for dry bone compared to those of wet bone.
9.3 Bone formation and resorption
Bone tissue is renewed throughout life, where small amounts of bone is removed and
replaced by new bone. Most of the skeleton is replaced about every 10 years. The renewing
process serves three main purposes: (i) reparation of micro-cracks in the skeleton caused
by physical stress of the bones, (ii) maintenance of the elasticity of the bone, as old bone
may become brittle over the years and (iii) exchange of calcium and phosphates to and
from the blood.
Osteoclast
Osteocytes
Newly formed 
bone
Old bone
Osteoblasts
Bone resorption
Bone formation
Bone-lining cells
Figure 9.3: Bone remodelling process in which osteoclasts break down old tissue, whereas new
bone is formed by osteoblasts. Some osteoblasts are trapped within the newly formed bone and
converted into osteocytes. Figure was drawn using Servier Medical Art, (Servier, 2012).
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The bone cells are embedded in the organic collagen matrix in the bone tissue, and are
involved in the remodelling process, Figure 9.3. In the resorption process osteoclasts break
down old tissue e.g. around a micro-crack. The osteoclasts carve tunnels around the dam-
aged areas, which are then filled up by osteoblasts depositing new lamellar bone. After
formation of bone some osteoblasts are entombed in the newly formed bone matrix where
they are converted into osteocytes, others die or form new bone-lining cells, (Parfitt, 1996).
Osteocytes are involved in the bone metabolism and probably sense bone deformation,
thereby signalling the need for remodelling, (Han et al., 2004).
9.4 Osteoporosis and treatment with Sr medicaments
Osteoporosis is characterized by an imbalance between the rates of bone resorption and
bone formation, leading to a reduced bone mass and increased risk of fractures. The dis-
ease is a major worldwide health problem in the industrialized countries, and it has been
estimated that more than 10 millions Americans older than 50 years (mostly women) are
affected by osteoporosis. Treatment with strontium containing medicaments have shown
to increase the bone mass in post-menopausal osteoporosis patients and to reduce resorp-
tion of old bone (Marie et al., 2001).
At present, a general understanding of the therapeutic effect of strontium towards bone
tissue is not fully achieved, but the combined action on bone metabolism sets Sr2+ unique
as compared to existing osteoporosis therapies and has lead to an excessive research and
development in strontium containing medicament during the last decade, (Schrooten et al.,
2003). Strontium ranelate, (SrR), 5-[bis(carboxymethyl) amino]-3-carboxy-methyl-4-cyano-
2-thiophenecarboxylate, Figure 9.4, is one pharmaceutical compound for treating osteo-
porosis marketed as Protelos® by Servier®, (Horvath et al., 2008).
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Figure 9.4: The structure of strontium ranelate, (5-[bis(carboxymethyl) amino]-3-carboxy-methyl-
4-cyano-2-thiophenecarboxylate).
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Clinical trials have shown that SrR reduces the risk of vertebral and non-vertebral frac-
tures in womenwith osteoporosis (Meunier et al., 2004; Reginster et al., 2005, 2008). In expe-
rimental studies, SrR treatment has been shown to prevent loss of trabecular bone strength
(Bain et al., 2009) and to improve fracture healing in oestrogen-deficient rats (Ozturan et al.,
2011). Ammann et al. (2004) reported that 2 years of treatment with SrR increased trabecu-
lar and cortical bone mass and bone strength in healthy rodents.
9.5 Incorporation of Sr into bones
Strontium has a great affinity for bone and is readily incorporated into bone tissue. One of
the key factors to understand the effect of strontium as a drug against osteoporosis is the
mechanism by which strontium is inserted in bone tissue during treatment. Considering
the physicochemistry of the main composites of bone, possible pathways of incorporation
of ions have been suggested (Rey et al., 2007; Cazalbou et al., 2004), and three hypotheses
summarize plausible locations of strontium (Bazin et al., 2011), Figure 9.5. Sr2+ cations may
be present in the serum surrounding the bones or be adsorbed on the surface of collagen
(hypothesis I), for which Sr2+ will be surrounded by an inner coordination sphere consist-
ing of oxygen atoms only. The Sr2+ cations may then be absorbed in collagen or bind to
poorly crystalline Ca phosphates present on the surface of the nano-crystals (hypothesis
II) and finally Sr2+ may incorporate in the calcium hydroxyapatite CaHA (hypothesis III).
Determining the localisation of Sr2+ cations may help to confirm or disprove the suggested
hypotheses.
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Figure 9.5: Schematic representation of the three hypotheses of the localisation of strontium in
bone tissue. (a) Hypothesis I: Sr2+ is surrounded by an inner coordination sphere consisting of
oxygen atoms in the serum, or the surface of collagen. (b) Hypothesis II: Sr2+ cations are absorbed
in collagen or bind to poorly crystalline calcium phosphates present on the surface of the nano-
crystals. (c) Hypothesis III: Sr2+ is incorporated in the apatite crystals.
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The amount of strontium incorporated into bones depends on the dose level and the
duration of treatment. Gender and bone types also influence on the incorporation since
the bone turnover alter in different bone types. For instance the bone remodelling rate is
higher in trabecular bone compared to cortical, (Dahl et al., 2001).
9.6 XAS studies on apatites and bone structures
Through the years many different techniques have been used for in vitro studies of the
distribution and localisation of Sr and other trace elements in calcified tissues. Particularly
studies including X-ray fluorescence (XRF) (Behets et al., 2005; Zhang et al., 2005; Zoeger
et al., 2008; Bellis et al., 2009; Pemmer et al., 2011) and X-ray diffraction (XRD) (Capuccini
et al., 2009) or a combination hereof (Bradley et al., 2007; Oste et al., 2007), have be have
been used to characterize the influence of trace metals on the spatial repartition of the
apatitic structure and to localise thesemetals, howevermostly on amacro-scale. Also small
angle X-ray scattering (SAXS) (Li et al., 2010) and scanning electron microscopy (SEM)
(Verberckmoes et al., 2004) count among the methods used for characterization of bone.
X-ray absorption spectroscopy (XAS) is well-suited for studying the local environment
of Sr present in small concentrations on the micro- or nano-scale and has been used dur-
ing the last 30 years for characterization of disorder in calcifications and apatite structures
often in combination with other complementary techniques such as diffraction and vibra-
tional spectroscopy (Bazin et al., 2009a).
The first XAS-studies of bone, carried out on the Ca K-edge, revealed a higher dis-
order of the calcium ion environment present in bones compared to that of a synthetic
prepared CaHA sample (Miller et al., 1981; Binsted et al., 1982). To interpret and model
EXAFS data from bone samples quantitatively, comparison with well analysed reference
compounds (Eanes et al., 1981) were required. An EXAFS analysis on mouse bone (Har-
ries et al., 1988), by comparison with synthetically prepared CaHAwith high (Harries et al.,
1986) and poor (Harries et al., 1987) crystallinity, revealed that the average calcium location
is best described by a partially crystalline hydroxyapatite.
Several years after an EXAFS study on human bone involving different bone types
confirmed that calcium is present as disordered hydroxyapatite and that its chemical en-
vironment remains the same in all the analysed bone types Peters et al. (2000). In these
studies the disorder of calcium is included in the EXAFS models as higher displacement
factors, which cover both static and thermal (Debye-Waller) disorder. The static disorder
among Ca ions is highest in bone tissue containing carbonates, which reduces the crys-
tallite size, whereby a larger fraction of non-apatitic calcium may be present in the gaps
between the HA-crystallites. Also the bone resorption process is closely related to the de-
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gree of disorder in the CaHA and thereby closely related to the composition of the mineral
phase (Peters et al., 2000).
XAS was used to study disordered CaHA nano-crystals (Liou et al., 2004) and calcium
phosphates in non-apatitic environments, e.g. dicalcium phosphate, tricalcium phosphate
and octacalcium phosphate (Eichert et al., 2005). The subtle features in the XANES spectra
allowed discrimination between the different species, which were found to be existent
in synthetic poorly crystalline apatites. A recent study demonstrated that XANES could
be used to assess and characterize calcium phosphates in human osteoarthritic articular
cartilage (Nguyen et al., 2011).
XAS has also been used to study the insertion of other elements in theHA structure, e.g.
Sr (Rokita et al., 1993), Cd (Sery et al., 1996), Ga (Korbas et al., 2004), Zn (Bazin et al., 2009b),
Ba, Pb (Sugiyama et al., 2001). Both gallium and strontium have been identified to have
therapeutic effects on bone, which is seen as inhibitory activity towards bone resorption.
XAS has been used to assess these sparsely distributed metals in bone samples and to
reveal how they are inserted in the bone structure (Korbas et al., 2004; Bazin et al., 2011).
9.7 Conclusive remarks
As a pharmaceutical agent, strontium has been shown to have positive effect against osteo-
porosis as it concomitantly reduces bone resorption and stimulates bone formation. Clin-
ical trials have shown that treatment with strontium ranelate reduces the risk of vertebral
and non-vertebral fractures in women with osteoporosis. The mechanism by which stron-
tium is incorporated in bone tissue and how it influences on the remodelling processes
are not fully understood. In principle, strontium can be localised in the serum, collagen
and hydroxyapatite, which constitute themain components of the hierarchically organized
structure of bone. X-ray absorption spectroscopy is well-suited for studying the strontium
incorporation, and the method has been used during the last 30 years for characterization
of calcifications and apatite structures.

Chapter 10
The crystal structures of polymorphs
of Sr ranelate
This chapter describes the structures of different polymorphs of strontium ranelate. When
crystallized from aqueous media strontium ranelate forms a nonahydrate. The crystal
structure of strontium ranelate nonahydrate is presented in Paper IV, (Ståhl et al., 2011)
Appendix A.4. Upon dehydration strontium ranelate undergoes a series of phase transi-
tions, resulting in several stable hydrates. These polymorphs have been studiedwith X-ray
powder diffraction and thermogravimetric analysis (TGA) and described in this chapter.
A manuscript on the polymorph studies is presently in preparation for publication.
10.1 Introduction
Strontium ranelate (SrR) is one of several drugs used for treatment of osteoporosis, (Sch-
rooten et al., 2003). The structural characterization of the compound has hitherto been
sparse, only an XRPD pattern of the nonahydrate is reported as the α-crystalline form in
the patent by Horvath et al. (2008). The main reason for this is the difficulties associated
with growing single crystals large enough for XRD analysis, as crystals of SrR are highly
sensitive to humidity and temperature, which is typical for many pharmaceutical com-
pounds. SrR is known to form several hydrates containing a total of nine, eight, seven and
four water molecules (Wierzbicki et al., 1990). XRPD and TGA are well-suited methods to
study the structural changes, which are observed upon dehydration.
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10.2 Experimental
10.2.1 Synthesis of Sr ranelate
The synthesis was performed as an alkaline hydrolysis of ranelic acid tetraethyl ester fol-
lowed by precipitation by strontium chloride, and was scaled down from the description
by Kumar et al. (2009). 2.05 g ranelic acid tetraethyl ester was placed in a round bot-
tom flask and suspended in 3 ml tetrahydrofuran (THF). 9.6 ml of an aqueous solution
of 10 %(w/w) lithuim hydroxide was added. The LiOH solution was filtered before use.
The reaction mixture was stirred for 4.5 hours at room temperature. The mixture was then
filtered to remove insoluble material. A solution of 4.9 g strontium chloride hexahydrate in
14.8 ml water was slowly added to the filtrate while stirring vigorously. After a few min-
utes a white precipitate was formed and the reaction mixture was moderately stirred for
19.5 hours. The precipitate was separated by filtration. The crude product was analysed
by XRPD.
(a) (b)
Figure 10.1: Crystals of strontium ranelate nonahydrate (a) before and (b) after evaporation of the
mother liquor.
10.2.2 Crystallization of Sr ranelate polymorphs
Recrystallization was performed by dissolving 0.5 g of the crude strontium ranelate in
100mL ultra-purewater (18.2MΩ·cm, milli-Q, Millipore). The solutionwas heated to 353 K
for 10 minutes and saturated with more crude strontium ranelate. The solution was then
heated to 363 K for 5 minutes and filtered hot. The filtrate was cooled to room tempera-
ture and left for evaporation in a petri dish covered with parafilm with holes in it. After
evaporation to almost dryness small crystals of 30–50 µm were observed. Growing larger
crystals was performed by successive recrystallizations, where the temperature at which
the crystals were redissolved was stepwise decreased. The crystals were washed and re-
crystallized a second time in 100 ml water at 333 K. A third recrystallization was carried
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out at 323 K. After a fourth recrystallization at 313 K and slowly evaporation controlled by
covering the petri dish with parafilm with holes in it, clusters of elongated crystals with
dimensions up to 500 µmwere observed, Figure 10.1(a).
When the crystals were removed from the mother liquor they rapidly degraded into
smaller fragments with less crystal water, Figure 10.1(b). A wetted crystal was therefore
quickly mounted on a goniometer and transferred for single crystal X-ray data collection
where it was cooled to 120 K, as described in Paper IV included in Appendix A.4.
Samples for XRPD analysis were taken from wet crystals and treated differently in or-
der to obtain different hydrates. Sample I: Crystals were dried at RT at ambient humidity,
resulting in disintegration of the crystals which broke into small units of 10–30 µm. Sam-
ple II: Crystals were dried over silica in a desiccator for 2 days at RT, resulting in a powder
of sub-micrometer crystals. Sample III: Crystals were dried by heating to 400 K.
10.2.3 X-ray powder diffraction
X-ray powder diffraction patterns for the different sampleswere collected on aHuber G670
diffractometer using CuKα1 radiation (λ = 1.5406 Å). Data collection times and temper-
atures are listed in Table 10.1. The SrR nonahydrate was prepared in a glass capillary
(0.5 mm in diameter) and wetted with water to ensure saturation. Samples dried at RT
were prepared on flat specimen holders. The sample dried by heating was prepared in a
glass capillary and dried at 400 K on the diffractometer using a nitrogen cryostream (Ox-
ford Cryosystems).
An in situ XRPD experiment upon dehydrationwas carried out at beam line 711, MAX-
lab, Lund, Sweden, using a wavelength λ = 1.26406 Å. A powder sample of crystals dried
at RT and ambient humidity were mounted in a capillary and heated from 323 K to 473 K
in steps of 5 K. The data collection time was 5 min per pattern with intervals of 3 min
between the measurements to raise an equilibrate the temperature, resulting in a heating
rate of 0.63 Kmin−1.
10.2.4 Thermogravimetric analysis
Thermogravimetric analysis was performed on a sample of dry crystals on a Netzsch
STA 409 PC/PG instrument. The sample was heated from 293 to 773 K with a rate of
1 Kmin−1.
10.3 Results
An overview over the phase transitions occurring upon dehydration was obtained from
the in situ XRPD experiment. The diffraction patterns are compared with the TGA results
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Figure 10.2: XRPD patterns and TGA of strontium ranelate collected upon dehydration by ramp-
ing the temperature with a rate of 1 Kmin−1. The XRPD patterns are shown as a surface plot
where white/yellow corresponds to high Bragg peak intensity. The patterns are collected using
synchrotron radiation with a wavelength λ = 1.2641 Å, but are converted to Cu Kα1 radiation
(λ = 1.5406 Å). The weight loss in % determined by TGA is plotted in blue (left axis) and the DTA
in turquoise (right axis). The first derivative of the weight loss (DTG) is included (dashed line).
and shown in Figure 10.2. Four dry phases were observed, which are referred to as phase I,
II, III and IV in the following.
Powder diffraction patterns of the crude product and different hydrates of recrystal-
lized SrR are shown in Figure 10.3. The crude product consists of SrR nonahydrate and
impurities of primarily Sr(OH)2·8H2O, Figure 10.3(a). It was found crucial to remove these
impurities to obtain larger crystals. The wet crystal sample was identified as the nonahy-
drate, Figure 10.3(b). The nonahydrate undergoes phase transitions upon drying. Two
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stable phases were observed when drying the crystals at ambient humidity (sample I)
and over silica (sample II). These phases were respectively identified as the phase I and
phase II, by comparing the XRPD patterns shown in Figure 10.3(c) and 10.3(d), respec-
tively, with those from the in situ experiment. Adding water to sample I and sample II
resulted in regeneration of the nonahydrate phase. An intermediate phase occurs when
drying the crystals at 400 K, Figure 10.3(e). This phase was identified as phase III.
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Figure 10.3: XRPD patterns of the crude product and different hydrates of recrystallized strontium
ranelate collected on a Huber G670 diffractometer using Cu Kα1 radiation (λ = 1.5406 Å). (a) The
crude product. (b) Wet SrR after recrystallization. (c) Recrystallized SrR dried at RT and ambient
humidity (sample I). (d) Recrystallized SrR dried at RT over silica (sample II). (e) Recrystallized SrR
dried at 400 K at the diffractometer (sample III).
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The unit cell parameters were determined by a full pattern profile fit of the four XRPD
patterns shown in Figure 10.3(b)–(e), and the respective cell volumes were calculated, Ta-
ble 10.1.
Table 10.1: Data collection specifications for XRPD experiments and unit cell parameters for hy-
drates of SrR as determined by full pattern profile fits.
SrR nonahydrate Sample I Sample II Sample III
Temperature (K) 293 293 293 400
Data collection time (min) 120 120 120 72
a (Å) 8.4308(2) 8.2754(2) 8.2085(3) 8.6453(2)
b (Å) 12.4360(3) 12.4669(4) 11.3906(5) 10.5297(4)
c (Å) 12.7717(3) 11.5163(3) 11.3921(6) 10.8499(3)
α (◦) 110.239(1) 112.545(1) 117.637(2) 118.305(2)
β (◦) 96.998(1) 89.869(2) 94.794(3) 91.538(3)
γ (◦) 105.813(1) 102.398(1) 92.535(4) 90.210(3)
V (Å3) 1173.7(2) 1067.5(2) 936.1(4) 871.3(3)
Estimated no. of H2O 9 7 5 3
10.4 Discussion
The crystal structure of SrR nonahydrate, presented in Paper IV (Appendix A.4), is a metal
organic framework (MOF) with ranelate anions interconnecting layers of polyhedra of
eight and nine-coordinated Sr2+-cations, thereby forming channels which contain water.
Four of the nine water in the nonahydrate are not directly coordinated to strontium but
found in these channels. The nonahydrate dehydrates very easily, which was indicated by
the crystal structure, as it only contains 8.79 out of nine molecules of water. Thereby 0.21
water molecules were lost during crystal mounting.
The dehydration was followed by XRPD and TGA during heating and four dry phases
were observed. The exact water content present in each phase cannot be determined, as
the initial water content is unknown in the experiments. However an estimation can be
done by comparing the relative weight losses from the TGA with the XRPD patterns. Each
water molecule is estimated to correspond to a weight loss of approx. 2.8 %. Naming the
phases after the highest possible number of water, results in an assignment of phase I–
IV to heptahydrate, pentahydrate, trihydrate and dihydrate, respectively. The estimated
number of water in each phase is included in Table 10.1. The loss of water is also reflected
in the decreasing unit cell volume.
During the transitions between nonahydrate, phase I and phase II the unit cell lengths
a, b and c are successively decreased as a consequence of the compression of solvent chan-
nels. Both phase I and phase II are stable and can be obtained at RT by varying the hu-
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midity. The phase transition is fully reversible, as the nonahydrate can be obtained from
phase I and phase II by addition of water. Conversely, the transition to phase III is irre-
versible and heating is required. A larger rearrangement in the structure is indicated by a
sudden increase of the unit cell length a. This intermediate phase is undergoes a transfor-
mation to phase IV when the equilibrated at 400 K.
10.5 Conclusive remarks
Strontium ranelate was synthesized by an alkaline hydrolysis of ranelic acid tetraethyl
ester followed by precipitation by strontium chloride. The growth of larger crystals was
optimized by successive recrystallization. The structure of SrR nonahydrate was solved
from single crystal XRD. The crystals were found to be very sensitive to humidity and
temperature, and deteriorate easily upon dehydration. Besides the nonahydrate four other
hydrates were observed from X-ray powder diffraction, and their water contents estimated
by thermogravimetric analysis from which the phases were identified as heptahydrate,
pentahydrate, trihydrate and dihydrate.

Chapter 11
Studies of incorporation of strontium
into bone using XAS
The work presented in this chapter includes a study of the localisation of strontium in-
corporation into bone tissue from dogs using XAS. Two series of XAS-studies were per-
formed one at room temperature and one at 100 K. The results presented here is for the
100 K study, as the data quality improves when cooling. A manuscript has been written on
the results presented in this chapter and will be published soon. The EXAFS analyses and
results from the RT reference samples (strontium chloride hexahydrate, strontium disali-
cylate dihydrate, strontium hydroxyapatite and strontium doped calcium hydroxyapatite)
are included in Appendix C. EXAFS results and analyses of RT bone samples series from
dog calvaria (52 weeks treatment), dog femur (4 weeks treatment) and rat spine (26 weeks
treatment) are presented in Appendix D.
11.1 Introduction
The disorder of calcium in bone material has in previous XAS studies been described by
increased Debye-Waller factors, (Harries et al., 1988; Peters et al., 2000). The classical shell-
models used for EXAFS interpretation may be insufficient for describing static disorder
among calcium or strontium in bone tissue (see Appendix D), wherefore a new approach
in which XAS spectra are analysed by a linear combination of spectra of selected compos-
ites present in the bone sample, has been used. This may give a more realistic chemical
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interpretation of the XAS data as it allows estimation of the relative distribution of stron-
tium in the different bone composites.
11.2 Experimental
11.2.1 Bone samples
Femur (thigh) bones and calvariae (skull-caps) were dissected from beagle dogs treated
with Sr malonate for 4 and 52 weeks, respectively (Scantox, Ejby, Denmark). The bone
dissection and preparation was performed by Anders C. Raffalt and further described in
Raffalt (2011). The Sr contents were determined by ICP-MS and is described in Raffalt et al.
(2008) and Raffalt (2011). Treatment dose, treatment time and bone Sr concentrations are
summarized in Table 11.1.
Table 11.1: Doses and content of Sr in the bone samples analysed.
Sample Sr ranelate dose Sr concentration
(mg kg−1 day−1) (mg g−1)
Femur, 4 weeks, low dose 59147-7 300 5.7± 0.5
Femur, 4 weeks, high dose 59147-15 1000 10.4 ± 1.6
Calvaria, 52 weeks, low dose 62346-16 100 16.2 ± 0.2
Calvaria, 52 weeks, high dose 62346-25 1000 36.7 ± 2.0
11.2.2 Reference compounds
Three reference compounds representing the Sr coordination in each of the three phases in
the incorporation hypothesis (see Section 9.5) was used in this study.
A 0.3 M solution of SrHPO4 was made by dissolving SrHPO4 in 10 % phosphoric acid.
Sr-soaked collagen was prepared from a suspension containing 35 mgml−1 Bornstein &
Traub type I collagen (Sigma C9879) and 0.1 M SrCl2 · 6H2O in isotonic NaCl solution
(0.9 %). The collagen was soaked for four weeks under agitation, and recovered by fil-
tration and washed six times with isotonic NaCl solution. Calcium hydroxyapatite with
approximately 5 % (w/w) Ca substituted by Sr was prepared by modifying the synthe-
sis of pure calcium hydroxyapatite reported by Kumta et al. (2005) to include SrCl2 as a
starting material in an amount corresponding to 5 %(w/w) Sr substitution of Ca. The Sr
concentration in the apatite was confirmed by ICP-MS analysis and further analysed by
X-ray powder diffraction (XRPD) and Rietveld refinement.
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11.2.3 X-ray powder diffraction
XRPD data for Sr-doped CaHA were collected on a Huber G670 diffractometer using
Cu Kα1 radiation (λ = 1.5406 Å) for 30 minutes at RT. XRPD data for bone samples were
collected at MAX-lab beam line 711, Lund, Sweden, on a Huber G670 diffractometer using
synchrotron radiation with a wavelength λ = 1.2641 Å. Data were collected on the bone
samples for 20 minutes at 323 K and on a femur sample after heating to 1073 K.
11.2.4 X-ray absorption spectroscopy
For XAS analysis the Sr phosphate solution and the collagen was mounted in a 1 mm
thick sample holder for XAS, see Chapter 5. Preparation of Sr-doped CaHA was done by
grinding the samples in a mortar and pressing the powder into tablets of approximately
1 mm thickness. A representative fragment of each bone sample was crushed to a powder
and pressed to a tablet with a pressure of 10 tons before it was mounted on the sample
holder of the cryostat.
SrK-edge X-ray absorption spectra were recorded on beam line 811 at MAX-lab, Lund,
Sweden, using a Si(311) double-crystal monochromator detuned 30 % at 16750 eV, further
specifications can be found in Carlson et al. (2006). Fluorescence data were collected at
100 K using a liquid nitrogen cryostat (Oxford Instruments, ITC503) and a passive im-
planted planar silicon detector. Two or three spectra were collected for each sample. The
data collection ranges are specified in Table 11.2, and the data collection times were as fol-
lows: pre-edge data (150–30 eV before the edge) were collected in steps of 5 eV for 1 s, the
edge (from 30 eV before to 30 eV beyond the edge) in steps of 0.3 eV for 1 s and the EXAFS
(from 30 eV beyond the edge) in steps of 0.05 Å−1 for 1–15 s. No degradation or radiation
damage of the samples was observed.
Table 11.2: Number of spectra and data collection ranges for the samples.
Number of Data collection range
spectra (eV)
Sr phosphate solution 2 15955–17065
Sr soaked collagen 3 15955–16600
Sr doped CaHA 2 15955–17065
Femur, 4 weeks, low dose 3 15955–16900
Femur, 4 weeks, high dose 3 15955–17050
Calvaria, 52 weeks, low dose 3 15955–16900
Calvaria, 52 weeks, high dose 3 15955–17050
Averaging, background subtraction and normalization were carried out using WinXAS
(Ressler, 1998) as described in Section 3.4. All spectra were energy-calibrated using a si-
multaneously collected spectrum of strontium chloride hexahydrate for which the main
edge inflection point was assigned to 16109.8 eV (Ubgade & Sarode, 1987).
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11.3 Results
11.3.1 X-ray powder diffraction
The X-ray powder diffractograms for calvaria, femur bone before and after pyrolysis at
1073 K and 5 % Sr-doped CaHA are seen in Figure 11.1. The powder patterns collected at
the synchrotron have been converted to Cu Kα1 radiation (λ = 1.5406 Å). Common for
all samples is that they consist of hydroxyapatite, however with different crystallite size,
which is seen as different peak broadenings. After heating the femur sample to 1073 K the
organic matrix is pyrolysed leaving the hydroxyapatite phase back.
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Figure 11.1: XRPD patterns of bone samples and Sr-doped CaHA. From top calvaria, femur bone,
femur bone after heating to 1073 K and 5 % Sr-doped CaHA. Patterns collected at λ = 1.2641 Å are
converted to CuKα1 radiation (λ = 1.5406 Å).
Rietveld refinement of the 5 % Sr-doped CaHA showed an almost equal occupation of Sr2+
(0.048(4) and 0.053(5)) among calcium site I and II, respectively. This further comfirms the
5 % doping level and is in accordance to previous observations (Bigi et al., 2007; Terra et al.,
2009).
11.3.2 X-ray absorption spectroscopy
XANES spectra for all bone samples and the three reference compounds are shown in
Figure 11.2. In the XANES region, the bone samples are very similar. For SrHA a small
feature is clearly observed at 16135 eV, which could be assigned to outer coordination
spheres (Bazin et al., 2011) and thereby verify the incorporation of Sr2+ cations in apatite.
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Figure 11.2: XANES spectra collected at the Sr K-edge of Sr-treated bone samples and reference
compounds.
The extracted EXAFS and the radial electron density distributions are shown in Figure 11.3.
The EXAFS of the three reference compounds are very different. For Sr2+ cations in solu-
tion, only the inner coordination sphere is observed, whereas for SrHA and Sr-soaked
collagen several coordination spheres are observed, implying that the Sr2+ cations are co-
ordinated to and inserted in the solid matrix.
It is clearly evident that strontium in the bone samples is partly incorporated in the
apatite structure. Likewise, it is also clear that the Sr2+ cations are not exclusively present
as apatite. As XAS probes the average localisation of the absorbing atom type the EXAFS
spectra for the bone samples, χBone(k), were modelled by a linear combination of EXAFS
spectra of the three representative reference compounds (SrHA, Sr soaked collagen and
Sr phosphate solution). The modelling was carried out using the linear combination fit
procedure included in ATHENA (Newville, 2001; Ravel & Newville, 2005), which uses a
function of the type
χBone(k) = aHA · χHA(k) + aCol · χCol(k) + aSol · χSol(k) (11.1)
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Figure 11.3: (a) Extracted and k3-weighted EXAFS functions, k3χ(k). The bone spectra are fitted
(dashed curve) with a linear combination of EXAFS spectra for SrHA, Sr-soaked collagen and Sr2+
cations in solution. The distribution coefficients are listed in Table 11.3. (b) The modulus of the
Fourier transform of k3χ(k) giving the radial electron density distribution. NB the distances, R,
have not been phase corrected.
in which χi(k) and ai are the EXAFS function and the fraction of reference compound i,
respectively. The coefficients ai were determined by least squares procedure and forced to
sum to 1:
aHA + aCol + aSol = 1 (11.2)
The fitted EXAFS spectra are shown in Figure 11.3(a), and the coefficients describing the
distribution of strontium location and the residuals are listed in Table 11.3. The R-factor
reported is given as:
Rexafs =
∑(
χExp(k) − χBone(k)
)2
(
χExp(k)
)2 · 100% (11.3)
11.4 Discussion
The localisation of strontium in physiological calcifications depends on the mechanism of
how strontium is inserted into bone tissue. The hierarchical structure of bone tissue and
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Table 11.3: Relative distribution of strontium localisation in the bone samples as deter-
mined by XAS. The distribution coefficients are given as fractions ai representing the
fraction of strontium incorporated in hydroxyapatite, coordinated to collagen or present
in solution. Standard deviations determined from the least squares fit are given in paren-
theses.
aHA aCol aSol Rexafs
Femur, 4 weeks, low dose 0.44(2) 0.15(4) 0.41(5) 4.9 %
Femur, 4 weeks, high dose 0.36(2) 0.18(5) 0.46(5) 6.7 %
Calvaria, 52 weeks, low dose 0.44(2) 0.17(4) 0.39(4) 4.0 %
Calvaria, 52 weeks, high dose 0.45(1) 0.21(3) 0.34(3) 3.7 %
its many different composites makes the material highly inhomogeneous and provides
many different coordination sites for strontium. In general, the suggested hypotheses
agree that the positively charged strontium ions have a high affinity for coordination to
oxygen atoms, which are available in high amounts in the bone composites.
In this study presence of Sr2+ cations in serumwas represented by an aqueous solution
of Sr2+. As only one coordination sphere is clearly visible in the XAS spectrum from the
Sr phosphate solution, a high static and/or kinetic disorder among the outer coordination
shells is well imitated by this sample. Further analysis of this spectrum reveals a strontium
coordination number of 8.1 oxygen atoms with a distance of 2.600 Å and a Debye-Waller
factor, σ2 = 0.009, which match the Sr–O distance of 2.57 Å and coordination number of 8
reported in an EXAFS study on solubilized Sr2+ cations performed at 298 K (Seward et al.,
1999).
As strontium is inserted into solid material the structural order increases. This is seen
for the Sr-soaked collagen, as the outer coordination spheres become visible in the radial
electron density distribution and in the hydroxyapatite, in which the structural order is
even higher, and the electron density shells become more intense and better resolved.
The hydroxyapatite present in the bone samples are poorly crystalline, as seen from
the peak broadening in the XRPD patterns. The XAS fitting results clearly demonstrated
that 35–45 % of the total strontium content is incorporated into CaHA. Demonstration of
a possible preference towards one of the sites in the bone samples is however beyond the
information level of the XAS-data presented here. But the for the 5 % Sr-dopedHA used as
model compound in this study, an approximately equal distribution of strontium among
the two calcium sites was confirmed by XRPD and a following Rietveld refinement.
The EXAFS spectra were fitted by a linear combination of three components. How-
ever, a correlation may exist between the collagen component and the solution component.
Therefore, it cannot be clearly distinguished by this method, whether Sr2+ cations tend to
coordinate to the collagen, are present in the serum, or both, but both hypotheses are plau-
sible. Generally, it is evident that strontium occupies highly disordered sites in which only
the first coordination shell is visible by XAS and that the distance to this inner coordination
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sphere resembles the bond lengths of Sr–O observed in other strontium compounds. Such
sites are better described by the aqueous Sr2+ cations in solution rather than Sr-soaked
collagen, and may account for at least 30–50 % of the total strontium content.
The result from the EXAFS analysis did not show any significant differences of the
relative distribution of strontium in the four bone samples. Thus, while the dose levels and
treatment time highly influence the bone strontium concentrations, the relative amounts
of strontium incorporated into CaHA seem to be independent of these factors.
XAS is a well-suited method to study the localisation of Sr2+ cations in bone tissue,
as the method is element specific and very sensitive to small concentrations. In general,
the concentration of strontium in the analysed bone samples is very high compared with
the natural levels of 0.07–0.13 mg g−1 found in the corresponding placebo treated animals.
However, the high concentrations present in these samples provided XAS spectra with
good signal-to-noise ratios.
Obtaining a representative average sample of the entire bone type for XAS experiments
depends on the dissections and requires careful sample preparation by which the sample
homogenized. Contrarily, working with beam sizes on a macro-scale (approx. 1×1.5 mm)
a representative average of the sample is obtained, as a relatively large area of the sample
was exposed. The distributions determined by this method may however be connected
with some degree of uncertainty, as bone types differs on the macro-scale (cortical and
trabecular).
11.5 Conclusive remarks
From this study of bone samples from dogs treated with Sr malonate, around 35–45 % of
the strontium present is incorporated into CaHA by substitution of some of the calcium
ions, and at least 30 % is located at sites with a high structural disorder similar to Sr2+
in solution. Strontium can be absorbed in collagen in which it obtains a higher structural
order than when present in solution, but less order than when it is incorporated in CaHA.
These observations strongly support that strontium uptake in physiological calcifications
follows the hypotheses presented in Section 9.5.
Analysing the EXAFS spectra by fitting a linear combination of spectra of selected com-
posites present in bone, resulted in a new compositional model. This approach allowed
the relative distribution of strontium in the different bone composites to be estimated, in
contrast to the common shell models. The distribution of strontium among the different
composites seems to be independent of treatment period and dose level.
Chapter 12
Conclusions and outlook
This thesis presents the work on three different projects, in which three different X-ray
techniques are used, XRPD, XRD and XAS. As structural information is obtained at differ-
ent resolution, these techniques have different applications and the combination of them
provides complementary information, which has been illustrated in this work.
XRPD for fast characterization of protein powders
Among the three techniques, X-ray powder diffraction provides the lowest resolution. This
makes the technique suitable for fast characterization of protein powders. A procedure for
fast identification and verification of protein powders has been developed and tested on
micro-crystals of lysozyme and insulin. Verification of a protein crystal form by XRPD re-
quires calculation of realistic powder diffraction patterns from PDB coordinate data. The
key factor to bring the calculated patterns in agreement with the observed patterns is cor-
rection for bulk-solvent, but also background, unit cell parameters and geometrical factors
have to be taken into account. Experimental powder diffraction patterns were obtained
using a standard laboratory X-ray powder diffractometer. Optimization of the sample
holder design and collimation of the beam by pinholes were found crucial to increase the
signal-to-noise ratios, while minimizing the sample volume. The final sample holder de-
sign operate with sample volumes down to 7 µl, and has been successfully applied for both
powder diffraction and XAS experiments. The method was successfully applied for verifi-
cation of micro-crystals of T6, T3R3 and R6 insulin prior to synchrotron XAS experiments,
and used to identify a phase transition in rhombohedral R6 insulin in which the unit cell
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volume is eight-fold doubled when cooled. Furthermore, XRPD was used after the XAS
experiments to monitor eventual degradations of the samples from radiation damage.
Combination of XRD and XAS for studying metalloproteins
Combination of XRD and XAS provides a strong tool for studying metalloproteins. The
overall three-dimensional structure is obtained at medium/high resolution from XRD,
whereas only the local structure around the metal sites are obtained from XAS, however at
ultra-high resolution. Hence XAS works as a magnifying glass centred on the metal site.
The synergy and complementarity between these two techniques were illustrated in the
study of hexameric insulin.
The crystal structures of all three conformations (T6, T3R3 and R6) of hexameric bovine
zinc insulin were solved by single crystal XRD to 1.40 Å, 1.30 Å and 1.80 Å resolution, re-
spectively. T6 insulin was furthermore crystallized with nickel, copper and iron, and their
XRD crystal structures were solved to 1.50 Å, 1.45 Å and 1.90 Å resolution, respectively.
The two metal sites in hexameric insulin were occupied by divalent cations of the same
metal type in all structures besides the Fe insulin. Crystals with Fe2+ in both metal sites
could not be obtained, as the affinity to iron is too low. Instead, a structure containing
one Fe2+ and one Zn2+ was obtained from crystals grown in presence of small amounts
of zinc. The bovine insulin crystal structures were highly similar to analogue human and
porcine insulin structures deposited in the PDB. At resolution better than 1.50 Å the atomic
positions were unambiguously clear, and hydrogen atoms were included in the structures.
In general, ordered water molecules were easily resolved, with exception of those located
in the open metal sites in T3-trimers.
Octahedral coordination fulfilled by three water molecules was observed in the T3-sites
of zinc and nickel insulin, however with quite long metal–water distances (up to 2.47 Å).
For copper insulin, a dual octahedral/tetrahedral coordination of copper was observed in
the crystal structure. Likewise, an octahedral zinc and a tetrahedral iron coordination, was
observed in the iron insulin structure. Whereas more undefined electron densities were
observed in the open T3-sites and themetal coordination geometry thus could be somehow
ambiguously interpreted, the electron densities around the Zn2+-ions in the closed R3-sites
clearly revealed tetrahedral coordinations of zinc, which is caused by the steric hindrance
from the α-helical conformation of the three B-chain N-termini.
A more accurate determination of the metal coordination distances, in particular in the
T3-sites, was obtained from EXAFS spectroscopy. XAS spectra with good signal-to noise
ratios to 13–14 Å−1 in k-space were collected frommicro crystalline insulin samples. Using
the coordinates from the crystal structures as starting models for the EXAFS refinement
the distances between the metal and its first coordination sphere ligands were determined
with standard deviations below 0.01 Å. The coordination geometries as determined by
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EXAFS were in agreement with those determined by XRD for all three conformations of
zinc insulin, as well as nickel T6 insulin. For copper T6 insulin, tetrahedral coordination
of copper was modelled in both sites. The tetrahedral copper coordination was further
supported by ab initio Hartree-Fock model calculations and calculated XANES spectra.
The XANES and EXAFS regions contain complementary information, as the XANES
region is more sensitive to multiple scattering and thus contains more information about
the three dimensional arrangement of atoms. Using finite difference methods, calculated
XANES spectra of themodels optimized from EXAFS reproduced the experimental XANES
spectra very well. The coordination geometries could be verified from the calculated
XANES spectra. Furthermore, coordination distances and, in particular, bond angles of
T6 and R6 zinc insulin were optimized from a quantitative XANES analysis.
Using synchrotron radiation, the energy load per sample area is generally higher for
XRD experiments compared to XAS. The concomitant radiation damage particularly in-
fluenced the coordination of water molecules in the open T3-sites, and thus explained the
more unstructured electron density observed in the XRD structures in these sites. As the
radiation dose was two orders of magnitude lower for the XAS experiments, less damage
was induced in these samples. Compared to the medium resolution XRD structures, the
EXAFS determinations were in perfect agreement with bond distances observed among
small molecules with similar coordination geometries, as well as with other high resolu-
tion crystal structures of insulin.
The cluster approach, in which atoms within the same molecule are grouped, was used
to refine coordination distances from EXAFS using PDB-coordinates from crystal struc-
tures as starting models. This approach enabled a three-dimensional model with inclusion
of full multiple scattering calculations to be refined. The constrained and restrained re-
finement strategies furthermore allowed refinement of distances and displacement factors
for many atoms, while keeping the number of refineable parameters to a minimum. This
makes the cluster approach superior for metalloprotein applications. EXAFS is best suited
for mononuclear metalloproteins or metalloproteins containing several metal clusters that
all have identical coordination geometry. Proteins containing different coordinations of the
same metal, as in the T3R3-conformation, highly increase the complexity of data treatment
and reduce the amount of structural information which can be resolved.
Although XAS may be a more gentle method compared to XRD, photoreduction may
occur. This was observed in the copper insulin, where the XANES spectrum revealed a
reduction of Cu2+ to Cu+. Contrarily, Zn2+ and Ni2+ are harder to reduce and remained
stable throughout the experiments.
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Combining XRD and XRPD for studying pharmaceuticals
Strontium ranelate is a drug used in the treatment of osteoporosis. Combination of XRD
and XRPD were used to study the structure of strontium ranelate and its polymorphs.
Strontium ranelate was synthesized and crystallized as a nonahydrate. The structure of
strontium ranelate nonahydrate was solved from single crystal XRD. The crystals were
found to be very sensitive to humidity and temperature, and deteriorate easily upon de-
hydration. Four other hydrates were observed from X-ray powder diffraction, and their
water contents estimated by thermogravimetric analysis fromwhich the phases were iden-
tified as heptahydrate, pentahydrate, trihydrate and dihydrate.
XAS for studying the distribution of strontium in bone tissue
The hierarchical structure of bone tissue and its many different composites makes the ma-
terial highly inhomogeneous and provides many different coordination sites for strontium.
The strontium distribution in bone samples from dogs treated with Sr malonate was stud-
ied with XAS. Analysing the EXAFS spectra by fitting a linear combination of spectra of
selected composites present in the bone sample, resulted in a new compositional model.
This approach allowed the relative distribution of strontium in the different bone compos-
ites to be estimated, in contrast to the common shell models.
Around 35–45 % of the strontium present is incorporated into CaHA by substitution
of some of the calcium ions, and at least 30 % is located at sites with a high structural
disorder similar to Sr2+ in solution. Strontium can be absorbed in collagen in which it ob-
tains a higher structural order than when present in solution, but less order than when it
is incorporated in CaHA. While the total amount of strontium present in bone depends on
treatment period and dose level, the distribution of strontium among the different com-
posites seems to be independent of these factors.
Outlook
X-ray powder diffraction has proven to be a fast technique to characterize protein pow-
ders, even with laboratory X-ray diffractometers. XRPD is thus a potent technique for
characterization of precipitates occurring in the enzyme production pipelines, where over-
expression and subsequently high protein concentrations create new challenges. Iden-
tification and verification of crystal forms may provide important information for later
purification and thereby optimize the production.
Many structural genomics programmes are currently in progress, and newmetallopro-
teins are being discovered. As metalloproteins constitute a significant fraction of all pro-
teins, the combination of XAS and XRD is highly needed to obtain information about the
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structure of metalloproteins and the processes taking place in their metal centres. Newly
built synchrotron facilities provide concomitant collection of both XRD and XAS data, and
experiments where both techniques are used, as well as in situ studies, may be seen more
frequently in the near future. Furthermore, XAS may found applications to metallopro-
teins which are difficult to crystallize. Recent improvements in fitting algorithms against
XANES spectra offer a possibility to use information from both the XANES and the EXAFS
in the model fitting.
Strontium was found to be incorporation into bone tissue in hydroxyapatite as well as
collagen. Substitution of calcium by strontium in the hydroxyapatite structure has already
been studied,whereas the influence on collagen remains unknown. Combining XAS, SAXS
and fibre diffraction may provide information about how strontium binds to collagen, and
could be complemented by mechanical test of how it affects its tensile strength.
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X-ray powder diffraction patterns of lysozyme and insulin were recorded on a
standard in-house powder diffractometer. The experimental powder diffraction
patterns were compared with patterns calculated from Protein Data Bank
coordinate data. Good agreement was obtained by including straightforward
corrections for background, unit-cell parameters, disordered bulk solvent and
geometric factors. In particular the solvent correction was found crucial for a
good agreement. A revised Lorentz factor was derived, which gave a minor, but
significant, improvement to the fit in the low-angle region. An attempt to include
calculated H-atom positions did not improve the overall fit and was abandoned.
The method devised was shown to be a quick and convenient tool for
distinguishing precipitates and polymorphs of proteins.
1. Introduction
X-ray diffraction on single crystals is the preferable method to
solve and characterize protein structures. The results are
usually unambiguously clear, when the structure is revealed.
One of the bottlenecks in this process is the need to find the
right conditions for growing suitable single crystals. The ability
to screen early precipitates for crystals and possible poly-
morphs would save large amounts of time and effort.
Furthermore, as structure-based drug design is a growing field
and drug candidates are often proteins themselves, there is a
growing need for quick characterization of polymorphs and
substrate–protein complexes. High-resolution synchrotron
X-ray powder diffraction (XRPD) has already proved its
ability for structure solution and refinements of small protein
structures from powder samples (von Dreele, 1999, 2001, 2005;
von Dreele et al., 2000; Margiolaki & Wright, 2008; Wright et
al., 2008), but synchrotron XRPD is not available on a daily
basis. However, in-house XRPD available in most chemistry
laboratories may offer an alternative. A recent study using
medium-resolution XRPD demonstrated the ability to quickly
and effectively distinguish between different polymorphs of
insulin in combination with multivariate data analysis
(Norrman et al., 2006). Based on these previous experiences
several challenges can be identified:
(a) The peak overlap problem. Only the first 15–20 in 2
with Cu K radiation will be of interest.
(b) The measured intensities fit poorly with those calculated
from known structures. Protein structures available from the
Protein Data Bank (PDB; Bernstein et al., 1977) do not
generally contain H-atom positions, and the contribution from
the disordered solvent in the solvent channels, which is the
major source for this discrepancy, is not described. Further-
more, the conventional Lorentz correction tends to infinity
when approaching 2 = 0.
(c) The measured peak positions sometimes deviate from
those derived from the literature. In many cases this is due to a
difference in data collection temperature, but small differ-
ences in the amount of solvent and the exact composition of
the solvent may also slightly affect the unit-cell parameters.
(d) The background problem. The relatively poor scattering
from the protein combined with the scattering from mother
liquor and sample holder result in a poor signal-to-noise ratio.
(e) A relatively large amount of sample and/or measuring
time is needed.
In this work we present a study of these challenges, and
show some solutions based on easily available software, which
can be routinely applied to in-house XRPD. Specifically, we
discuss the following: background fitting and subtraction, unit-
cell refinement, adding H-atom positions and solvent scat-
tering to the structure model, powder pattern calculation, and
proper Lorentz correction at low angles.
2. Experimental
Lyophilized lysozyme from chicken egg white, Gallus gallus
(95%, Sigma Aldrich L-6876), and insulin from bovine
pancreas, Bos taurus (Sigma Aldrich I-5500), were used in this
study. All crystals were grown using the vapour diffusion
technique.
2.1. Crystal growth
For the growth of tetragonal lysozyme the protein was
dissolved in 0.02M sodium acetate and the protein concen-
tration was determined to be 13.8 mg mlÿ1 using an extinction
coefficient at 280 nm, "280, of 37 470M
ÿ1 cmÿ1. The protein
was equilibrated in a sitting drop against a reservoir of 0.1M
HEPES [4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid]
and 0.8M potassium sodium tartrate (KNaC4H4O6) at pH 7.5
(cf. Crystal Screen HR-2-110 No. 29, Hampton Research). The
drops were formed of 200 ml of protein solution mixed with
200 ml of reservoir solution.
For the growth of trigonal insulin crystals the insulin was
dissolved in 0.01M HCl, the pH was adjusted to 6 with NaOH
and the protein concentration was determined to be
5.0 mg mlÿ1 using an "280 of 5960M
ÿ1 cmÿ1. Using the sitting-
drop method the protein was equilibrated against a reservoir
of precipitant solution of 33 vol.% acetone, 0.11M sodium
citrate and 16.6 mM zinc acetate at pH 6.5 (Smith et al., 1982).
The drops were formed of 200 ml of protein solution mixed
with 160 ml of reservoir solution.
For the growth of cubic insulin crystals the protein was
dissolved in a 0.02M Na2HPO4 and 0.01M Na3EDTA solu-
tion (EDTA is ethylenediaminetetraacetic acid) and the
protein concentration was determined to be 8.9 mg mlÿ1.
Using the sitting-drop method the protein was equilibrated
against a reservoir of precipitant solution comprising a 0.3M
Na2HPO4/Na3PO4 buffer system adjusted to pH 10.0 and
0.01MNa3EDTA. The drops were formed of 200 ml of protein
solution mixed with 200 ml of reservoir solution.
2.2. Single-crystal X-ray diffraction of lysozyme
The structure of lysozyme has been refined from a single
crystal from the same crystal batch as the powder sample in
order to obtain an optimal basis for the calculated powder
diffraction pattern of lysozyme.
A single crystal was soaked in a cryogenic solution of
mother liquor with 20 vol.% glycerol and mounted in a loop.
Data were collected at MAX-lab in Lund, Sweden, on
beamline I911-3, MAX II, using a Marresearch CCD detector.
The crystals diffracted beyond 2.05 A˚, but owing to the
emphasis on solvent and Lorentz correction in this study, high-
resolution data were not required and a data set to 2.05 A˚ was
collected. The data were processed in space group P43212 and
scaled using the programs XDS and XSCALE (Kabsch, 1993).
The structure was refined with starting coordinates from
PDB entry 1lsa (Kurinov & Harrison, 1995), with the ordered
water molecules omitted. The program REFMAC5
(Murshudov et al., 1997) included in the package CCP4
(Collaborative Computational Project, Number 4, 1994) was
used for refinement, and model building was carried out by
WinCoot (Emsley & Cowtan, 2004). One molecule of HEPES
and 116 ordered water molecules were found. Data collection
and refinement statistics are summarized in Table 1.
2.3. X-ray powder diffraction
X-ray powder diffraction patterns were recorded for
tetragonal crystals of lysozyme and for trigonal and cubic
insulin crystals. Batches containing 2–6 mg of protein of the
three types of crystals were grown and the crystals, in a slurry
with mother liquor, were gently crushed to a powder with a
pestle. The diffraction experiments were carried out at an in-
house Huber G670 diffractometer using Cu K1 radiation ( =
1.54059 A˚). The samples were mounted in a specially designed
sample holder (details to be published along with new design),
which contains approximately 150 ml of the powder suspension
(corresponding to approximately 5 mg of protein). The
measurements were performed on rotating samples at room
temperature. Lysozyme data were collected at room
temperature for 15 4 h, and insulin data for 4 4 h. None of
the powder diffraction series indicated any time decay.
The background was treated in the program PROTPOW
(http://www.xray.kemi.dtu.dk/English/Computer%20Programs/
PROTPOW.aspx) by manually picking between ten and 20
background points, fitting to a spline function and subtracting.
3. Corrections to XRPD patterns calculated from PDB
coordinates
Powder diffraction patterns were calculated for three different
protein crystals: tetragonal lysozyme, and cubic and trigonal
insulin. The lysozyme structure was refined from a crystal
originating from the same batch as the lysozyme powder
(x2.2). For insulin the structures were downloaded from the
PDB. The resulting structure factors, before and after
corrections, were entered into PROTPOW for powder
diffraction pattern calculations. The following section
describes how application of a solvent correction, including
H-atom positions, and using a revised Lorentz factor affects
the calculated data. All corrections were carried out on the
calculated patterns.
3.1. Optimization of unit-cell parameters
It was necessary to optimize the unit-cell parameters to
obtain fully comparable powder patterns. This could be due to
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Table 1
Data collection and refinement statistics for the lysozyme single-crystal
data set.
Data collection
Beamline I911-3, MAX II, MAX-lab
Wavelength (A˚) 1.5000
Temperature (K) 100
Resolution (A˚) 40.00–2.05 (2.31–2.05)†
No. of reflections 99 201 (29 371)†
No. of unique reflections 7511 (2202)†
Redundancy 13.2 (13.3)†
Completeness (%) 99.9 (100.0)†
Rsym (%)‡ 4.1 (9.2)†
hI=ðIÞi 43.93 (25.68)†
Processing
Space group P43212
No. of molecules per asymmetric unit 1
a (A˚) 77.05 (5)
c (A˚) 37.30 (3)
Solvent content 35.8%
Refinement
R§ 0.1695
Rfree§ 0.1729
† Values in parentheses are for the outermost resolution
shell. ‡ Rsym ¼
P
hkl
P
i jIiðhklÞ ÿ hIðhklÞij=
P
hkl
P
i IiðhklÞ where hIðhklÞi is the mean
intensity of a set of equivalent reflections. § R and Rfree ¼
P
jjFobsj ÿ jFcalcjj=
P
jFobsj,
where Fobs and Fcalc are the observed and calculated structure-factor amplitudes,
respectively. Rfree was calculated with a random 5% subset of all reflections excluded
from the refinement.
differences in data collection temperatures (lysozyme powder
data were collected at room temperature while the single-
crystal data set was collected at 100 K) or variations in solvent
concentrations. Optimization can be carried out with a full-
pattern profile fit in the program PROTPOW. Optimal para-
meters describing the peak width (FWHM) and peak shape of
a pseudo-Voigt function are included in the pattern fit. The
peak width is modelled by (v tan + w)1/2 and the fraction of
Lorentzian and Gaussian character is modelled by a  para-
meter. The peak asymmetry effects can be modelled by
splitting the peak into a left (l) and a right (r) hand side
contribution. The unit-cell and peak-shape parameters were
optimized from the experimental patterns. In the present cases
the profile parameter set consisted of wl, wr, v,  l and . The
resulting unit-cell parameters are given in Table 2.
3.2. Correction of disordered solvent
Protein crystals contain 30–80% of disordered solvent
throughout the structure. The contribution to the diffraction
pattern from the disordered solvent is most important for low-
resolution data (11–40 A˚). Several correction models have
been developed. The simplest is the exponential scaling model
based upon the Babinet (1837) principle, according to which a
simple scale factor function is used (Moews & Kretsinger,
1975). This model assumes that the contribution from the
disordered solvent is distributed isotropically. However, this is
an approximation since protein crystals contain solvent
channels along specific crystallographic directions. The flat
bulk-solvent correction model is anisotropic and assumes a flat
solvent profile in the solvent regions (Phillips, 1980). The
model defines the solvent regions by a solvent mask. Other
models, which are all based on the solvent mask principle but
assume more complex distributions of electron density in the
solvent regions, are reviewed by Jiang & Bru¨nger (1994), from
which it is concluded that the flat bulk-solvent model is the
simplest model that still gives a realistic correction. The model
takes two parameters: ksol defining the level of electron
density in the solvent region, and Bsol defining the steepness of
the border between the solvent and the macromolecular
regions. The parameters are refined in today’s single-crystal
X-ray structure refinement software, and based on 1162
structures Fokine & Urzhumtsev (2002) found that they
accumulate around ksol = 0.35 e A˚
ÿ3 and Bsol = 46 A˚
2.
The flat bulk-solvent correction model is used in the
following to correct for the disordered bulk solvent. This is
done using PHENIX.pdbtools (Adams et al., 2002), which only
requires a PDB coordinate file, ksol and Bsol as input. The
parameters ksol and Bsol can be set to the average values in
case no other information is found, but refined values or
values found from the Electron Density Server (EDS; Kley-
wegt et al., 2004) can improve the result. PHENIX.pdbtools
calculates the structure factors for the model, Fmodel, which
include the contributions from both the protein, Fcalc, and the
solvent, Fsol. Fmodel can then be used for powder pattern
calculations.
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Table 2
Refined cell parameters from experimental patterns, parameters from the
solvent and the geometrical corrections, and residual values evaluating
the effects of the corrections.
The bulk-solvent parameters are found from refinement of our own data using
PHENIX.refine (Adams et al., 2002) for lysozyme data and in the EDS
(Kleywegt et al., 2004) for insulin data.
Lysozyme
Without H With H Insulin, trigonal Insulin, cubic
General parameters
PDB This work 2zp6 1bph
Space group P43212 R3 I213
a (A˚) 76.699 (3) 82.584 (8) 79.136 (7)
c (A˚) 37.112 (2) 33.862 (4) –
Rp before solvent
correction† (%)
92 99 100
Hydrogen and bulk-solvent correction
ksol (e A˚
ÿ3) 0.39 0.45
Bsol (A˚
2) 51 58
Reference This work This work
Rp after solvent
correction† (%)
23.6 26.6
Bulk-solvent correction
ksol (e A˚
ÿ3) 0.39 0.34 0.28
Bsol (A˚
2) 51 90 90
Reference This work EDS EDS
Rp after solvent
correction† (%)
23.6 19.1 23.3
Geometric correction
 (A˚–1) 0.031 0.053 0.032
Rp after geometric
correction† (%)
23.4 16.5 21.9
† Rp ¼
P
jIobs ÿ kIcalcj=
P
jIobsj.
Figure 1
Overview of the trends from the different corrections. The effects are
shown as the relative intensity difference (Inon-corr ÿ Icorr)/Inon-corr plotted
as functions of the scattering angle 2 (using Cu K1) and resolution d =
/(2 sin). The curves are based on average corrections of lysozyme and
insulin data. Inon-corr is the raw intensity from a calculated pattern which
has only been Lorentz corrected using the expression in equation (2). Icorr
for the solvent and hydrogen corrections have been calculated according
to the procedures described in xx3.2 and 3.3. The geometric correction
curve has been calculated from the expression in equation (3) using  =
0.045 A˚ÿ1.
The effect of the solvent correction was evaluated as the
relative intensity difference given as (Inon-corr ÿ Isol)/Inon-corr,
where Inon-corr and Isol are the calculated intensities from non-
solvent- and solvent-corrected powder diffraction patterns,
respectively. The average effect is shown in Fig. 1 and is based
on solvent corrections for lysozyme and for trigonal and cubic
insulin. The stepwise effect from each of the solvent para-
meters ksol and Bsol has been investigated in more detail for
lysozyme (Figs. 2a and 2b, respectively). For ksol, the effect has
been evaluated relative to a calculated reference powder
pattern using ksol = 0.00 e A˚
ÿ3 which corresponds to the case
where no solvent correction has been carried out. For Bsol, ksol
has been kept constant at the average value 0.35 e A˚ÿ3 and the
effect has been evaluated relative to a calculated reference
powder diffraction pattern using ksol = 0.35 e A˚
ÿ3 and Bsol =
0 A˚2. The bulk-solvent correction is highly anisotropic and
both parameters affect the anisotropy. While ksol shows its
largest influence at low resolution, Bsol seems to scale the
correction with a much smaller dependence on resolution.
The PDB coordinates and the bulk-solvent parameters were
given as inputs to PHENIX.pdbtools, which returned a set of
calculated structure factors Fmodel. In this study the bulk-
solvent parameters for the two insulin types were taken from
EDS (Kleywegt et al., 2004), while our own data were used for
lysozyme. The parameters used are listed in Table 2. The
solvent correction effect is demonstrated in Fig. 3 on cubic
insulin and is also seen as a decrease in the high initial Rp
values listed in Table 2.
3.3. Hydrogen correction
Ideal H-atom positions can be calculated using
PHENIX.pdbtools and then included in the PDB file. The
assignment of B factors for the new H atoms is achieved by
using the B factor from the adjacent non-H atom. The solvent
correction can then be carried out according to the procedure
described in x3.2 using the model with the H atoms included.
The effect of H-atom inclusion was evaluated as the relative
intensity difference given as (Inon-corr ÿ Ihyd)/Inon-corr, where
Inon-corr and Ihyd are the calculated intensities without and with
H-atom positions, respectively.
The average effect is shown in Fig. 1, and the separate
effects for lysozyme and for trigonal and cubic insulin are
shown in Fig. 2(c). As for the solvent correction, the effect is
anisotropic and affects mostly the low-resolution data, indi-
cating that there may be a strong correlation between these
two corrections.
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Figure 2
The influence of the solvent correction parameters (a) ksol and (b) Bsol on calculated powder patterns for lysozyme and (c) the influence of H atoms on
calculated powder patterns for lysozyme and for trigonal and cubic insulin. The effect is plotted as the relative intensity difference (Inon-corr ÿ Icorr)/
Inon-corr against 2 (using Cu K1) and resolution d = /(2 sin). For the variation of ksol (a), the parameter Bsol has been kept constant to 50 A˚
2. For
the variation of Bsol (b), ksol has been kept constant at the average value 0.35 e A˚
ÿ3.
Figure 3
Calculated powder diffraction patterns for cubic insulin before (solid)
and after (dashed) solvent correction. The experimental powder pattern
(dotted) is included for comparison. The patterns have been scaled in
order to obtain comparable intensities for 2 > 12, meaning that the scale
factor k in equation (4) has been determined solely on the reflections
where 2 > 12 [d = /(2 sin) < 7.37 A˚]. The calculated powder patterns
are corrected by the traditional Lorentz factor [equation (2)]. The powder
diffraction patterns have been translated along the y axis.
3.4. Geometric intensity correction for small crystals with
large unit cells
The geometric intensity correction, known as the Lorentz
factor, L, describes the fraction of a reflection that is in the
reflecting condition. In the case of Bragg–Brentano and
Debye–Scherrer geometries it is given by
L ¼
1
sinð2Þ
1
sin 
: ð1Þ
In the case of the Guinier geometry an additional term is
required, which is related to the angle between the tangent of
the focusing circle and the primary beam, G (typically 45
)
(Sas & de Wolff, 1966; Sta˚hl, 2000):
LG ¼
1
sinð2Þ
1
sin 
1
cosðG ÿ 2Þ
: ð2Þ
Equations (1) and (2) both assume ideal crystals resulting in
infinitesimally small reciprocal lattice points. However, the
true size of the reciprocal lattice points depends on the crys-
tallite size, on the internal stress and on defects (Snell et al.,
2003), hence the larger and more perfect the crystals, the
smaller and more well defined the points. The quality of
macromolecular crystals is more erratic than crystals of small
molecules, resulting in a considerable smearing of the reci-
procal lattice points. This effect has to be included in the
Lorentz factor and is introduced by the parameter , which
describes the uncertainty of the length of the scattering vector
|s|. A revised Lorentz correction factor Lrev for protein powder
has been derived using  (the derivation is found in
Appendix A):
Lrev ¼
1
sinð2Þ
1
sin 
1
cosðG ÿ 2Þ
sin2 
ðsin2  þ 22=12Þ
: ð3Þ
With this model the Lorentz factor does not approach
infinity when 2 approaches zero. The corrective effect of the
revised Lorentz factor has been calculated as (Inon-corr ÿ Igeo)/
Inon-corr = 1 ÿ [sin
2/(sin2 + 22/12)], where Inon-corr and Igeo
are the calculated intensities from powder diffraction patterns
corrected with the traditional Lorentz factor, equation (2),
and the revised Lorentz factor using  = Cu K1 and  =
0.045 A˚ÿ1, equation (3), respectively. Fig. 1 shows that the
correction to the Lorentz factor has a much smaller effect than
either the solvent or the H-atom corrections.
The parameter  was determined empirically by testing
different values of  and evaluating the fit between the
calculated and the experimental powder diffraction patterns.
Again the largest influence is observed for low-resolution
data, although the effect is isotropic. The optimal  values
found for the protein powders are presented in Table 2.
4. Discussion
In order to evaluate the improvements of the correction a
profile R factor has been calculated before any correction,
after solvent correction and after geometrical correction. The
values are calculated from the intensities I:
Rp ¼
P
Iobs ÿ kIcalc




P
Iobs



 ; ð4Þ
where k is a scale factor scaling the calculated intensities, Icalc,
to the background-subtracted observed intensities, Iobs. The Rp
values are listed in Table 2.
The effect of the solvent correction for the cubic insulin,
which has the highest content of solvent (65.5%) along the
(100) and (111) directions, is seen in Fig. 3. The effect on the
intensities is, as seen, dramatic and brings the observed and
calculated intensities into quite good agreement. However, the
solvent parameters are quite sensitive and ksol and Bsol may be
further refined when experimental structure factors are
available.
The inclusion of the H-atom positions in the calculation of a
powder diffraction pattern was carried out for lysozyme.
Because the effect of including H atoms correlates with the
solvent correction, the solvent-correction parameters were
refined after refining the lysozyme structure with and without
H atoms using PHENIX.refine (Adams et al., 2002). Both ksol
and Bsol increase by 10–15% when H atoms are included
(Table 2). As seen from the R factors the hydrogen correction
does not improve the fit, rather the contrary, possibly because
modelling H atoms in ideal positions is too crude. The
hydrogen correction was thus abandoned and it was decided
to rely on the bulk-solvent correction only.
The patterns were finally corrected by the Lorentz factor
Lrev, given in equation (3), and scaled. Comparing the inten-
sities at the smallest 2 angles, the correction seems to slightly
improve the agreement between the calculated and the
experimental patterns for all three crystal types. The effect is
larger for the insulin data since the first strong reflections
occur at 2 < 4, whereas for lysozyme the first strong
measured reflections occur at 2 = 4. It should be noted that
the nature of the Lorentz correction and the parameter  is
such that it will correlate with, for instance, the background
correction, the general level of the bulk-solvent correction,
errors in temperature factors etc. Even when all corrections
are carefully conducted the parameter  must be cautiously
interpreted when obtained from a limited interval in 2. The
utilization of the parameter  is thus only necessary in the
presence of data below 15 A˚ where the effect of  is demon-
strable.
The combined effects of applying background subtraction,
optimizing the unit-cell parameters, bulk-solvent correction
and the improved Lorentz correction are seen in Fig. 4 for all
three samples. The agreement between the experimental and
the corrected calculated patterns are generally very good. The
profile R factors are in the range 20–25%. Even in the region
where 2 = 12–20 the agreement is good, meaning that for
well diffracting crystals it is possible to detect the detailed
diffraction pattern down to resolutions of 4 A˚ on in-house
equipment. However, there still remain minor disagreements
between the calculated and experimental patterns, which have
not been accounted for. The following factors may influence
the experimental data:
research papers
880 Christian Grundahl Hartmann et al.  In-house characterization of protein powder J. Appl. Cryst. (2010). 43, 876–882
(i) Preferred crystal orientation, which causes a nonrandom
distribution of reflecting planes.
(ii) Insufficient or excess background correction. The
overlap problem may result in a background subtraction that
also includes some of the signal.
(iii) Despite solvent and hydrogen corrections the structural
model may still be deficient.
For the powder patterns the difference in accuracy between
lysozyme and insulin is not very large even though the
calculated pattern for lysozyme was based on a structure
determination from a single crystal from the exact same batch
from which the experimental powder pattern was obtained.
Fitting our lysozyme powder data with a calculated pattern
using the coordinates from PDB entry 2hub (S. Lagziel Simis,
Y. Wine, N. Cohen-Hadar, A. Freeman & F. Frolow) gives a
similar result (Rp = 27.5%). Matching both Fobs and Fcalc with
the experimental powder data gives overall similar results.
However, generally the low-angle reflections measured in
single-crystal experiments suffer from a large uncertainty
reflecting the difficulties in integration and data treatment in
this region. Furthermore, the low-angle region is often
incomplete. Therefore we recommend using Fcalc instead of
Fobs for powder comparison. This means that PDB coordinate
files can be used directly from the Protein Data Bank to
calculate realistic powder patterns.
5. Conclusion
Using a standard in-house X-ray powder diffractometer, it has
been possible to collect powder patterns up to 4 A˚ resolution
from well diffracting powder samples of lysozyme and insulin.
Calculated powder patterns were generated from PDB coor-
dinate data or data presented in this work. By performing
corrections for background, unit-cell parameters, disordered
bulk-solvent and geometrical factors the agreement between
the experimental and the calculated patterns is generally very
good, with profile R factors in the range 20–25%. The key
factor to bring the calculated patterns into agreement with the
observed patterns is the bulk-solvent correction. The
improved Lorentz factor gives a minor, but significant,
improvement to the fit, in particular at the lowest angles. An
attempt to include H-atom positions gave no improvement
and was abandoned. Moreover, the corrections are all
straightforward using easily available standard programs and
PDB coordinates.
The main drawback of the method is the large amount of
sample needed, about 5 mg presently. It was found that in the
vertical mount used the sample tends to settle in the bottom
part of the sample compartment, so by an improved sample
holder design we aim to reduce the sample amount by an
order of magnitude and at the same time to improve the
signal-to-noise ratio. Another issue is the data collection time.
For this study data were collected for 16–60 h to obtain
convincing statistics to 20 in 2. However, for polymorph
identification 1–2 h is sufficient even in the present setup. The
data collection time and the angular resolution of the peaks
may furthermore be improved simply by the use of chromium
K radiation instead of Cu K.
APPENDIX A
Derivation of a revised Lorentz correction factor
Assuming that the reciprocal lattice points have a certain
spatial extension parallel to the scattering vector, s, the sphere
of reflections will have a thickness 2. The parameter  thus
reflects the distribution of the length of s. The fraction f of a
reciprocal lattice point P touching the Ewald sphere is given as
the area emphasized in grey in Fig. 5, divided by the volume
Vshell, i.e.
f ¼
Aspherical segment
Vshell
¼
Alarge spherical cap ÿ Asmall spherical cap
Vlarge sphere ÿ Vsmall sphere
; ð5Þ
with
Alarge spherical cap ÿ Asmall spherical cap ¼ 2sð2Þ ð6Þ
and
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Figure 4
Calculated and experimental powder patterns for (a) lysozyme, (b)
trigonal insulin and (c) cubic insulin. The calculated patterns (blue) are
corrected for bulk-solvent and geometrical effects using the revised
Lorentz factor [equation (3)].
Vlarge sphere ÿ Vsmall sphere ¼ ð4=3Þ½ðsþ Þ
3
ÿ ðsÿ Þ
3
: ð7Þ
Insertion of these geometrical sizes expressed in terms of s and
using the fact that s = 2sin/, f becomes
f ¼
3
2
s
3s2 þ 2
¼

4
sin 
sin2  þ 22=12
: ð8Þ
The revised Lorentz factor Lrev then becomes
Lrev ¼
1
sinð2Þ
sin 
sin2  þ 22=12
: ð9Þ
In contrast to the traditional Lorentz correction the diver-
gence towards infinity for the geometrical term f is prevented
by this model. Instead f converges towards zero at low angles
as a result of the sine term in the numerator in equation (9). At
higher angles f does not deviate much from the simple factor
1/sin; this means that the revised expression would not affect
normal XRPD patterns, which typically start at 2 = 3.
Plotting Lrev for different values of  it is seen that there is a
large effect for small angles compared to the conventional
correction ( = 0 A˚ÿ1; Fig. 6). Combining the geometrical term
f with the original Lorentz term it is seen that the entire
Lorentz factor has a finite value for 2 = 0.
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Figure 6
The entire Lorentz factor given in equation (9) as a function of the
scattering angle 2 (using Cu K1) and resolution d = /(2 sin), for
different sizes of the uncertainty parameter  at small angles.
Figure 5
Three-dimensional model of the intersection of the Ewald sphere and the
shell of reflections. The intersection is the area of a spherical segment
emphasized in grey.
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Abstract. Collecting protein powder diffraction data on standard in-house powder diffracto-
meters requires careful handling of the samples. Specially designed sample holders com-
bined with optimized collimation were found to be the key factors in improving the data 
quality and reducing the data collection time. For safe identification of the crystal form the 
experimental patterns have to be compared with patterns calculated from known crystal 
structures. Very good agreement with Protein Data Bank data was obtained after including 
corrections for background, unit cell parameters, disordered bulk-solvent, and geometric 
factors. The data collection and correction procedures were demonstrated by the identifica-
tion of three different crystal forms of insulin. 
1. Introduction 
Since the first protein structure was refined from X-ray powder diffraction (XRPD) data ten 
years ago [1], high-resolution protein powder diffraction at synchrotron sources has been 
developed and used for refining and even solving small protein structures [2]. Furthermore, it 
has recently been shown that in-house XRPD can be successfully used for the identification 
of different crystal forms of proteins [3,4]. It thereby offers a convenient and quick way to 
characterize crystalline protein precipitate in the laboratory.  
Growing suitable protein crystals of sufficient size and quality is one of the major bottle-
necks in solving protein structures from single-crystal X-ray diffraction experiments. Screen-
ing for the optimal crystallization conditions is trial-and-error based and often gives many 
hits with precipitate. Early powder diffraction characterization of those precipitates would be 
valuable when optimizing the crystallization process. 
Protein crystals contain 30–70 % of disordered solvent and they must be prevented from 
drying out and are thus kept in the mother liquor. Due to the large molecules and the high 
solvent content, protein crystals are soft and in general poor scatterers. Combined with the 
non-Bragg scattering from the surrounding mother liquor and the sample holder, it results in 
poor peak-to-noise ratios (P/N). Minimizing the sample amount and improving the P/N re-
quires careful design of the sample holders and collimators. 
164 European Powder Diffraction Conference, EPDIC 12  
Furthermore, the large unit cells result in Bragg peaks occurring at very low angles and at 
higher angles the reflections are suffering from a severe peak overlap limiting the data reso-
lution to about 4 Å (2  = 2–20° with CuK 1-radiation in our tests).  
Reliable identification of crystal forms requires calculation of realistic protein powder pat-
terns based on for example Protein Data Bank (PDB) coordinate files. Including straightfor-
ward corrections for background, unit cell parameters, disordered bulk-solvent and geometric 
(Lorentz) factors we have obtained very good agreements between measured and calculated 
patterns [3]. The techniques will be demonstrated with data from three crystal forms of insu-
lin. 
2. Collection of protein powder data using in-house equipment 
The diffraction experiments were carried out on a standard in-house Huber G670 diffracto-
meter with a Guinier (transmission) geometry setup using CuK 1-radiation (! = 1.54059 Å). 
The data were recorded on an imaging strip in the range 2–100° in 2 . The diffractometer 
was equipped with an Oxford Cryo-cooler. Crystals were grown in batches containing 2–6 
mg of protein and suitable powder samples were obtained by gently crushing the crystals in 
the mother liquor resulting in a powder slurry. As cryo-protectant glycerol was added for the 
sample used in sample holder model 3 (loop). The samples were mounted in specially de-
signed sample holders. Two sample holders for room temperature measurements and a loop 
for cryo-cooling temperatures (100–120 K) were tested. These are shown in figure 1. The 
sample holder design must fulfil several requirements. In general the major challenge is to 
find a way to support a thin film of wet powder. Firstly, the samples must be kept in sealed 
sample chambers or alternatively kept cryo-cooled in order to prevent the samples from dry-
ing out.  Secondly, data collections are run in transmission mode meaning that the thickness 
of the samples must be as low as possible and the sample chamber windows must be made of 
a material with low absorption and low contribution to the background. Mylar was shown to 
be an ideal choice. Thirdly, the crystallite packing efficiency must be high and homogeneous 
and collimation of the X-ray beam must ensure that it hits the homogeneous part of the sam-
ple in order to maximize the P/N. 
 
 
 
(a) (b) (c) 
Figure 1. Different sample holders for in-house powder diffraction on proteins. The sample holders 
support slurries of protein crystallites in mother liquor. (a) Sample holder model 1 contains 120–150 
µL of sample. (b) Sample holder model 2 contains 10 µL of sample. (c) Model 3: The loop supports 1–2 
µL of cryo-cooled sample. 
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Sample holder model 1 requires approx. 150 µL of sample in an O-ring between two pieces 
of mylar foil. The O-ring and the foil are held in place by two metal discs providing a tight 
fit. Rotation of the sample is possible. Model 2 consists of a polycarbonate plate with a hole 
with mylar windows which are glued to the plate after the sample has been loaded. The sam-
ple size is approximately 10 µL. The polycarbonate holder is mounted on a goniometer head 
with a lead pinhole placed in front to reduce the background level. It is not possible to apply 
rotation of the sample. The holder was easily adaptable to synchrotron beamlines for X-ray 
absorption spectroscopy (XAS) without the lead pinhole. Model 3 is a loop (diameter approx. 
2 mm) where small sample amounts are required. A thin film of wetted powder is easily 
supported on the loop cut from mylar and prevented from drying out by cryo-cooling. The 
loop was used in combination with the lead pinhole from model 2. 
All the sample holders were tested with insulin to compare their performances. Data were 
collected for 4 h for sample holder model 1 and 2 and for 12 h for model 3 (loop). The raw 
powder diffraction patterns from trigonal insulin prior to background subtraction are directly 
compared on figure 2. The peak-to-noise ratios have been calculated for each powder pattern 
in figure 2 and are given as P/N = (IBragg+IBG)/IBG, evaluated at the most intense peak at 2  = 
6.84º.  
 
 
Figure 2. Raw data prior to background subtraction. The patterns have been collected on trigonal 
insulin for 4 h for sample holder model 1 and 2 and for 12 h for model 3. Comparison with calculated 
pattern (bottom), where the intensities have been scaled to the pattern from model 2. 
The effect of reducing the background using the lead pinhole is clearly demonstrated by 
comparing model 1 with model 2. Presently 10 µL of sample is required to collect good 
powder diffraction patterns within hours, but in fact the crystal form can be safely identified 
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in 15 minutes. The sample volumes can be further reduced to 1–2 µL using the loop (model 
3), but at the expense of longer data collection time and poorer P/N. 
3. Data treatment 
The background was subtracted in the program PROTPOW [3] (available from 
http://www.xray.kemi.dtu.dk/English/Computer%20Programs/PROTPOW.aspx) by manu-
ally picking between 10 and 20 background points, fitting to a spline function and subtract-
ing. The manual procedure is necessary to distinguish background from overlapping signal. 
Optimization of the unit cell parameters was done by a full-pattern profile fit. Optimized 
parameters describing the peak width (FWHM) and peak shape of a pseudo-Voigt function 
are included in the pattern fit by PROTPOW. 
 
 
(a) 
(b) 
Figure 3. Comparison of calculated and experimental powder diffraction patterns for trigonal insulin. 
(a) Before correction for disordered bulk-solvent. (b) After correction for disordered bulk-solvent. 
Powder patterns were calculated in PROTPOW from PDB coordinate files using the opti-
mized unit cell and peak profile parameters. In general the peak positions fit well, but with-
out taking into account the disordered bulk-solvent, the intensities fit poorly with the meas-
ured intensities, in particular at low 2 , as seen in figure 3(a). The contribution from the 
solvent was calculated in PHENIX [5] using the flat bulk-solvent model [6] where a constant 
level of electron density is assumed in the voids between the macromolecule. The bulk-
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solvent model takes two parameters ksol defining the level of electron density and Bsol defin-
ing the steepness of the border between the solvent and the macromolecular regions. The 
parameters are refined in today’s single-crystal X-ray structure refinement software, but in 
case no other information is available following average values can be used ksol = 0.35 e Å
–3 
and Bsol = 46 Å
2 [7]. The contribution from the solvent is added to the calculated structure 
factors. The improved fit from the powder pattern based on calculated structure factors is 
seen on figure 3(b). Applying an improved geometrical (Lorentz) factor further improves the 
fit [3]. 
4. Results and discussion 
The applicability of the methods has been demonstrated in a recent study where XRPD was 
used to verify three different conformations (T6, T3R3
f and R6) of hexameric Zn-insulin be-
fore and after EXAFS experiments. The same samples in model 2 sample holders were used 
for both experiments. The differences between the crystal forms are obvious in figure 4.  
 
 
(c) 
(b) 
(a) 
Figure 4. Verification of three different conformations of hexameric insulin before an X-ray absorption 
spectroscopy study. XRPD patterns for insulin powders (a) T6 , (b) T3R3
f and (c) R6. 
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For well known protein structures the XRPD data can be used to identify and verify different 
protein crystal forms. A reliable identification requires that a comparable powder pattern can 
be calculated, which requires a priori knowledge about the space group and the cell parame-
ters, e.g. from a preliminary indexation. An in-house XRPD pre-characterization could be 
applied to conclude that a material is crystalline and from the appearance of low angle reflec-
tion distinguish between protein and salt crystals from the precipitant – also for unknown 
structures. 
5. Concluding remarks 
Collecting XRPD data on well diffracting proteins for identification and verification of 
known crystal forms can be carried out on in-house equipment. Special sample holders are 
required in order to prevent the protein crystallites from drying out, and a careful sample 
preparation as well as an optimized collimation is crucial in order to obtain best possible 
P/N. Further, it is essential that unit cell parameters are optimized for the calculated patterns 
and that the patterns are corrected for solvent scattering. With the sample holder designs 
presented here 1–10 µL of well-diffracting protein powder are required for identification 
within 0.5–2 h. The technique may today be applied to screening of well-crystallized protein 
powders and thus be of interest also to the enzyme production industry where identification 
could be used as a tool for controlling the enzyme products during manufacturing as well as 
for quality control of the final product. By reaching even smaller sample sizes and testing 
“not-so-well” diffracting protein powders the screening of early precipitates for crystals by 
XRPD is now within reach. 
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A sample holder for handling samples of protein for in-house X-ray powder
diffraction (XRPD) analysis has been made and tested on lysozyme. The use of
an integrated pinhole reduced the background, and good signal-to-noise ratios
were obtained from only 7 ml of sample, corresponding to approximately 2–3 mg
of dry protein. The sample holder is further adaptable to X-ray absorption
spectroscopy (XAS) measurements. Both XRPD and XAS at the Zn K-edge
were tested with hexameric Zn insulin.
1. Introduction
During the past decade, X-ray powder diffraction has proven itself
able to solve and refine small protein structures from high-resolution
powder data using synchrotron radiation (see e.g. Margiolaki &
Wright, 2008, and references therein). Powder diffraction patterns
with well resolved peaks can also be obtained from highly optimized
laboratory equipment (Margiolaki et al., 2007), but at the cost of
longer data collection times. However, for a fast characterization and
fingerprinting of protein crystal forms, X-ray powder diffraction
(XRPD) can be carried out on widely used standard laboratory
diffractometers (Hartmann et al., 2010, 2011). This ‘rough’ technique
may be well suited for detection of substrate binding and verification
of different protein conformations of already known
systems (Norrman et al., 2006), and could thereby become
a valuable complementary tool in the laboratory, as well
as for product characterization in the pharmaceutical
industry and enzyme production.
Metalloprotein structure determinations from single
crystals are increasingly complemented by X-ray
absorption spectroscopy (XAS). Quick in-house XRPD
characterization of crystal forms before and after XAS
measurements is indeed possible. In the present note the
design of a sample holder for both in-house XRPD and
XAS is described and tested on lysozyme and two
conformations of hexameric Zn insulin, T6 and R6.
2. Sample holder design
The sample holder was developed for the Huber G670
diffractometer equipped with a flat powder specimen
holder. The holder has been further improved from the
holder used in the study by Hartmann et al. (2010) and is
also adaptable for XAS experiments, as demonstrated by
tests on hexameric Zn insulin. To collect as much signal as
possible on the in-house X-ray sources, the general
principle behind the design is to support a thin film of
protein crystallites with a relatively large surface area.
Rotation of the sample around an axis  orthogonal to the
detector is also important to avoid sedimentation on the
windows and walls of the sample chamber and so to avoid
multiple layers of powder. Schematic drawings and a
photograph of the sample holder are shown in Fig. 1.
The sample holder consists of a 1.0 mm-thick polycarbonate plate
with a hole (either 4.5 or 3.0 mm in diameter, creating sample
chamber volumes of 16 and 7 ml, respectively). Further dimensions
are specified in Figs. 1(a) and 1(b). Metal-free polycarbonate was
chosen to avoid a fluorescence signal from the sample holder, which
for XAS experiments would conflict with the fluorescence signal from
metalloproteins. Small holes have been drilled so that the holder fits
the cryostat (Oxford Instruments, ITC503) available at the 8-11 XAS
beamline at the synchrotron at MAX-lab, Lund, Sweden. The sample
holder takes a small cylindrical volume of protein powder wetted by
its mother liquor, and with a sample thickness of 1.0 mm this holder
still allows the diffractometer to work in transmission mode. The
Figure 1
XRPD sample holder for the Huber G670 diffractometer. (a) Drawing of the individual parts of
the unassembled sample holder. (b) Dimensions of the polycarbonate plate. (c) Photograph of
the sample holder.
sample is sealed by two pieces of mylar foil, which are attached to the
polycarbonate plate with either epoxy glue or double-sided adhesive
tape. For powder diffraction, a lead plate with a pinhole matching the
diameter of the sample chamber is glued on top of the assembled
holder and serves for efficient shielding of the background scattering.
The inner edge profile of the lead plate has been cut at a 45 angle to
prevent shielding of the incoming X-ray beam. The pinhole plate fits
exactly into the flat powder specimen holder at the Huber G670
diffractometer, allowing the sample to be centred in the beam. The
relatively compact shape of the sample chamber eases mounting of
the sample.
3. Experimental
The sample holder was tested on the Huber G670 diffractometer with
protein powder of lysozyme from chicken egg white (Gallus gallus,
95% Sigma Aldrich L-6876) and Zn insulin from bovine pancreas
(Bos taurus, Sigma Aldrich I-5500). Tetragonal lysozyme crystals and
trigonal T6 insulin crystals were grown according to the procedures
described by Hartmann et al. (2010). R6 insulin crystals were grown
with the phenol derivative m-cresol according to the procedure of
Smith et al. (2000). The T6 and R6 insulin crystals were filtered using
an Ultra-free-MC centrifuge filter (Amicon/Millipore) with a pore
size of 0.22 mm, and excess zinc was eliminated by washing the
crystals three times with a solution having a composition similar to
the mother liquors except for containing zinc. Excess mother liquor
was removed and the wetted crystals were gently crushed to a
concentrated homogeneous suspension of protein powder.
The sample holders were loaded with the suspensions taking care
that no air bubbles were trapped in the sample chambers when gluing
the top foil in place. Rotation around  was applied to the samples
and data were collected on two lysozyme samples (16 and 7 ml,
corresponding to approximately 5–6 and 2–3 mg of protein) for 4 h at
room temperature using Cu K1 radiation ( = 1.5406 A˚). The raw
lysozyme powder diffraction patterns are compared in Fig. 2. For Zn
insulin, data were collected for 30 min on 7 ml samples. The raw
powder patterns are shown in Fig. 3, from which the crystal forms can
be distinguished. For these systems, no radiation damage was
observed.
An X-ray absorption spectrum was collected at the Zn K-edge
(9659 eV) on the mounted insulin sample at the XAS beamline 8-11
at the synchrotron at MAX-lab, using an Si(111) double-crystal
monochromator (Carlson et al., 2006). Fluorescence data were
collected at 100 K with a passive implanted planar silicon detector as
three scans of 60 min, which were subsequently averaged. To check
for occurrence of radiation damage the spectra were compared prior
to averaging. No radiation damage was observed. The absorption
spectra at the Zn K-edge are shown in Fig. 4. The extended X-ray
laboratory notes
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Figure 2
XRPD patterns of tetragonal crystals of hen egg white lysozyme prior to
background subtraction. The data collection time was 4 h and Cu K1 radiation ( =
1.5406 A˚) was used. A pattern calculated using optimized unit-cell and peak-shape
parameters is shown for comparison (bottom).
Figure 3
XRPD patterns of trigonal crystals of T6 and R6 insulin prior to background
subtraction. Data were collected on 7 ml of sample for 30 min using Cu K1
radiation ( = 1.5406 A˚). Unit-cell parameters were optimized from a full pattern
profile fit.
Figure 4
XAS spectra of hexameric Zn insulin collected at the ZnK-edge with the combined
XRPD and XAS sample holder. Insets: Extracted and k3-weighted EXAFS spectra.
Data with good signal-to-noise ratios were obtained to 13–14 A˚ÿ1 in k-space.
absorption fine structure (EXAFS) spectra were extracted using
WinXAS (Ressler, 1998).
4. Results
The background intensity levels and the peak-to-noise ratios, P/N,
which are interrelated, were estimated by looking at the raw lyso-
zyme powder patterns presented in Fig. 2. Separating background
from diffraction is, however, not straightforward because of the heavy
peak overlap. The estimation of the background intensity was
therefore done by scaling a calculated pattern to the experimental.
Prior to the calculation of a powder pattern, unit-cell and peak-shape
parameters were optimized using the procedure described by Hart-
mann et al. (2010). The background level, BG, was evaluated as a sum
of intensities I in the 2 range 2–20 by the following equation:
BG ¼
P
IBackgroundP
IBragg þ IBackground
ÿ  100% ¼
P
ITotal ÿ IBragg
ÿ 
P
ITotal
100%;
ð1Þ
where IBragg was evaluated from a calculated pattern that was scaled
to the experimental using PROTPOW (http://www.xray.kemi.dtu.
dk/English/Computer Programs/PROTPOW.aspx). The background
levels for lysozyme were 87.4 and 92.3% for the 16 and 7 ml holders,
respectively.
The P/N ratios and the background levels depend on the colli-
mation of the beam. Pinholes integrated into the design of the flat
specimen sample holder ensure that the beam irradiates only the
homogeneous part of the sample and thereby reduce the background,
in particular at low 2 angles. After an optimization of the beam stop
position, it is possible to measure reflections down to 2.0.
The adaptability of the sample holder was illustrated with insulin,
where the same sample holder was used for XRPD and XAS. This
ensures that both analyses are carried out on exactly the same sample,
which reduces the amount of sample used and the preparation time.
Both T6 and R6 insulin form trigonal crystals belonging to space
group R3, but with different Zn coordination and unit-cell para-
meters. As seen from the powder patterns in Fig. 3, the two crystal
forms are clearly distinguishable, and the difference in Zn coordi-
nation is clearly evident from the absorption spectra shown in Fig. 4.
5. Conclusions
A sample holder for identification and fast characterization of protein
crystal forms by XRPD using a standard laboratory source has been
developed. Optimizing the collimation by pinholes, the design was
improved to operate with sample volumes down to 7 ml, which is
comparable to the performance of capillaries but the samples are
easier to prepare. For metal-containing proteins the improved sample
holder design was successfully applied to samples used for both
powder diffraction and XAS experiments.
Special thanks to Katarina Nore´n for assistance at the XAS
experiments. We acknowledge the workshop at DTU Chemistry for
fabrication of the sample holders and Susanne Helmark for illustra-
tions and the photograph.
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The title compound, poly[[-aqua-tetraaqua{-5-[bis-
(carboxylatomethyl)amino]-3-carboxylatomethyl-4-cyanothio-
phene-2-carboxylato}distrontium(II)] tetrahydrate], [Sr2(C12-
H6N2O8S)(H2O)5]3.79H2O, crystallizes with nine- and eight-
coordinated Sr2+ cations. They are bound to seven of the eight
ranelate O atoms and five of the water molecules. The SrO8
and SrO9 polyhedra are interconnected by edge-sharing,
forming hollow layers parallel to (011). The layers are, in turn,
interconnected by ranelate anions, forming a metal–organic
framework (MOF) structure with channels along the a axis.
The four water molecules not coordinated to strontium are
located in these channels and hydrogen bonded to each other
and to the ranelates. Part of the water H atoms are disordered.
The compound dehydrates very easily and 0.210 (4) water
molecules out of nine were lost during crystal mounting
causing additional disorder in the water structure.
Related literature
For the effect of strontium on osteroporosis, see Schrooten et
al. (2003). For a patent describing the synthesis and powder
diffraction pattern of the title compound, see Horvath et al.
(2008). For related strontium carboxylate structures, see, for
example: Stahl et al. (2006).
Experimental
Crystal data
[Sr2(C12H6N2O8S)(H2O)5]3.79H2O
Mr = 671.84
Triclinic, P1
a = 8.3585 (3) A˚
b = 12.3865 (5) A˚
c = 12.6474 (5) A˚
 = 109.880 (1)
 = 97.148 (1)
 = 105.321 (1)
V = 1154.00 (8) A˚3
Z = 2
Mo K radiation
 = 4.80 mmÿ1
T = 120 K
0.15  0.10  0.07 mm
Data collection
Bruker SMART APEX
diffractometer
Absorption correction: multi-scan
(SADABS; Sheldrick, 2002)
Tmin = 0.574, Tmax = 0.710
17404 measured reflections
6617 independent reflections
5375 reflections with I > 2(I)
Rint = 0.032
Refinement
R[F 2 > 2(F 2)] = 0.033
wR(F 2) = 0.075
S = 1.02
6617 reflections
375 parameters
21 restraints
H atoms treated by a mixture of
independent and constrained
refinement
max = 1.48 e A˚
ÿ3
min = ÿ1.23 e A˚
ÿ3
Table 1
Selected bond lengths (A˚).
Sr1—O8 2.4557 (18)
Sr1—O3i 2.4782 (19)
Sr1—O5 2.5234 (16)
Sr1—O7ii 2.6149 (19)
Sr1—O25 2.652 (2)
Sr1—O22 2.6560 (19)
Sr1—O27 2.657 (2)
Sr1—O8ii 2.7834 (17)
Sr2—O6iii 2.5452 (16)
Sr2—O23 2.5921 (18)
Sr2—O2i 2.6222 (17)
Sr2—O21 2.6445 (17)
Sr2—O6 2.6628 (16)
Sr2—O2iv 2.6848 (16)
Sr2—O1iv 2.6944 (17)
Sr2—O22 2.7108 (18)
Sr2—O5 2.7228 (16)
Symmetry codes: (i) ÿxþ 1;ÿy þ 1;ÿzþ 1; (ii) ÿxþ 1;ÿyþ 1;ÿzþ 2; (iii)
ÿx;ÿy;ÿz þ 1; (iv) x; yÿ 1; z.
Table 2
Hydrogen-bond geometry (A˚, ).
D—H  A D—H H  A D  A D—H  A
O21—H21A  O25 0.81 (2) 1.98 (2) 2.781 (3) 169 (3)
O21—H21B  O24iii 0.85 (2) 1.93 (2) 2.765 (3) 169 (3)
O22—H22A  O2i 0.81 (2) 2.16 (3) 2.761 (2) 131 (3)
O22—H22B  O26iv 0.82 (2) 1.94 (2) 2.755 (3) 173 (3)
O23—H23A  O21iii 0.81 (2) 1.96 (2) 2.766 (3) 174 (4)
O23—H23B  O26i 0.80 (2) 2.11 (2) 2.867 (3) 159 (3)
O24—H24A  O1v 0.82 (2) 2.03 (2) 2.760 (3) 148 (3)
O24—H24B  O4 0.84 (2) 1.93 (2) 2.756 (3) 172 (3)
O25—H25A  N1ii 0.82 (2) 2.15 (2) 2.898 (3) 152 (3)
O25—H25B  O27ii 0.80 (2) 1.93 (2) 2.648 (3) 150 (4)
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D—H  A D—H H  A D  A D—H  A
O26—H26A  O28vi 0.85 (2) 1.90 (2) 2.731 (3) 164 (5)
O26—H26C  N1 0.85 (2) 2.37 (4) 3.108 (3) 146 (5)
O27—H27A  O4i 0.83 (2) 1.79 (2) 2.615 (3) 172 (4)
O27—H27B  O29vii 0.82 (2) 1.94 (2) 2.727 (4) 160 (4)
O28—H28A  O24v 0.80 (2) 1.97 (2) 2.756 (3) 167 (4)
O28—H28B  O28viii 0.82 (2) 2.02 (2) 2.835 (4) 174 (8)
O28—H28C  O29 0.82 (2) 2.04 (3) 2.836 (4) 164 (7)
O29—H29A  O7 0.83 (2) 1.78 (2) 2.595 (3) 168 (7)
O29—H29B  O28 0.83 (2) 2.03 (3) 2.836 (4) 164 (7)
Symmetry codes: (i) ÿxþ 1;ÿyþ 1;ÿzþ 1; (ii) ÿx þ 1;ÿyþ 1;ÿzþ 2; (iii)
ÿx;ÿy;ÿzþ 1; (iv) x; yÿ 1; z; (v) ÿx;ÿyþ 1;ÿzþ 1; (vi) ÿxþ 1;ÿyþ 2;ÿzþ 2;
(vii) x þ 1; y; z; (viii) ÿx;ÿy þ 2;ÿzþ 2.
Data collection: SMART (Bruker, 1999); cell refinement: SAINT-
Plus (Bruker, 1999); data reduction: SAINT-Plus; program(s) used to
solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to
refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics:
ORTEP-3 (Farrugia, 1997) and ATOMS (Dowty, 2000); software
used to prepare material for publication: SHELXL97.
Ms L. Berring and Ms A. Schøneberg are gratefully
acknowledged for the data collection and Dr Stephan
Christgau for supplying the strontium ranelate.
Supplementary data and figures for this paper are available from the
IUCr electronic archives (Reference: SI2343).
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Appendix B
XRD structures of T6 insulin with Rb
and Cs
Insulin was crystallized with monovalent cations of rubidium and caesium, and the struc-
tures were solved. The structures are breifly presented in this appendix.
B.1 Growth of single crystals
The crystals were grown using insulin solutions where the zinc was not chelated and re-
moved prior to the crystallization experiments. Insulin was dissolved in 0.01 M HCl and
pHwas carefully raisedwithNaOHuntil all proteinwas re-dissolved at pH around 7.0 The
protein concentration was determined to 13.0 mgml−1. The crystals were grown using the
vapour diffusion technique. 4 µl of the insulin solution was mixed with 2 µl reservoir so-
lution and 2 µl 0.1 M RbCl or CsCl and equilibrated in a sitting drop against 1 ml reservoir
containing of 1 M ammonium sulfate and 0.05 M sodium citrate. After 2 months small
crystals with dimensions of approx. 100 µmwere observed.
B.2 Single crystal diffraction
Single crystal diffraction data were collected at MAX-lab, Lund, Sweden, on beam line
911-3, MAX-II using a MarResearch CCD detector. The wavelength was 1.00 Å and the
data were collected at 100 K. The structures were refined and validated as described in
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Chapter 7. Data collection, data processing, refinement and validation statistics for all
crystals are summarized in Table B.1.
Table B.1: Data collection parameters, processing-, refinement- and validation statistics.
All data were collected at beam line 911-3, MAX II, MAX-lab, Lund, Sweden. Values in
parentheses are for the outermost resolution shell.
Rb+ insulin Cs+ insulin
Data collection
Detector distance (mm) 263 203
Resolution collected (Å) 2.37 1.92
Data processing
Resolution (Å) 24.15–2.60 (2.68–2.60) 24.29–2.06 (2.31–2.06)
No. of reflections 10137 (886) 29630 (8618)
No. of unique reflections 2500 (223) 5139 (1505)
Redundancy 4.05 (3.97) 5.76 (5.73)
Completeness (%) 99.9 (100.0) 99.9 (100.0)
Rsym (%) 17.5 (79.3) 7.5 (42.8)
〈I/σ(I)〉 7.81 (1.86) 18.43 (4.45)
Space group R3 R3
No. of molecules per asu 2 2
a (Å) 80.93 81.70
c (Å) 33.34 33.40
Average mosaicity (◦) 0.52 0.45
Overall B-factors (Å2) 32 31
No. of atoms in the model
Total non H-atoms 774 840
Total protein atoms 766 795
Total ordered water molecules 6 43
Total M+-ions 2 2
Type of M+ siteI/siteII Rb/Rb Cs/Zn
RMS deviation from ideal
Bonds (Å) 0.01 0.01
Angles (◦) 1.23 1.08
Ramachandran plot
In core regions (%) 98.9 98.9
Outliers (%) 1.1 1.1
R-factors
R 0.1947 0.1891
Rfree 0.2747 0.2272
The structures were refined using the peptide chain from the T6 Zn insulin structure
described in Chapter 7. In the rubidium structure both metal sites were modelled with
rubidium, whereas in the caesium structure one site was modelled with caesium and the
other with zinc. Residues PheB1.1, AlaB30.1, PheB1.2 and AlaB30.2 in the rubidium struc-
ture and residues PheB1.1 and AlaB30.1 in the caesium structure were disordered and
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could not be modelled. In the caesium structure the side chains of residues GluB21.1 and
GluB21.2 were modelled in two alternating conformations. Water molecules were inserted
and restrained refinement was carried out in PHENIX. The atomic displacement factors
for the peptide chain were refined isotropically. Validation of both structures showed that
only one residue SerA9.1 fell into the outlier region in the Ramachandran plot using the
regions defined by Kleywegt & Jones (1996).
B.3 Results
Both the Rb and the Cs structure adopted same comformation as the Zn T6 insulin (RMS
displacement of Cα < 0.4), where the conformation of the backbone of residues B1–B8 was
extended in both structures. The coordination geometries of each metal site are shown in
Figure B.1.
Zn
Cs
Rb
Rb
2.55 Å
3.53 Å
3.12 Å
2.43 Å
2.53 Å
2.07 Å
3.45 Å
2.86 Å
3.63 Å
(a)
(b)
(c)
(d)
Figure B.1: (a) Rubidium site I and (b) rubidium site II in the 2.60 Å Rb insulin structure. The Rb+
cations are possibly seven-coordinated in both sites, however the electron density is too weak in
site I. (c) Caesium site I and (d) site II, which is best modelled by a zinc atom in the 2.06 Å Cs insulin
structure. The Cs+ ion is nine coordinated, whereas the Zn2+ ion shows tetrahedral coordination
geometry. Distances to the first coordination sphere are shown. The σA-weighted 2Fo − Fc maps
have been contoured at 1.0 σ.

Appendix C
EXAFS analysis of Sr reference
compounds
This appendix describes the EXAFS analysis performed at room temperature on selected
strontium salts, which have been used as reference compounds for the EXAFS studies on
strontium containing bone samples.
C.1 Introduction
The positions of Sr-atoms in the pure reference compounds are unambiguously deter-
mined from X-ray crystal structures. Analysing well characterized structures with XAS
means that factors dependent on equipment and experimental design, e.g. the amplitude
reduction factor and the general level of Debye-Waller factors, could be determined.
C.2 Experimental
C.2.1 Samples
The following strontium containing compounds were analysed: Strontium chloride hex-
ahydrate (Merck, analytical grade) strontium disalicylate dihydrate (preparation kindly
provided by J. E. T. Andersen, Technical University of Denmark), strontium hydroxya-
patite (sample kindly provided by H. Birkedal, Aarhus University) and 5 % strontium
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doped calcium hydroxyapatite (preparation kindly provided by J. E. T. Andersen, Techni-
cal University of Denmark).
Preparation of the reference samples were done by grinding the samples in a mortar.
The samples with high strontium contents were diluted 3 to 4 times with boron nitride in
order to obtain a good EXAFS signal. The powder was pressed into tablets and mounted
on the XAS sample holder using kapton tape.
C.2.2 X-ray absorption spectroscopy
SrK-edge X-ray absorption spectra were recorded on beam line 811, MAX-lab, Lund, Swe-
den in accordance to the procedure described in Chapter 11. Room temperature data were
collected in the region 15954–16754 eV except the 5 % Sr-doped CaHA sample where data
were collected to 17003 eV. At least three spectra were collected for each sample to en-
sure reproducibility and that no degradation or radiation damage of the sample had taken
place.
The spectra for each sample were averaged, subtracted for background and normal-
ized before the EXAFS, χ(k) was extracted, as described in Section 3.4. The EXAFS data
reduction and modelling was performed in WinXAS (Ressler, 1998) using ATOMS, which
is a part of the IFEFFIT-package (Ravel & Newville, 2005), to calculate distances from the
strontium absorber to the surrounding atoms and FEFF8 (Ankudinov et al., 1998; Rehr &
Albers, 2000) to calculate the XAFS scattering paths. The model fits were evaluated with
the following residual (Ressler, 1998):
R =
∑N
i=1
∣∣yexp(i) − ytheo(i)∣∣∑N
i=1
∣∣yexp(i)∣∣ · 100% (C.1)
C.3 Results and discussion
C.3.1 Strontium chloride hexahydrate
The crystal structure of SrCl2·6H2O (English & Nassimbeni, 1984), see Figure C.1 was used
as a model for the EXAFS refinement. Distances within a radius of 6.3 Å and Debye-Waller
factors were determined and listed in Table C.1. The energy scale offset ∆E0 was refined
and finally, by keeping the refined distances constant, the amplitude reduction factor σ20
was refined to 0.71. A residual of 3.8 % was obtained. The calculated k3-weighted χ(k)
and its Fourier transform are compared with the experimentally obtained and shown in
Figure C.2.
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(a) (b)
Figure C.1: Strontium chloride hexahydrate crystallizes in space group P321 and the structure
contains Sr2+ cations (orange) coordinated to nine oxygen atoms (red). Chlorine atoms are shown
in olive. (a) The structure viewed along the crystallographic a-axis and (b) along the c-axis.
Table C.1: Sr environment in SrCl2·6H2O within a radius of 6.3 Å, as determined by
X-ray crystallography (English & Nassimbeni, 1984) and EXAFS.
Rj(Å) Rj (Å) σ2j (Å2)
Atom type Nj (X-ray) (EXAFS) (EXAFS)
Oxygen 9.0 2.660a 2.611(9) 0.016(1)
Strontium 2.0 4.12 4.08(4) 0.017(4)
Chlorine 6.0 4.91 4.95(5) 0.021(7)
Chlorine 6.0 5.18 5.18(3) 0.014(4)
Oxygen 12.0 6.43 6.33(6) 0.019(6)
a Weighted average value of 3 oxygen atoms at 2.562 Å and 6 oxygen atoms at 2.709 Å.
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Figure C.2: Left: The background subtracted EXAFS χ(k) as a function of the photoelectronic wave
number k of SrCl2·6H2O. The function is k3-weighted in order to enhance the details at high k-
values. Right: The modulus of the Fourier transform of χ(k) which gives the radial distribution of
electron density around an average Sr. The R-values are not absolute due to a phase shift α.
208 Chapter C. EXAFS analysis of Sr reference compounds
C.3.2 Strontium disalicylate dihydrate
The crystal structure of strontium disalicylate dihydrate (SrC14H14O8·2H2O) has been sol-
ved from XRD (Ståhl, 2009), see Figure C.3 and used as a model for the EXAFS refinement.
Distances within a radius of 4.4 Å from the Sr-atom and Debye-Waller factors were de-
termined and listed in Table C.2. The energy scale offset ∆E0 was refined and finally, by
keeping the refined distances constant, the amplitude reduction factor σ20 was refined to
0.86. A residual of 1.7 % was obtained. The calculated k3-weighted χ(k) and its Fourier
transform are compared with the experimentally obtained and shown in Figure C.4.
(a) (b)
Figure C.3: Strontium disalicylate dihydrate crystallizes in space group C2/c and the structure
contains Sr2+ cations (orange) coordinated to eight oxygen atoms (red). Carbon atoms are shown
in grey. (a) The structure viewed along the crystallographic b-axis and (b) along the c-axis.
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Table C.2: Sr environment in Sr disalicylate dihydrate within a radius of 4.4 Å, as deter-
mined by X-ray crystallography (Ståhl, 2009) and EXAFS.
Rj(Å) Rj (Å) σ2j (Å
2)
Atom type Nj (X-ray) (EXAFS) (EXAFS)
Oxygen 6.0 2.57a 2.53(1) 0.017(1)
Oxygen 2.0 2.77 2.90(1) 0.005(1)
Carbon 2.0 3.07 3.13(1) 0.005(1)
Carbon 2.0 3.67 3.71(1) 0.002(1)
Carbon 2.0 4.15 4.00(3) 0.002(1)
Strontium 2.0 4.17 4.08(3) 0.010(1)
Carbon/Oxygen 4.0 4.35b 4.40(5) 0.017(3)
a Weighted average value of 6 oxygen atoms in the range 2.52–2.64 Å.
b Weighted average value of 2 carbons at 4.33 Å and 2 oxygen atoms at 4.36 Å. The
EXAFS for this shell was modelled by oxygen.
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Figure C.4: Left: The background subtracted k3-weighted χ(k) as a function of the photoelectronic
wave number k of Sr disalicylate dihydrate. Right: The modulus of the Fourier transform of χ(k)
which gives the radial distribution of electron density around an average Sr. The R-values are not
absolute due to a phase shift α.
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C.3.3 Strontium hydroxyapatite
SrHA contains two different Sr-sites, see Figure C.5. Since it is the average strontium en-
vironment which is detected by EXAFS, the average Sr environment have to be calculated
as a weighted linear combination of the Sr(I) and Sr(II) environment which make up 40 %
and 60 % of the Sr-sites, respectively.
Distances Rj and coordination numbers Nj for all composite shells j were calculated
based on the crystal structure (Sudarsanan & Young, 1972). From this analysis a shell
model for Rj < 4 Å for an average Sr atom in the structure could be suggested, see
Table C.3, which as a consequence of the different weighting of Sr-sites, contains non-
integral coordination numbers, Nj . Distances to the same type of atom, which are close to
each other, were grouped into the same composite shells, in analogy to the EXAFS anal-
ysis of CaHA (Harries et al., 1986). The resolution of the different shells was estimated to
π/(2∆k) = 0.16 Å, roughly meaning that distances separated with less than 0.2 Å cannot
be distinguished and was therefore used as a criterion for grouping close-lying shells.
From the refinement of the shell model the distances and Debye-Waller factors were
determined and listed in Table C.3. The energy scale offset ∆E0 was refined and finally,
by keeping the refined distances constant, the amplitude reduction factor σ20 was refined
to 0.89. Only single scattering (SS) paths have been included in the model. A residual of
4.0 % was obtained.
Table C.3: Average strontium environment for hydroxyapatite up to Rj = 4.0 Å away
for the Sr-atom as determined by X-ray crystallography (Sudarsanan & Young, 1972)
and EXAFS.
Rj (Å) Rj (Å) σ2j (Å
2)
Atom type Nj (X-ray) (EXAFS) (EXAFS)
Oxygen 4.8 2.53 2.561(4) 0.021(1)
Oxygen 3.0 2.78a 2.944(4) 0.019(1)
Phosphorus 2.4 3.31 3.53(2) 0.023(2)
Oxygen 1.8 3.47 – b –
Strontium 0.8 3.63 3.679(2) 0.005(1)
Phosphorus 3.0 3.76 3.80(1) 0.010(1)
a Weighted average value of 1.2 oxygen atoms at 2.661 Å and 1.8 oxygen atoms at
2.853 Å.
b The oxygen shell at 3.47 Å could not be modelled separately, but the low Debye-
Waller factor for the 3.63 Å Sr–Sr distance indicate lacking electron density in this
region.
The calculated EXAFS and the Fourier transform of the model are compared with the ex-
perimentally obtained and shown in Figure C.6. Inconsistencies between the data and the
model observed in the low k-region e.g. the shoulder at k = 3.6 Å−1 may be explained
from missing inclusion of path with Rj > 4 Å as well as MS-paths.
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(a)
(b) (c)
Figure C.5: The structure of Sr hydroxyapatite. (a) Overview over the arrangement of atoms,
viewed along the crystallographic c-axis. (b) Schematical representations of the nearest neighbours
at the Sr(I) site and (c) the Sr(II) site, which occupy 40 % and 60 % of the Sr sites, respectively. The
Sr atoms at the Sr(I) and Sr(II) sites are coordinated to nine and seven oxygen atoms, respectively.
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Figure C.6: Left: The background subtracted EXAFS χ(k) as a function of the photoelectronic wave
number k of Sr hydroxyapatite. The function is k3-weighted in order to enhance the details at high
k-values. Right: The modulus of the Fourier transform of χ(k) which gives the radial distribution
of electron density around an average Sr. The R-values are not absolute due to a phase shift α.
C.3.4 5 % Strontium-doped calcium hydroxyapatite
As mentioned in Chapter 9 strontium may have a preference to either of the two crystal-
lographic sites (Bigi et al., 2007; Terra et al., 2009; O´Donnell et al., 2008), depending on the
doping level. From Rietveld refinements of X-ray powder diffraction patterns, see Chap-
ter 11 no significant preference for substitution is seen, why a model, assuming Sr to be
randomly distributed at both sites respecting the different weighting of Ca sites, has been
used. Due to the relatively low doping level (5 %) it is assumed that no Sr atoms have
been substituted at adjacent Ca sites. If the Sr-doping is fully randomised the assumption
seems meaningful as the most probable Sr–Sr distance will be in the range of 10 Å, which
is beyond the limit of what can be detected by EXAFS.
Both CaHA and SrHA form hexagonal crystals belonging to the same crystallographic
space group, P 63/m with a similar structural arrangement. Due to the large radius of a
Sr2+ ion compared to Ca2+ shorter unit cell parameters a and c are observed in CaHA. A
linear relationship has been reported between the unit cell parameters and the doping level
(Bigi et al., 2007; O´Donnell et al., 2008). With a doping level of 5 % the unit cell parameters
could be estimated to a = 9.43 Å and c = 6.88 Å compared to a = 9.41 Å and c = 6.86 Å
for pure CaHA.
A shell model for Rj < 6.3 Å for an average Sr atom in the structure was suggested
from the X-ray structure, Table C.4. Distances and coordination numbers for the shell
model were calculated based on the CaHA crystal structure (Kay et al., 1964) using the
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expanded unit cell parameters. Only the calcium atom at the absorbing atom site were
substituted by strontium, thereby calcium occupies all neighbouring M2+ sites and the
EXAFS contributions from these sites are exclusively modelled by Sr–Ca paths.
Table C.4: Average Sr environment in 5 % Sr-doped CaHA assuming that all neighbouring M2+
sites are occupied by calcium. Distances up to Rj = 6.3 Å away for the absorbing atom have been
calculated from the CaHA structure by Kay et al. (1964) and determined by EXAFS.
Rj (Å) Rj(Å) σ2j (Å2)
Atom type Nj (X-ray) (EXAFS) (EXAFS)
Oxygen 7.8 2.50a 2.495(2) 0.012(1)
Phosphorus 2.4 3.20 3.233(5) 0.006(2)
Oxygen 1.8 3.42 – b –
Calcium 0.8 3.44 3.46(1) 0.012(1)
Phosphorus 3.0 3.60 3.65(1) 0.008(2)
Oxygen 6.0 3.99 – b –
Calcium 8.4 4.06 4.09(1) 0.014(1)
Oxygen 4.2 4.46 4.54(2) 0.004(1)
Oxygen 6.6 4.81 4.93(2) 0.010(4)
Calcium 2.4 5.84 5.80(2) 0.004(1)
Calcium 6.0 6.30 6.30(2) 0.009(1)
a Weighted average value of 4.8 oxygen atoms at 2.40 Å and 1.2 oxygen atoms at 2.51 and 1.8
oxygen atoms at 2.76 Å. Experimental data are best modelled by a single shell at 2.50 Å with
Nj = 7.8, resulting in a higher Debye-Waller factor.
b The oxygen shells at 3.42 Å and 3.99 Å could not be modelled separately, however low Debye-
Waller factors in the nearby regions indicate lacking electron density.
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Figure C.7: Left: The background subtracted EXAFS χ(k) as a function of the photoelectronic wave
number k of 5 % Sr-doped CaHA. The function is k3-weighted in order to enhance the details
at high k-values. Right: The modulus of the Fourier transform of χ(k) which gives the radial
distribution of electron density around an average Sr. The R-values are not absolute due to a phase
shift α.
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The shell model was refined and the distances and Debye Waller factors were deter-
mined and presented in Table C.4. σ20 was refined to 0.81 by keeping the distances con-
stant. The calculated EXAFS and the Fourier transform of the model are compared with
the experimentally obtained and shown in Figure C.7. Inconsistencies between the data
and the model observed in the low k-region may be explained from missing inclusion of
MS-paths. Comparing the results with that of pure SrHA a larger k-space (2.5–11.0 Å) is
seen because data were collected over a larger range and the shells are thus better resolved.
The distances of the shells are different in the two cases although the general arrangement
of atoms in the structure are similar, but due to the larger unit cell parameters in pure SrHA
the distances are changed. This is found as the explanation for why the oxygen distances
between 2.4 and 2.8 Å are grouped into the same shell, whereas the inner O-shell could be
resolved in two shells for pure SrHA.
C.4 Conclusions
EXAFS spectra have been collected on four Sr compounds, all with Sr coordination to
oxygen. A typical Sr–O bond distances has been determined to 2.5–2.7 Å and the Debye-
Waller factors generally fall within a range of σ2 = 0.005−0.025Ådepending on the degree
of static disorder. Amplitude reduction factors, S20 were determined to be around 0.8–0.9,
except for SrCl2·6H2O, where it was 0.71.
Appendix D
EXAFS analysis of Sr in bone
This appendix describes a pre-study of strontium location in bone samples with EXAFS
performed at room temperature.
D.1 Experimental
The bone samples originated from three different clinical tests: femur from dogs treated
with Sr malonate for 4 weeks, calvariae from dogs treated with Sr malonate for 52 weeks
(see Chapter 11) and spine from rats treated with Sr malonate for 26 weeks. Each series in-
cluded three dose levels giving a total number of nine samples. The amounts of strontium
have been determined by ICP-MS by Anders C. Raffalt and reported elsewhere, (Raffalt,
2011).
Bone samples from clinical tests with strontium containing medicaments were prepared
as tablets. A representative fragment of a bone was crushed to a powder and pressed to a
tablet and mounted on the XAS sample holder using kapton tape. Data collection and data
treatment was analogue to the procedure described in Chapter C.
D.2 Results and discussion
D.2.1 Qualitative comparison of EXAFS spectra
The background subtracted and k3-weighted EXAFS spectra and the radial electron den-
sity distributions are respectively shown in Figure D.1 for dog femur (a) and (d), dog cal-
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varia (b) and (e), and for rat spine (c) and (f ). Each test group consists of three samples
which have been treated with Sr-medicament in three different dose levels: Highest dose
(red), medium dose (orange) and lowest dose (yellow). All spectra are compared with the
data from 5 % Sr-doped CaHA (grey spectra in Figure D.1).
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Figure D.1: (a)–(c) The background subtracted and k3-weighted EXAFS function, χ(k), for (a) dog femur,
(b) dog calvaria and (c) rat spine. (d)–(f ) The radial electron density distribution given as the modulus of
the Fourier transform of χ(k), for (d) dog femur, (e) dog calvaria and (f ) rat spine. The R-values are not
absolute due to the phase shift α. Each series consists of three samples with different dose level: Highest
dose (orange), medium dose (olive) and lowest dose (blue). The EXAFS function and the radial electron
density function for 5 % Sr-doped CaHA are plotted in grey for comparison. Glitches are observed at
9.8 Å−1.
A qualitative comparison of all the spectra reveal a high similarity among the bone sam-
ples. The local environment for Sr ions is thereby be expected to be quite similar. Com-
paring the radial electron distribution functions for the bone samples with the one for the
5 % Sr-doped CaHA, Figure D.1(d)–(f ), it is observed that the coordination shells occur at
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similar distances Rj from the absorbing Sr-atom, which gives an evidence for the incor-
poration of strontium ions in the hydroxyapatite structure by substitution of the calcium.
From the relative heights of the peaks it seen that strontium is not exclusively present as
hydroxyapatite, but may coordinate to other material with distances around 2.5 Å, e.g.
oxygen atoms in collagen and/or water.
A quantitative EXAFS analysis were tried by a linear combination fit in analogy to that
described in Chapter 11. However no sample containing a disordered form of strontium
(e.g. Sr in solution or Sr absorbed in collagen fibres) was included in this RT-study. Per-
forming a linear combination analysis using the spectra of Sr-doped CaHA collected at RT
and the collagen and strontium solution collected at 100 K as reference samples result in
bad fits (R > 10 %), as the distances to the first coordination shell is different at the two
temperatures. The periodical difference of the main oscillation, which originates from the
first coordination shell, is directly observed when EXAFS spectra collected at respectively
RT and 100 K are compared.
D.2.2 EXAFS modelling using the shell approach
A shell model was fitted to the EXAFS spectrum from dog calvaria (highest dose) using
the EXAFS model from Sr-doped CaHA presented in Appendix C as an initial model. The
shell model was refined and the distances and Debye-Waller factors were determined and
presented in Table D.1. The calculated EXAFS and the Fourier transform of the model are
compared with the experimentally obtained and shown in Figure D.2.
Table D.1: Strontium location in dog calvaria (high dose) Rj < 5.0 Å as determined
by fitting a model to the EXAFS data using the shell approach. The model has been
compared with the EXAFS results for 5 % Sr-doped CaHA.
Dog calvaria 5 % Sr-doped CaHA
Atom type Nj Rj(Å) σ2j (Å
2) Rj (Å) σ2j (Å
2)
Oxygen 7.8 2.525(2) 0.015(1) 2.495(2) 0.012(1)
Phosphorus 2.4 3.24(2) 0.010(1) 3.233(5) 0.006(2)
Calcium 0.8 – a – 3.46(1) 0.012(1)
Phosphorus 3.0 3.57(4) 0.015(6) 3.65(1) 0.008(2)
Calcium 8.4 4.14(4) 0.019(5) 4.09(1) 0.014(1)
Oxygen 4.2 – a – 4.54(2) 0.004(1)
Oxygen 6.6 4.89(5) 0.011(4) 4.93(2) 0.010(4)
a These shells could not be included in the model.
Most of the shells from the Sr-doped CaHA can be adopted in the bone model. How-
ever, higher uncertainties as well as higher Debye-Waller factors was observed in the bone
model, indicating a higher disorder among strontium. This is in agreement with previ-
ously reported EXAFS studies on calcium in which its coordination in bone tissue and in
ordered apatites has been compared (Harries et al., 1988). However the chemical informa-
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tion from the shell model is limited as it can only be concluded that strontium is disordered
and not how it is disordered.
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FigureD.2: Left: The background subtracted EXAFS χ(k) as a function of the photoelectronic wave
number k of dog calvaria treated with Sr malonate for 52 weeks. The function is k3-weighted in
order to enhance the details at high k-values. Right: The modulus of the Fourier transform of χ(k)
which gives the radial distribution of electron density around an average Sr. The R-values are not
absolute due to a phase shift α.
D.3 Conclusions
XAS data were collected at room temperature to study the strontium location in bone sam-
ples were presented. The qualitative comparison of EXAFS spectra shows high similarity
in strontium coordination in different bone samples. A comparison with Sr-doped apatite
indicates that the strontium ions partly substitute some of the calcium atoms in the apatite
structure and partly is present at highly disordered sites, in which it may coordinate to
other biological material, probably collagen and water. Using the shell approach to fit a
model for a bone sample to the EXAFS resulted in higher Debye-Waller factors, as com-
pared to Sr-doped CaHA. Hence a higher disorder of strontium in the bone tissue can be
concluded, but themodel does not contain information about how strontium is disordered,
which illustrates the weakness of the shell approach.


